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p73 is a member of the p53 family of transcription factors. It shares similar 
properties to p53 such as the induction of genes required for regulating cell arrest 
and apoptosis. Genetic evidences have established an important role of p73 as a 
tumor suppressor. In addition, p73 has been also demonstrated to play vital pro-
apoptotic role in regulating chemotherapeutic drug sensitivity. However studies of 
p73 function is complicated by the expression of numerous N- and C-terminal 
variants. DNp73, an alternate promoter expressed N-terminal p73 variant blocks 
both p53 and p73 pro-apoptotic functions. In human cancers, p73 is rarely found 
mutated but often over-expressed. Other studies have also found that both full-
length p73 and DNp73 have the ability to regulate growth promoting factors. 
Hence suggesting that p73 have unique roles in regulating cell death as well as 
growth and survival. We show in this research proposal that p73 is capable of 
both playing a pro-apoptotic role in mitotic cell death as well as a survival role in 
up-regulation of anti-apoptotic caspase-2S gene. 
Mitotic cell death is a form of cell death that is triggered upon prolonged mitotic 
cell arrest. Although many chemotherapeutic drugs trigger mitotic cell death, the 
mechanism is unknown. In this PhD project, we found that p73 but not p53, is 
important for inducing mitotic cell death. Cells lacking p73 or cells in which p73 
expression is silenced are resistant to mitotic cell death. The phenomenon is not 
due to the potential p73 regulation on spindle checkpoint proteins bubr1 and 
mad2, but instead, is due to the inability of p73 knockout cells to trigger 
mitochondria permeabilization. Cytochrome c release from the mitochondria and 
activation of caspases are defective in p73-silenced cells. This is found to be due 
to the requirement of p73 to trans-activate bim. Bim is a BH3-only protein, which 
interact with other Bcl-2 family members to permeabilize the mitochondria 
membrane upon apoptotic signal. p73 knockout cells have reduced levels of bim. 
Bim silenced cells are also resistant to mitotic cell death. Lastly, p73 can bind to 
bim promoter and induce bim expression. Together, our data define a critical 
regulatory role for p73 in inducing mitotic death, which occurs independently of 
p53.  
 vii
In addition, we have discovered caspase-2S to be a novel target gene of p73. 
Caspase-2S is a smaller variant of caspase-2 and is known for promoting survival 
instead of cell death. Ectopic expression of p73 do not affect the transcript level 
of any other caspases tested except caspase-2S. The induction of caspase-2S is 
unique to p73β and DNp73β but not p73α, p53 or p63. This induction of caspase-
2S by p73β depends on a 22 bp unique p73β recognition sequence. Additionally, 
we are able to demonstrate direct binding of p73 to this recognition sequence on 
caspase-2S promoter. Lastly, Sh5y neuroblastoma cells stably expressing DNp73β 
have higher caspase-2S levels and are resistant to cell death induced by serum 
starvation. 
Overall, we have demonstrated a dual role of p73 in regulation of cell death: first 
as a pro-apoptotic protein involved in mitotic cell death, and secondly as an anti-
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1.1 p53 tumor suppressor family 
The family of transcription factors consists of three members; p53, p63 and p73. 
The p53 family suppresses tumor formation through induction of genes necessary 
for apoptosis or cell cycle arrest. It does that by binding to p53-responsive 
elements located in the promoters of the target genes, and either transcriptionally 
activate or repress target genes. The p53 family members share significant 
sequence homology with each other (Irwin and Kaelin, Jr., 2001). Each of them 
consists of a N-terminus trans-activation domain, a central DNA binding domain 
and a C-terminus regulatory domain (Illustration 1). All three p53 family 
members can trans-activate overlapping subset of p53 target genes due to the 










Illustration 1: Primary protein structure of the p53 family of tumor suppressor. 
TA: transactivation domain, DBD: DNA binding domain, OD: oligomerization 
domain, SAM: sterile α motif domain. The numbers are the amino acid length of 
each protein. ∆N variants, which lack the TA domain is generated by alternate 
promoter usage.  
 
p53
1 45 113 290 319 363
TAp73α
1 54 131 310 345 484380 549
DNp73α
TAp63α
1 59 142 321 353 506397 571
DNp63α
TA DBD OD SAM
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1.1.1 p53 
Interestingly, p53, which is the first member of the p53 family to be discovered 
more than 26 years ago, was originally believed to be an oncogene (Lane and 
Crawford, 1979; Linzer et al., 1979). However subsequent experimental data 
proved otherwise and p53 was instead shown to be an essential component of the 
tumor suppression network (Vogelstein et al., 2000). More importantly, knockout 
of p53 in mice result in spontaneous tumor formations (Donehower et al., 1992). 
Conversely, over-expression of p53 kills the cells. Thus endogenous levels of p53 
must be kept extremely low. This tight regulation is mainly achieved at the level 
of the protein stability. p53 is rapidly degraded by Mdm2 and MdmX, both E3 
ubiquitin ligases that bind to and ubiquitinate p53, tagging it to proteasome for 
degradation. So tight is this regulation of p53 protein that embryonic lethality of 
Mdm2-/- and MdmX-/- mice can only be rescued by concomitant deletion of p53 
(Jones et al., 1995; Parant et al., 2001). p53 is activated by a variety of cellular 
stresses ranging from DNA damage to aberrant hyperproliferative signals. DNA 
damage and cytotoxic stress mainly work by stabilizing p53 via phosphorylation 
of p53 by upstream kinases such as ataxia telangiectasia mutated (ATM) and 
Chk2. Phosphorylation of p53 results in its dissociation from Mdm2/MdmX as 
well as recruitment of co-activators. Aberrant hyperproliferative signals from 
human cancer cells on the other hand usually result in activation of p14ARF which 
trigger the dissociation of p53 from Mdm2 thus stabilizing and activating p53 
(Stott et al., 1998). Once activated, p53 can promote either apoptotic cell death or 
growth arrest through trans-activation or repression of wide array of target genes.  
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However the decision of when to trigger apoptosis or cell cycle arrest by p53 
remains unclear. Besides transcriptional activation to regulate apoptosis, p53 has 
also been shown to regulate cell death via a transcriptional independent manner. 
p53 binds to anti-apoptotic Bcl family member Bcl-2 and Bcl-XL thereby freeing 
Bax, which in turn permeabilizes the mitochondrial membrane leading to 
activation of caspases and cell death (Chipuk and Green, 2004; Leu et al., 2004; 
Mihara et al., 2003). However these data are controversial to whether p53 exist in 
complex with Bcl-2 during normal or stress conditions and whether additional 
input is required before cell death is triggered. 
 
1.1.2 p63 
Two genes with significant homology to p53 were discovered eight years ago, 
named p63 and p73 (Jost et al., 1997; Kaghad et al., 1997; Yang et al., 2002). p63 
gene generates numerous different protein isoforms because of transcription from 
an alternate promoter located at the third exon as well as because of post-
transcriptional splicing events at the C-terminal of the transcripts. Alternate 
transcription generates either transcription capable p63 (TA-p63) or transcription 
deficient p63 (DN-p63). Unlike p53 null mice, which develop spontaneous 
tumors, p63 knockout mice die at birth (Mills et al., 1999). The pups develop 
numerous developmental defects, ranging from absence of apical ectodermal 
ridge, which is an embryological structure required for limb outgrowth, to 
absence of structures required for ectodermal-mesenchymal interactions during 
morphogenesis. These pups also have abnormal epidermal and p63 was shown to 
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be important for epithelial development (Koster and Roop, 2004; Koster et al., 
2004). Evidence suggests that the role of both TA-p63 and DN-p63 are important 
for epithelial development (Ihrie et al., 2005; Lee and Kimelman, 2002). In 
addition, p63 has also been implicated in neuronal and ovary oocytes apoptosis 
(Jacobs et al., 2004; Suh et al., 2006). 
 
1.1.3 p73 
Like p63, p73 has numerous N- and C-terminal isoforms, capable of trans-
activation (TA-forms) or dominant negative effect (DN-forms). However the 
phenotype of p73 knockout animals are vastly different from that of p63. p73-/- 
mice, though born alive, are runted and die within a few weeks of postnatal birth 
(Yang et al., 2000). The p73-/- mice develop immunological problems such as 
chronic inflammation, and nervous system defects such as hippocampal 
dysgenesis, olfactory neuron defects and sympathetic neuron loss (Pozniak et al., 
2000; Yang et al., 2000). However studies on mechanism underlying these 
phenotypes have been complicated due to the presence of multiple protein 
isoforms with opposing functions (TA- and DN- isoforms). For example, 
developmental sympathetic neuron cell death have been shown to be partially 
dependent on p53, thus it was expected that p73-/- mice will also show enhanced 
survival in its sympathetic neurons. However researchers found dramatic decrease 
in sympathetic neuron number in p73-/- mice sympathetic superior cervical 
ganglion (SCG) (Ponziak et al., 2000). This was because predominant form of 
p73 in SCG is the DN-isoforms. Nerve growth factor (NGF) deprived sympathetic 
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neurons result in decrease in DN-p73 expression and subsequent cell death, which 
can be rescued by DNp73 overexpression. This anti-apoptotic role of DNp73 is 
partially through antagonizing the apoptotic role of p53 (Zaika et al., 2002). 
 
1.1.3.1 p73 and cancers 
p73, unlike p53, is rarely lost or mutated in cancers. Extensive mutational analysis 
have failed to uncover significant p73 mutations in human cancers (Moll and 
Slade, 2004). Instead, overexpression of p73 mRNA and/or protein relative to the 
respective normal tissues has been demonstrated in a large variety of tumor types, 
including neuroblastoma, glioma, breast, lung, colon, stomach, ovarian, bladder, 
liver, cholangiocellular carcinoma, ependymoma, chronic myelogenous leukemia 
and acute myelogenous leukemia (Moll and Slade, 2004). Up-regulation of p73 in 
cancers is not restricted just to the DNp73 isoforms, but also to the TA-p73 
isoforms. While the over-expression of DNp73 in cancers can contribute to 
increase resistance to cell death through antagonizing p53 functions, the reason 
for over-expression of TA-p73 in cancers is not well understood. It could either be 
a response to control tumor development or a contributing factor to tumorigenesis 
in human cancers. Increasing evidence suggest the latter reason is more likely. 
Gastrin, a secreted peptide hormone that promotes cell growth and survival in 
gastrointestinal cells, has been shown to be regulated by p73 (Tomkova et al., 
2006). The authors further showed that over-expression of gastrin correlated with 
over-expression of TA-p73 isoforms in human gastric cancers. In addition, our lab 
have shown that over-expression of TA-p73, together with c-jun, can drive the 
 7
expression of cyclin D and collagenase, further suggesting a role of p73 in 
tumorigenesis (Vikhanskaya et al., 2007). 
Nonetheless, ectopic expression of p73 can induce apoptosis. Many 
chemotherapeutic drugs trigger apoptosis through activation of p73 (Irwin et al., 
2003). Current research suggests that p73 triggers apoptosis via two pathways 
(Ramadan et al., 2005). The first is via the trans-activation of scotin. Scotin 
induces endoplasmic reticulum stress, calcium release and caspases dependent 
apoptosis. The second pathway is through trans-activation of PUMA. Puma 
mediates Bax conformation change and translocation to the mitochondria where it 
triggers cytochrome c release.  
Therefore p73 appears to possess opposing functions in regulating cell death as 
well as tumorigenesis. Although the idea seems radical, it is not restricted just to 
p73 alone, as many other genes also have such dual ability e.g. E2F-1, c-myc and 
c-jun, suggesting deep complexity of p73 regulation and function (Secombe et al., 
2004; Eferl and Wagner, 2003; Bell and Ryan, 2004). 
 
1.1.3.2 p73 regulation 
Under normal circumstances, endogenous p73 protein levels are kept extremely 
low in the cells, implying its tight regulation. Given the similarity between p53 
and p73, it is not surprising that mdm2 will be able to degrade p73. Although 
mdm2 does bind to p73, this interaction stabilizes instead of degrading p73 
(Wang et al., 2001; Zeng et al., 1999).  The task of keeping p73 levels low in the 
cells is dependent on a HETC-E3-ubiquitin ligase, Itch, which targets p73 for 
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protein ubiquitination in a highly specific manner (Rossi et al., 2005). This 
regulation depends on the binding of p73 through its proline rich domain to the 
WW domain of Itch. Knockdown of Itch results an in increase in levels of 
endogenous TA- and DN-p73 isoforms. However, unlike mdm2, Itch null cells 
survive, indicating the presence of other mechanisms that regulate p73 levels. 
Indeed, p73 can be degraded via a Nedd8 conjugation pathway. Using a cell line 
containing temperature labile Nedd8 activation enzyme, the authors were able to 
show that upon inactivation of the enzyme, p73 protein level but not p53 
accumulate (Bernassola et al., 2004). Physiologically, Nedd8 conjugation to TA-
p73 was shown to be dependent on Mdm2 (Watson et al., 2006), though this 
finding contravene that of earlier studies showing Mdm2 stabilize p73. 
Transcriptionally, p73 is up-regulated by E2F-1, a G1/S regulating protein (Stiewe 
and Putzer, 2000). The ectopic expression of E2F-1 results in apoptosis, which is 
dependent on p73. Another group demonstrated that E2F-1 up-regulation of p73 
happens in the presence or absence of DNA damage (Urist et al., 2004). This 
raised the possibility that p73 may be cell cycle regulated and expressed at the 
G1/S stage of the cell cycle.  
 
1.1.3.3 p73 protein modifications 
Like p53, p73 transcriptional and apoptotic activities are also regulated post-
transcriptionally. Cisplatin treatment results in phosphorylation of tyr-99, ser-289 
at p73 by c-abl and protein kinase Cδ catalytic fragment respectively (Agami et 
al., 1999; Gong et al., 1999; Ren et al., 2002). In addition, cisplatin treatment also 
 9
results in phosphorylation of p73 at position ser-47 by Chk1 (Urist et al., 2004). 
The phosphorylation on p73 after DNA damage, allows the interaction of p73 
with Pin1, which is a peptidy-prolyl cis/trans isomerase (Urist and Prives, 2004; 
Mantovani et al., 2004). Pin1 dependent p73 prolyl isomerization, results in p73 
stabilization and ultimately the increase in its activity. Other forms of DNA 
damage agents such as doxorubicin have been shown to induce acetylation of p73 
by p300 (Zeng et al., 2000). All in all, modifications such as phosphorylation and 
acetylation of p73 upon DNA damage stabilize p73 and increase its pro-apoptotic 
ability (Illustration 2). 
In the non-stressed state, TA-p73 is phosphorylated in a cell cycle dependent 
manner. During mitosis, TA-p73 is phosphorylated by cdk1/cyclinB, which in 
turn decreases the ability of p73 to bind to DNA and activate transcription in 
mitotic cells (Fulco et al., 2003). Upon mitotic exit, p73 is hypo-phosphorylated 
and this modification seems to be important in regulating mitotic to G1 transition 



















Illustration 2: Post-translational modifications on p73 after DNA damage (Ozaki 
and Nakagawara, 2005). DNA damage induces phosphorylation of p73 by c-abl, 
chk1 and PKCδ. The phosphorylation in turn recruits other modifiers e.g. p300 to 
acetylate p73 and pin1 which induces p73 prolyl isomerization. These 





1.1.4 p53 family in apoptosis and as tumor suppressors 
Despite the numerous conflicting and confusing data on different isoforms of p63 
and p73 in regulating apoptosis or tumorigenesis, genetic data suggest that the key 
role of p53 family is in regulating cell death and tumor suppression. p53, together 
with p63 and p73 have been shown to play an important role in apoptosis in 
various biological systems (Flores et al., 2002; Irwin and Kaelin, Jr., 2001; 
Melino et al., 2003). Efficient apoptosis requires all the three p53 family 
members. This was demonstrated using genetic experiments where E1A-
transformed mouse embryonic fibroblasts (MEFs), lacking in p63 and p73, cannot 
undergo apoptosis after DNA damage, despite the presence of p53 (Flores et al., 
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2002). These experiments suggest that DNA damage activates either a single 
apoptotic pathway, which involves all three p53 family members, or activate 
several different apoptotic pathways, where individual p53 members acts 
separately to induce efficient cell death. However the data could not explain why 
p63 and p73 null mice do not develop spontaneous tumors like p53 null mice. The 
suspicion was because p63 and p73 null mice do not live long enough for tumor 
development. True enough, p73+/- and p63+/- mice, which survive, developed wide 
array of tumor phenotype (Flores et al., 2005). In fact, mice heterozygous for both 
p53 and p73 develop higher tumor burden as well as more metastatic tumors than 
p53+/- alone, suggesting p53 family members act through different mechanisms 
for tumor suppression. Together these data support the important role of p53 
family as tumor suppressors, at least in murine genetic systems. 
 
1.2 Control of genomic integrity 
The presence of abnormal chromosomal content is one of the most common 
hallmarks of cancer. The acquisition of abnormal chromosomal content is largely 
in part due to the lost of control checkpoints to remove abnormal cells from the 
system. The integrity of the genome is frequently challenged by DNA strand 
breaks caused by oxidative stresses induced by cellular metabolic activities, 
exposure to uv-irradiation and environmental agents capable of interacting with 
DNA. The p53 family plays an important role to maintain and prevent this lost of 
genomic integrity. Cellular surveillance mechanisms in normal cells help to detect 
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and repair the genome damage to ensure genomic integrity to the subsequent 
generations of cells.  
 
1.2.1 G1 checkpoint 
The most well studied checkpoint is that of the G1/S checkpoint or DNA damage 
checkpoint. This checkpoint prevents the replication of damaged DNA by 
arresting the cell at G1 phase of the cell cycle to allow the genome to be repaired 
or to initiate cell death. Central to this DNA damage response is p53, which 
activate a plethora of genes required for cell cycle arrest e.g. p21, p16, p57, for 
DNA repair e.g. GADD45, and for apoptosis e.g. Bax, Puma, 53AIP (Harris and 
Levine, 2005). Although how p53 decides to trigger either cell cycle arrest or 
apoptosis remains unclear. It is likely to depend on the extent of the DNA 
damage. If repair can be carried out cell cycle arrest may be triggered but if 
damage is too extensive, apoptosis ensures. In addition, the decision is also found 
to be cell type dependent; fibroblasts prefer arrest while lymphocytes and stem 
cells chose apoptosis upon DNA damage. Whatever the case, cells without p53 
have a defective DNA damage checkpoint and will continue progress into the S 
phase to duplicate its genome and enter G2 phase of the cell cycle with the 
mutated DNA.   
 
1.2.2 G2 checkpoint 
At the G2 phase of the cell cycle, cells with damaged DNA are arrested at the 
G2/M checkpoint. Unlike G1/S checkpoint, G2/M checkpoint can be maintained in 
 13
the absence of p53. Rather G2/M checkpoint is dependent on the cdc25 and cdk1 
interaction (Taylor and Stark, 2001). Under normal condition, cdc25 phosphatase 
removes inhibitory phosphorylation on cdc2 kinase, which allows it to complex 
with cyclin B1 and to drive cell into mitosis. DNA damage activates checkpoint 
kinases such as Chk1 and Chk2, which phosphorylate cdc25, keeping it inactive. 
Without dephosphorylation of Thr-14 and Tyr-15 on cdc2 by cdc25, cells arrest at 
G2 phase until the damage is repaired.  
 
1.2.3 Spindle checkpoint 
In the event where both G1 and G2 checkpoint are defective, cells with damage 
DNA can then enter mitosis where they encounter another checkpoint, the spindle 
checkpoint. The main responsibility of the spindle checkpoint is to ensure equal 
segregation of genetic material to each of the daughter cells during cell division 
(May and Hardwick, 2006). It occurs during metaphase of mitosis and it prevents 
anaphase transition until all chromosomes have obtained bipolar attachment. Cells 
with damaged DNA often fail to achieve stable bipolar chromosome alignment 
and arrest at this stage. Normal cells whose sister chromatids are aligned along a 
single plane and achieve bipolar attachment are allowed to enter anaphase. The 
entry into anaphase depends on the destruction of the cyclin B/cdk1 activity by 
anaphase promoting complex (APC), the critical component of the spindle 
checkpoint (Nigg, 2001). APC is a complex of 13 core subunits and either of the 2 
loosely associated regulatory subunits, cdc20 and cdh1 (Thornton et al., 2006). 
APC is an E3 ubiquitin ligase that ubiquitinate proteins whose degradation is 
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necessary for anaphase progression. APC is directed by regulatory subunit cdc20 
to its targets proteins during metaphase-anaphase transition. Besides cyclin B, 
another important target of APC is securin, whose degradation allows the release 
of separase which in turn cleaves cohesins, glue-like protein complexes holding 
sister chromatids together during mitosis, thus allowing chromatids to separate 
during anaphase towards opposing poles. In the cells, the spindle checkpoint is 
kept active through the binding of inhibitory proteins BubR1 and Mad2 to the 
APC. Only upon satisfaction of the chromatin alignment will this inhibitory 










Illustration 3: Molecular mechanism of chromosome segregation. At the 
metaphase-anaphase transition, APCcdc20 ubiquitinates securin and cyclin B. This 
results in the degradation of securin and cyclin B by the proteoasome. 
Degradation of securin activates separase, which then cleaves the Scc1 subunit of 
cohesion, allowing chromosome segregation. In response to sister chromatids not 
properly attached to the mitotic spindle, the spindle checkpoint promotes the 
assembly of checkpoint protein complexes that inhibit the activity of APC/C, 
leading to preservation of sister chromatid cohesion and delay in the onset of 




1.3 Mitotic catastrophe   
Failure of cells to overcome the spindle checkpoint can trigger mitotic 
catastrophe, which is a form of cell death resulting from abnormal mitosis 
(Roninson et al., 2001). It is the final mechanism in the cell cycle whereby cells 
with compromised genomic integrity are killed to prevent subsequent generation 
of cells from acquiring abnormal chromosomes number or mutated DNA. Many 
anti-cancer drugs work by acting on this stage of cell cycle checkpoint e.g. 
paclitaxel, docetaxcel, vincristine (Kisurina-Evgen'eva et al., 2006). These drugs 
act by interfering with microtubule dynamics, thus preventing proper alignment of 
sister chromatids. The cells treated with these drugs such as taxol arrest in mitosis 
due to abnormal spindle and subsequently undergo cell death (Illustration 4). 
Mitotic catastrophe can also be triggered by removal of certain genes regulating 
mitosis e.g. Plk1 (Liu and Erikson, 2003). Phenotypically, plk1 silenced cells 







Illustration 4: Spindle defects produced by anti-mitotic drug Taxol. A: A normal 
bipolar spindle of untreated cells at metaphase. B: Taxol-stabilized microtubules 





1.3.1 How mitotic arrest results in apoptosis? 
The morphological characteristics of cell death in mitotic catastrophe are similar 
to normal apoptosis such as membrane blebbing and DNA laddering. 
Mitochondria membrane permeabilization with release of cytochrome c and 
activation of caspase-9, caspase-2 and caspase-3 have also been described 
(Castedo and Kroemer, 2004). However despite the wealth of information, the 
sensory mechanism linking mitotic arrest to cell death remains unclear. For 
example what triggers the apoptotic processes during mitotic arrest? Is it the 
activation of the spindle checkpoint components? This hypothesis although 
reasonable, is unlikely to be the trigger because even during normal mitosis, 
spindle checkpoint is activated until the chromosomes are aligned, albeit for a 
shorter period of time compared with drugs induced spindle checkpoint arrest. 
This phenomenon suggests perhaps the length of time the cells spend in mitosis 
could be the determinant whether apoptosis will be triggered. Recently published 
work support the timing theory. They show that the inhibitory phosphorylation of 
caspase-9 by cdk1/cyclin B prevents the cells in mitosis to undergo apoptosis. 
Prolonged mitosis results in the gradual decay of cdk1 activity caused by cyclin B 
degradation which will trigger the activation of caspase-9 and thus apoptosis 
(Allan and Clarke, 2007). In addition, prolonged mitotic arrest bought about by 
inhibition of APC can also trigger mitotic catastrophe (Margottin-Goguet et al., 
2003; Teodoro et al., 2004). The prolonged inhibition of APC results in prolonged 
cdk1 activation, suggesting sustained cdk1 activity may initiate apoptosis. Though 
increase cdk1 activity can be detected in many other apoptotic conditions and 
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inhibition of cdk1 activity by chemical inhibitors such as roscovitine can block 
mitotic catastrophe induced by chk1 inhibition, it is unclear whether cdk1 activity 
directly initiates apoptosis or indirectly through initiating mitosis, which is 
required for mitotic catastrophe to occur (Castedo et al., 2002; Castedo et al., 
2004). Removal of BubR1 and Mad2 by knockdown approach have also been 
shown to protect cells from mitotic catastrophe induced by spindle poisons (Sudo 
et al., 2004). This raises an interesting possibility that BubR1, which has a kinase 
domain, could be the sensor that triggers apoptosis during prolonged mitotic 
arrest. Unfortunately this is complicated as inhibition of BubR1 also activates 
APC, thus allowing the cells undergoing mitotic arrest to exit mitosis 
prematurely, therefore escaping the possible catastrophe.  
The role of p53 family is regulating mitotic catastrophe has never been well 
studied. No studies were done to determine if p63 have any role in mitotic 
catastrophe. For p53, while it is required for DNA checkpoint to function 
properly, it has not been shown to play an important role in mitotic checkpoint. 
Apoptosis during mitotic catastrophe that happens during metaphase is p53 
independent. In fact, loss of p53 has been shown to sensitize cells to microtubule 
poisons, which kill cells by triggering mitotic catastrophe (Vikhanskaya et al., 
1998). Perhaps cells without p53 have a shorter cell cycle thus enter mitosis, the 
stage where spindle poison act on, faster than normal cells. However p53 plays an 
important role in regulating cell fate for cells that escape the mitotic checkpoint 
with aberrant chromosome segregation. These cells are arrested in post-mitotic G1 
state in a p53 dependent manner and eventually killed in a partially p53 dependent 
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manner (Andreassen et al., 2001). Cells without p53 and escaping mitotic arrest 
developed tetraploidy, leading eventually to polyploidy. Thus the major role of 
p53 in mitotic arrest seems to be at the polyploidy checkpoint, which is after 
mitotic checkpoint. The role of p73 in mitotic catastrophe is not known, although 
use of dominant negative p73 as well as knockdown techniques have been shown 
to reduce cell death attributed to spindle poisons (Irwin et al., 2003).  
 
1.4. Apoptosis   
Apoptosis or programmed cell death is a form of cell death where the cell plays 
an active role in its own demise. Classic features of apoptosis are chromatin 
condensation, mitochondrial release of proapoptotic proteins e.g. cytochrome c 
and AIF, caspases activation and DNA degradation (Castedo et al., 2004).  
The activation of apoptosis is effected through at least two pathways, the intrinsic 
and extrinsic pathway. The intrinsic pathway activates apoptosis via caspase-9 
activation while the extrinsic pathway activates apoptosis via the caspase-8 
pathway. Besides these two caspases, a third initiator caspase, caspase-2 has been 
shown to trigger apoptosis via intrinsic as well as extrinsic pathway (Shin et al., 
2005; Tinel and Tschopp, 2004).  
 
1.4.1. Caspase-9 activation pathway 
Upon mitochondria membrane permeabilization (MMP), pro-apoptotic factors 
such as cytochrome c, AIF, SMAC are released from the mitochondria inter-
membrane to the cytoplasm. Cytochrome c in particular induces a energy-
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dependent formation of an oligomeric complex known as apoptotic protease 
activating factor 1 (Apaf-1) apoptosome (Cain et al., 2002). This structure 
contains a caspase recruitment domain (CARD) that binds to procaspase-9 
zymogen, facilitating its autoactivation into a holoenzyme complex. In the 
apoptosome, close proximity of individual procaspase-9 initiates its autoactivation 
where procaspase-9 is cleaved into monomers, which then dimerized into 
catalytic active form. It is the active form that in turn cleaves and activates 
effector caspases such as caspase-3 and caspase-7. The effector caspases are 
responsible for the classic phenotype associated with apoptosis e.g. DNA 
laddering, membrane blebbing, nuclear envelope breakdown and proteolysis of 
cellular contents. Caspase-9 activation is regulated further at the post-proteolytic 
cleavage by inhibitors of apoptotic proteins (IAPs) (Miller, 1999). There are eight 
mammalian IAPs, which include XIAP, c-IAP1, c-IAP2, ML-IAP, ILP2, NAIP, 
Bruce and survivin. XIAP is the main IAP responsible for inhibiting caspase-9 in 
mammals. It does its function by binding to monomeric caspase-9, preventing 
caspase-9 dimerization and dimerization-dependent catalytic activity (Shiozaki et 
al., 2003). XIAP inhibition of caspase-9 is in turn negatively regulated by SMAC, 
which is released from mitochondria during MMP. SMAC has a similar IAP 
tetrapeptide binding motif that competes with caspase-9 for XIAP, thereby freeing 
caspase-9 to auto-activate (Srinivasula et al., 2001). Most intrinsic death signals 
e.g. from DNA damage or mitotic catastrophe result in the activation of this 
mitochondria-cytochrome c-caspase-9 pathway.  
 
 20
1.4.2 Caspase-8 activation pathway 
Caspase-8 activation, on the other hand, depends on the engagement of death 
receptors on the cell surface. Immune cells activate this extrinsic pathway during 
tumor surveillance to kill tumor cells. Binding of ligands such as FasL and tumor 
necrosis factor (TNF) to the FAS and TNF receptor respectively induced the 
formation of the death induced signaling complex (DISC). Procaspase-8 is 
recruited to the DISC through binding to fas-associated death domain (FADD) 
(Barnhart et al., 2003). As the activated death ligands are homo-trimeric, it 
induces the oligomerization of death receptor upon binding. This brings 
procaspase-8 together, facilitating in its autoactivation. Cleaved caspase-8 
dimerized together to form catalytic active units, which in turn activate other 
effector caspases to complete apoptosis.  
 
1.4.3 Caspase-2 pathway 
Caspase-2 has been implicated in both DNA damage as well as mitotic 
catastrophe induced apoptosis (Castedo et al., 2004; Lassus et al., 2002). Caspase-
2 deficient mice exhibit increase ovarian germ cells, indicating defect in female 
germ cell apoptois (Bergeron et al., 1998). Like initiator caspase-9, caspase-2 also 
contains a CARD domain for recruitment to adaptor protein complex such as 
apoptosome to aid its autoactivation. In this case, caspase-2 activation requires the 
assembly of a large protein complex containing adaptor protein, RIP-associated 
Ich1-homologous protein with a death domain (RAIDD) and the p53-induced 
protein with a death domain (PIDD), referred as the PIDDosome (Tinel and 
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Tschopp, 2004). However unlike well-studied caspase-9 or caspase-8 whose close 
proximity of seven caspase-9 or three caspase-8 trigger their respective 
autoactivation, the stoichiometry required for caspase-2 autoactivation in the 
PIDDosome remains unknown. 
 
1.5 Mitochondria membrane permeabilization (MMP) 
A key feature of apoptosis is the release of cytochrome c from the mitochondria to 
the cytoplasm. This event is generally termed as MMP with the outcome being 
cell death (Kroemer, 2002). The outer membrane permeabilization, which results 
in the release of cytochrome c, is regulated by the Bcl-2 family of proteins. This 
family consists of myriads of proteins, some forming pore complexes and 
promoting apoptosis e.g. Bax, Bak, others inhibiting this pore complex formation 
and blocking apoptosis e.g. Bcl-2, Bcl-XL, and yet others regulating these 
processes e.g. Bim, Bid and Bad (Green and Kroemer, 2004).  
Proapoptotic Bcl-2 family members Bax and Bak aid apoptosis by forming the 
pore complex in the outer membrane through which apoptotic factors are released 
from the mitochondrial intermembrane space (Korsmeyer et al., 2000). In the 
unstressed situation, Bax is either found loosely attached to the outer membrane 
of the mitochondria or sequestered in the cytosol (Guo et al., 2003; Nomura et al., 
2003). Similarly, Bak is attached to the outermembrane via interaction with 
voltage-dependent anion channel (VDAC) (Cheng et al., 2003). Upon apoptotic 
stimuli, Bax translocates to the mitochondria and together with Bak undergo 
conformation change, resulting in their oligomerization and pore complex 
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formation. These two proteins are absolutely important for MMP, as cells lacking 
Bax and Bak do not undergo outer membrane permeabilization and are 
completely resistant to wide array of apoptotic stimuli (Degli and Dive, 2003). 
Anti-apoptotic Bcl-2 family members have been proposed to work via inhibitory 
interaction with Bax and Bak, and thereby blocking their oligomerization and 
subsequent pore formation (Sedlak et al., 1995). Indeed transfection of MMP 
inhibitors such as Bcl-2 and Bcl-XL has been shown to block apoptosis (Zamzami 








Illustration 5: Schematic diagram of the role of different Bcl-2 family members 
on mitochondria outer-membrane permeabilization. In the unstressed state, Bax is 
either in the cytosol or attached to the mitochondria membrane, similar to Bak. 
Anti-apoptotic Bcl-2 members bind to and keep Bax/Bak inactive. BH3-only 
members are normally kept inactive e.g. Bim sequestered in the microtubules. 
Upon induction of apoptotic signal, Bax translocate to the mitochondria and 
oligomerized to form pore complex, releasing pro-apoptotic proteins cytochrome 
c and Smac into the cytosol. Bcl-2 are blocked by BH3-only proteins from 



















1.6 BH3-only Proteins 
While the interplay between Bcl-2 and Bax determine MMP, the BH3-only 
members of the Bcl-2 family determine when to induce apoptosis by sensing the 
various different stresses. Induction and activation of each of the BH3 members 
are subjected to the type of cell stimulus (Shibue and Taniguchi, 2006). Therefore 
unlike the Bax knockout model, which develops complete resistance to wide array 
of apoptotic stimuli, individual BH3 member knockout mice develop resistance 
only to specific stress signals. Nonetheless, all the BH3-only members act by 
interfering with anti-apoptotic Bcl-2 members, thus allowing Bax and Bak to 
promote apopotosis. Members of this BH3-only include Noxa, Puma, Bim, Bad, 
Bmf, Bid and Hrk. Of which, only Puma and Noxa are able to translocate directly 
to the mitochondria to activate apoptosis (Shibue and Taniguchi, 2006). Except 
for Noxa and Puma, the rest of the BH3-only members require post-translational 
modifications before being able to translocate to the mitochondria. 
 
1.6.1 Bim 
Bim is the BH3-only member that is of particular interest because Bim-/- cells are 
resistant to taxol, which is a spindle poison that causes mitotic catastrophe, hence 
suggesting an important role of Bim in regulating apoptosis during mitotic 
catastrophe (Tan et al., 2005). In addition, Bim-/- lymphocytes are resistant to 
other stresses such as, cytokine deprivation and calcium ion influx (Bouillet et al., 
1999). Bim knockout animals have abnormalities in the hematopoietic system and 
consistent with it, apoptosis of the hematopoietic cells involves bim (Boulliet et 
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al., 1999). Physiologically, Bim is attached to the microtubule in the cytoplasm of 
unstressed cells. Its pre-dominant forms (BimEL and BimL), in unstressed state, 
bind to the dynein light chain, a component of the microtubule dynein motor 
complex (Puthalakath et al., 1999). Upon specific stress such as anoikis, Bim 
dissociates from the microtubule and translocates to the mitochondria to promote 
apoptosis (Puthalakath et al., 1999; Puthalakath et al., 2001). Bim can bind to all 
members of the pro-survival Bcl-2 members to initiate MMP (Chen et al., 2005). 
Indeed no clones can be obtained from overexpression of Bim in fibroblasts 
(Chen et al., 2005). Unfortunately, the exact mechanism by which Bim 
dissociates from microtubules is not clear. Although studies have shown JNK 
phosphorylation of Bim upon UV stress allows Bim to dissociate from the 
microtubules, it is unclear if other stresses use the same mechanism (Lei and 
Davis, 2003). Transcriptionally, Bim is regulated by E2F-1, FOXO3A and Myc 
(Egle et al., 2004; Gilley et al., 2003; Hershko and Ginsberg, 2004). While Bim is 
not a known transcriptional target of p53 family, overexpression of DNp73β, a 
dominant negative form of p73, during NGF withdrawal in wildtype neurons 









Cells with damaged DNA or compromised genomic integrity have increased risk 
of becoming malignant. p53 family members prevent these cells from becoming 
cancerous by arresting the growth or initiating apoptosis. Although much work 
has been done to understand the role of p53 family during DNA damage response, 
not much is known about its role in maintaining genomic integrity through 
initiating mitotic catastrophe. The main aim of this research proposal therefore is 
to study if p73 regulates mitotic cell death. Specifically, the aims are: 
1) To study the role of p73 in mitotic cell death by 
(i) characterizing mitotic cell death induced by taxol; 
(ii) studying the function of p73 during mitotic cell death; 
(iii) determining the mechanism of action of p73 on inducing 
mitotic cell death. 
 
Caspases are key components that regulate apoptosis. Though the protein 
regulation of caspases is well studied, not much is known about its transcriptional 
regulation. Our initial data indicate that caspase-2S can be up-regulated by ectopic 
expression of p73β. For the secondary aim of the project, the potential role and 
mechanism of p73 in regulating caspase-2S will be discussed. Specifically, the 
aims are:  
2) To investigate the potential regulation of caspases by p73 
(i) establishing which caspases are regulated by p73 
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(ii) establishing the site of action by p73 on caspase-2S 
promoter 
(iii) investigating the mechanism of caspase-2S regulation; 





















2.1.1 Dulbecco’s modified Eagle’s medium (DMEM) culture medium  
DMEM is supplemented with 10% fetal bovine serum (FBS) (Hyclone 
Laboratories, Logan, UT), 100U/ml of penicillin (Invitrogen Life Technologies), 
100µg/ml of streptomycin (Invitrogen Life Technologies), and 2 mM L-glutamine 
(Sigma-Aldrich Corp., St. Louis, MO). 
2.1.2 Cells-freezing medium 
Cells-freezing medium was prepared by adding tissue culture grade dimethyl 
sulfoxide (DMSO) (Sigma-Aldrich Corp.) to FBS to a final concentration of 10%. 
2.1.3 RNase A (DNase Free) 
Source: Sigma-Aldrich Corp. 
Stock concentration: 20 mg/ml 
Dissolve in PBS. Store as aliquots at -20oC. 
2.1.4 Propidium Iodide (PI) solution 
Source: Sigma-Aldrich Corp. 
Stock concentration: 100 µg/ml 
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Dissolve PI in PBS containing 0.1% Triton X-100. Store at -20oC covered with tin 
foil. 
 
2.1.5 Sucrose solution 
Dissolve 25 g or 30 g in 100 mL of PBS to a concentration of 25% and 30% 
respectively. Filter sterilize and store at -4oC. 
 
2.1.6 Tris-EDTA (TE) 
Dilute 10 mM Tris (pH 8.0) and 1 mM EDTA (pH 8.0) in water. Sterilize by 
autoclaving. 
 
2.1.7 Diethylpyrocarbonate (DEPC) water 
Add 0.2 ml of DEPC to 100 ml of water. Shake vigorously and incubate overnight 
in a fume hood. Inactivate remaining DEPC by autoclaving. 
2.1.8 Ampicillin 
Source: Sigma-Aldrich Corp. 
Stock concentration: 100 mg/ml 
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Dissolve in sterile water. Filter sterilized and store at -20oC in aliquots. 
 
2.1.9 Luria broth (LB) 
Mix 10 g Bacto-Tryptone, 5 g Bacto-Yeast extract and 10 g sodium chloride in 
900 ml of water. Adjust pH to 7.0 with sodium hydroxide. Sterilize by 
autoclaving. 
 
2.1.10 Escherichia coli strain DH5α 
Escherichia coli DH5α was purchased from New England Biolabs (Beverly, 
MA). 
 
2.1.11 Escherichia coli strain BL21 
Escherichia coli BL21 was purchased from New England Biolabs (Beverly, MA). 
 
2.1.12 Isopropyl β-D-thiogalactoside (IPTG) 
Source: Invitrogen Life Technologies 
Stock concentration: 50 mg/ml 
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Dissolve IPTG in ddH20 to a final concentration of 50 mg/ml. 
 
2.1.13 Tris-buffered saline (TBS) 
TBS contains 100 mM Tris-HCl (pH 7.5) and 0.9% NaCl in ddH20. 
 
2.1.14 Protein lysis buffer 
Protein lysis buffer contains 50 mM Tris-HCl (pH 7.6), 0.1% Triton X-100, 150 
mM NaCl in ddH20. Add 1X protease inhibitor before use. 
 
2.1.15 Luciferin buffer 
Mix 25 mM glycylglycine (pH 7.8), 15 mM MgSO4, 4 mM EGTA in ddH20. 
Store at 4oC. 
 
2.1.16 Luciferase assay Buffer 
Mix 25 mM glycylglycine (pH 7.8), 15 mM MgSO4, 4 mM EGTA and 15 mM 




Source: Roche Diagnostics GmbH, Mannheim, Germany 
Stock concentration: 10 mM 
Dissolve 10 mg of luciferin powder in 3.57 ml of 25 glycylglycine (pH 7.8). 
Aliquot and store in -20oC. 
 
2.1.18 Resolving gel (10%) 
10% (10 ml) gels were cast by mixing 3.3 ml of 30% acrylamide mix (30% 
acrylamide/0.8% bisacrylamide) with 2.5 ml of 1.5 M Tris-HCl pH 8.8, 4 ml 
water, 50 µl of 20% SDS, 100 µl 10% ammonium persulfate (APS) (Amersham 




2.1.19 Stacking gel (5%) 
0.83 ml of 30% acrylamide mix with 0.63 ml of 1 M Tris-HCl, pH 6.8, 3.4 ml of 
water, 25 µl of 20% SDS and 50 µl of 10% APS with 6 µl of TEMED. 
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2.1.20 Protein loading buffer 
Protein loading buffer is prepared by mixing 62.5 mM Tris-HCl pH 6.8, 10% 
glycerol, 2% SDS, 100 mM DTT, 0.0005% bromophenol blue in water. 
 
2.1.21 SDS electrophoresis buffer 
Mix 25 mM Tris-base, 192 mM glycine (electrophoresis grade) and 0.1% SDS in 
water. 
 
2.1.22 Protein transfer buffer 




2.1.23 Western hybridization blocking buffer 




2.1.24 Fractionation buffer 
Fractionation buffer is prepared by 22 mmol/L mannitol, 70 mmol/L sucrose, 50 
mmol/L piperazine-N,N’-bis (ethanesulfonic acid) PIPES-KOH, pH 7.4, 50 
mmol/L KCI, 5 mmol/L EGTA, 2 mmol/L MgCL2 and 1mmol/L dithiothreitol 
and protease inhibitors (Sigma). 
 
2.1.25 CHAPS lysis buffer 
10 mM Tris-HCl, pH 8.0, 1 mM MgCl2, 1 mM EGTA, 2% CHAPS, 10% 
glycerol. 
 
2.1.26 FACS machine 
The FACS machine used is from BD Biosciences FACScalibur (Mountain View, 
CA). 
 
2.1.27 Fixative for cell cycle, caspase-3 FACS and immunofluoresence 
4% paraformaldehye (Sigma-Aldrich) is dissolved in PBS in a heated water bath 
set at 65oC, with constant agitation. 
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2.1.28 Blocking buffer for immunofluoresence 




Monoclonal anti-caspase-3 conjugated with FITC (BD biosciences) Cat 550480 
Polyclonal anti-phospho Histone H3 (Upstate ) Cat 05-817  
For western hybridization: 
Monoclonal anti-p73 ER-15 (Oncogene Science, Cambridge, MA) Cat OP109T, 
which can detect all isoforms of p73 proteins. 
Polyclonal anti-p53 (Novo Castra), Cat NCL-p53-CM1 
Polyclonal anti-p53 (Novo Castra), Cat NCL-p53-CM5P 
Monoclonal anti-Plk1 (Santa Cruz Biotechnology Inc), Cat sc-17783 
Monoclonal anti-Bubr1 (BD Bioscience), Cat 612502 
Polyclonal anti-Mad2 (Santa Cruz Biotechnology Inc), Cat C-19 
Polyclonal anti-Caspase-3 (Cell Signaling Technology Inc), Cat 9665 
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Monoclonal anti-Caspase-8 (Cell Signaling Technology Inc), Cat 9746 
Monoclonal anti-Caspase-9 (Cell Signaling Technology Inc), Cat 9502 
Monoclonal anti-Caspase-2  (BD Bioscience), Cat 611022 
Polyclonal anti-Actin (Sigma), Cat A1978 
Polyclonal anti- Bim (Cell Signaling Technology Inc), Cat 2819 
Polyclonal anti-Bax (Santa Cruz Biotechnology Inc), Cat sc-493 
Polyclonal anti-Puma (Cell Signaling Technology Inc), Cat 4976 
Polyclonal anti-Bik (Cell Signaling Technology Inc), Cat 4592 
Polyclonal anti-poly ADP-ribose polymerase (PARP; Cell Signaling Technology 
Inc), Cat 9532 
Polyclonal anti-cdc20 (Santa Cruz Biotechnology Inc) Cat sc-53399 
Polyclonal anti-p21 (Santa Cruz Biotechnology Inc), Cat C24420 
 Polyclonal anti-adenine nucleotide  transferase (ANT; Santa Cruz Biotechnology 
Inc), Cat sc-11433 
Monoclonal anti-flag (Stratagene), Cat 200470 
Polyclonal anti-cytochrome c (Santa Cruz Biotechnology Inc), Cat sc-65396 
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2.1.30 4',6-diamidino-2-phenylindole (DAPI) 
DAPI is obtained from Vector labs. 
 
2.1.31 Purvalanol A (Purv A) 
10 mM stock solution is prepared by dissolving 10 mg Purvalanol A powder 
(Sigma, P5234) in 231 µl DMSO (Sigma). Stored at -20oC. 
 
2.1.32 MG132 




100 mM stock solution prepared by dissolving 1.21 g of thymidine (Sigma) in 50 
ml PBS. Solution is filtered sterilized and stored in 4oC. 
2.1.34 Taxol 
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1mM Taxol solution prepared by dissolving 5 mg of Taxol (Sigma) in 5.85 ml of 
ethanol. Solution is stored at -20oC.  
2.1.35 Plasmids 
pcDNA p53, p73α and p73β were cloned previously from our lab (Toh et al., 
2005). Caspase-2S expression plasmid is obtained from Dr Yuan Junying, 
Cardiovascular research center, Boston, Massachusetts. Flag tagged p63α 
expression plasmid is obtained from Dr  Giovanni Blandino, Regina Elena Cancer 
Institute, Rome, Italy. All the caspase-2 promoter luciferase reporter constructs, 




siRNA were purchased from Qiagen. The target human sequences are as follows - 
p73: AAA AGC TGA TGA GGA CCA CTA, p53: AAG ACT CCA GTG GTA 
ATC TAC, mad2: AAA CCT TTA CTC GAG TGC AGA, bubr1: AAG GGA 
AGC CGA GCT ATT GAC, plk1: AAC CAG TGG TTC GAG AGA CAG, 
caspase-2: AAA CAG CTG TTG TTG AGC GAA, caspase-8: AAG GAG CTG 
CTC TTC CGA ATT, caspase-9: AAG CTT CGT TTC TGC GAA CTA, bim: 





2.2 General methods 
2.2.1 Tissue culture 
2.2.1.1 Cell lines 
Human osteosarcoma U20S and small cell lung carcinoma H1299 cell lines were 
obtained from ATCC.  p53-/- and p73-/- fibroblasts were obtained from Dr Gerry 
Melino, Medical Research Council, Leicester, UK. Saos-2, osteosarcoma (with 
the doxycycline-inducible p73β) cells were kindly supplied by Dr Karen 
Vousden, National Cancer Institute, Frederick, Maryland. Sh5y neuroblastoma 
cell line containing stably transfected pcDNA or DNp73β was made by Iqbal 
Dullo.  
 
2.2.1.2 Culture conditions of cell lines 
All cell lines, except Saos2 (73β inducible), were cultured in 37oC DMEM 
supplemented with 10% fetal bovine serum, 100U/mL penicillin, and 10µg/ml 
streptomycin.  Saos2 (73β inducible) is maintained in DMEM supplemented with 
10% tetracycline free FBS, 100U/ml penicillin, and 10µg/ml streptomycin. All 




2.2.1.3 Subculturing of cells 
Subculturing of cells was carried out using 0.25% trypsin-EDTA. Briefly, when 
the cells reach confluency, the medium was discarded and the cell monolayer was 
washed gently with PBS. After removing excess PBS, appropriate amount of 
trypsin was added for approximately 3 to 5 mins until most cells became 
suspended. This was followed by resuspending the cells in complete medium and 
centrifuged for 5 mins at 1000 rpm (Beckman Coulter, Palo Alto, CA). The 
pelleted cells was then resuspended in appropriate medium and divided into 
individual flasks. 
 
2.2.1.4 Cryopreservation of cells 
To cryopreserve cells, cells were trypsinized and pelleted as above. Cell pellet 
was resuspended in cell freezing medium and store in liquid nitrogen using 
cryovials (Nunc). 
 
2.2.1.5 DNA transfections 
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H1299 and p73-/- fibroblasts were transfected in 6 well plates using Lipofectamine 
(Invitrogen Life Technologies) according to manufacter’s instructions. Briefly, on 
the day of transfection, the wells containing the cells are flushed twice with serum 
free medium before 0.8 ml of serum free DMEM is added to each well. Then 0.5 
µg of pcDNA p73α and p73β plasmids are mixed with 6 µl of plus reagent 
(Invitrogen) in 1.5 ml eppendorf tube, top up to 100 µl with serum free DMEM 
and incubated for 15 mins at RT. After, 4 µl of Lipofectamine 2000 (Invitrogen) 
mixed with 96 µl of serum free DMEM are added to each tube and further 
incubated for 15 mins at RT. 200 µl of the DNA lipofectamine mixture is then 
added to each appropriate well and incubated at 37oC in the incubator for 3 hrs. 
After which 1 ml of complete DMEM is added to each transfected well and 
cultures incubated until 48 hrs for harvest. Procedures for transfection of p53, p63 
and p73 into H1299 cells for caspase-2S regulation follow that of above. 0.5 µg of 
each plasmids are used for transfection. 
 
2.2.1.6 siRNA Transfection  
H1299 and U20S cells were transfected with siRNA using RNAifect transfection 
reagent (Qiagen). Cells were seeded at 80% confluency in 6-well plates 24 hrs 
prior to transfection. 10 µM of individual siRNA were mixed with 10 µl of 
RNAifect reagent and top up with DMEM till 100 µl. The mixtures were then 
incubated for 15 mins in RT prior to addition to a well from a 6-well plate 
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containing 1.9 ml of DMEM. The cultures were incubated for 24 – 48 hrs prior to 
analysis. 
2.2.1.7 Synchronization and released of cells from the G1/S phase 
To induce G1/S block, 2mM of thymidine is added to cultures and incubated for 
24 hrs. The cultures are then released from the G1/S block by removing the 
thymidine containing medium and flushing the wells three times with PBS. 
Normal DMEM or DMEM containing indicated drugs are added to the culture. 
 
2.2.1.8 Drugs treatment 
To test for mitotic cell death by Taxol (Sigma), cultures after released from G1/S 
block were incubated with 100 nM of Taxol for indicated amount of time before 
harvest. To test premature mitotic exit after taxol treatment block mitotic 
catastrophe, 4 µM of Purvalanol A are added to taxol treated cells 15 hrs after 
thymidine block release, samples are collected 1 hr, 5 hrs and 9 hrs later for 
immunoblot. To test blockage of cells from exiting mitosis during taxol treatment 
augment mitotic catastrophe, 10 µM of MG132 are added to taxol treated cells 15 
hrs after thymidine block release, samples are collected 1 hr, 5 hrs and 9 hrs later 
for immunoblot. To test if MG132 induce mitotic catastrophe require mitotic 
arrest, 10 µM of MG132 is added to cells 10 hrs after release from thymidine 
block and Purvalanol A added 4 hrs later. Samples are collected 24 hrs after 





H1299 cells are seeded at 80% confluence overnight in 6 well plates before 
subjected to gamma-irradiation with 20Gy dose using a cobalt source. 
 
2.2.2 Molecular biology procedures 
2.2.2.1 Bacterial transformation 
Heat shock method is used to introduce DNA into bacteria. DNA is mixed with 
100 µl of competent DH5α and incubated in ice for 30 mins. The bacteria DNA 
mixed is then heat shock for 1 min at 42oC, transferred to ice for 1 min and 900 µl 
of LB broth added. The mix is then incubated at 37oC shaker for 30 mins before 
plating to LB plates containing 50 µg/ml of ampicillin. 
 
2.2.2.2 Site directed mutagenesis 
Site directed mutagenesis is used to mutate GC box of Del 4 promoter. The 
primer sequences used for that are as follows: Del4 sdm-for: AACATTTCTCT 
ATCGATAGGTACCGACGCTTGCTCGAGCCGCTCCGAGCCTGACTCCGC 
GC. Del4 sdm-rev: GCGCGGAGTCAGGCTCGGAGCGGTCGAGCAAGCGTC 
GGTACCTATCGATAGAGAAATGTT. PCR is performed using 50 ng of Del 4 
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plasmid, 125 ng of Del4 sdm-for, 125 ng of Del4 sdm-rev, 1 µl of 10mM dNTP, 5 
µl of 10X Pfu buffer and 1 µl of Pfu enzyme (Stratagene), top up to 50 µl with 
H20. The conditions for PCR are as follow: Activation 95oC, 30 secs, 
amplification 95oC, 30 secs, 55oC, 30 secs, 68oC, 18 mins, repeat 18X. After 
PCR, 1 µl of Dpn1 (New England Biolabs) enzyme is added to the PCR mix and 
incubated at 37oC for 2 hrs. 10 µl of the mix is then used for bacterial 
transformation. 
 
2.2.2.3 DNA sequencing 
Sequencing reactions were performed using Big Dye terminator mix (Applied 
Biosystems). Briefly, 100 ng of DNA, 3.2 pmol of sequencing primer GL2, 4 µl 
of Big dye mix, were top up to 10 µl of water. Reactions were PCR using 
conditions initial denaturation 96oC, 10 mins, 96oC 30 secs, 50oC, 15 secs, 60oC, 
4 mins for 25 cycles. After PCR, the reactions were precipitated by mixing with 
50 µl 95% ethanol, 10 µl of water and 2 µl 3M sodium acetate for 15mins at RT. 
The mix were then centrifuged for 15 mins at 13000rpm, washed with 70% 
ethanol once and left to dry. The precipitated sequences are sent to Research 
biolabs, Singapore, for sequencing. 
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2.2.2.4 Cloning of p73α, p73β and p53 into pGEX-4T1 
p73α, p73β and p53 cDNA were excised from pcDNA backbone using BamH1 
and Xho1 (New England Biolabs) and sub-cloned into pGEX4T1 BamH1 and 
Xho1 restriction sites. Briefly, digested inserts are separated from the vector by 
electrophoresis as described by Sambrook et al., (1989). 1% agarose gels were 
prepared with DNA grade agarose (Invitrogen Life Technologies) in 1X TAE 
buffer. The digested vector and inserts were purified from agarose gel using Gel 
purification kit (Qiagen GmbH). DNA fragments were excised from the agarose 
gel using a scalpel and put into a clean 1.5 ml microcentrifuge tube. Three volume 
of QG buffer was added to the agarose piece and incubated at 50 oC for 10 mins. 
After solubilization, the DNA solution was transferred to a column and subjected 
to centrifugation at 13 000g for 1 min using a tabletop centrifuge. The column 
was rinsed once with PE buffer, excess PE was removed by additional round of 
centrifugation. DNA were eluted in 30 µl of buffer EB (10 mM Tris-HCI, pH 
8.5). The ligation reaction was carried out in a vector to insert ratio of 1:3. The 
ligation reactions were performed in a final volume of 15 µl containing 1X 
ligation buffer (New England Biolabs), appropriate amount of vector and insert, 
and 1 unit of T4 DNA ligase (New England Biolabs) and water. The ligation 
reactions were incubated at RT for 1 hr followed by transformation into DH5α 
competent cells.  
 
2.2.2.5 Cloning of Del 4 truncations 
 46
Del4 truncation Del4.1, Del4.2 and Del4.3 were constructed using PCR cloning. 
Del4.1 primer-for: AAAAGGTACCAGCCTGACTCCGCGCAAGG, Del4.2 
primer-for: AAAAGGTACCTCCTTATGAGGGAAACTATAA, Del4.3 primer-
for: AAAAGGTACCGTCTCTCGTGGGAAAAGACTGGC and Del4-rev: 
ACTTAGATCGCAGATCTCGAGTCGATAC were used to PCR Del4.1, Del4.2 
and Del4.3 respectively from Del4 reporter construct. PCR was performed using 
Taq polymerase (Qiagen) and Proofstart (Qiagen) in a 30µl solution: 1 µl of Del4 
reporter, 1 µl each of 10pmol/µl of primers, 1 µl of 10mM dNTPs, 3 µl of 10X 
buffer and 0.4 µl of Taq polymerase, 0.1 µl of Proofstart, top up with H20 till 30 
µl. PCR reaction was amplified for 33 cycles at 94oC for 50s, 54oC for 30s and 
72oC for 2 mins. PCR products were run on an 1.5% agarose gel and gel extracted 
using Qiagen gel extracted kit. PCR products were then digested with Kpn1 and 
Xho1 together with pGL3 basic (Promega). Ligation and transformation were 
then performed as 2.2.2.4. 
 
2.2.2.6 Miniprep 
Plasmids are transformed into DH5α and plated out on LB plate containing 50 
µg/ml of ampicillin. Colonies are then picked up and grow overnight at 37oC in 3 
ml LB broth containing ampicillin. The bacteria is collected by centrifugation and 
resuspended in 250 µl of Buffer 1 (50mM Tris, pH 8.0, 10mM EDTA, 100 µg/ml 
RNase A). The suspension is then lyzed with 250 µl of Buffer 2 (200mM NaOH, 
1% SDS (w/v)) for 4 mins at RT. 350 µl of Buffer 3 (3M potassium acetate, pH 
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5.5) is then added to the lyzed sample at mixed. The mixture is spun at 13000rpm 
at RT for 10 mins. The supernatant is then transferred to spin column (Qiagen, 
Plasmid minprep kit) at spin at 13000rpm for 1 min. 750 µl of Buffer QC (1M 
NaCl, 40mM MOPS pH 7.0, 15% isopropanol v/v, 0.15% Triton X v/v) is added 
to the column at spin at 13000rpm for 1 min. The eluent is removed and the 
column spun one more time to remove excess buffer. 40 µl of TE buffer (10mM 
Tris-HCI, pH 8.0, 1mM EDTA) is added to the column, which is then spin at 
13000rpm for 1 min at RT. The eluent, containing the plasmid, is collected in a 
1.5 ml eppendorf tube. 
 
2.2.2.7 RNA extraction 
Harvested cell pellets from 6 well plates are collected in 1.5 ml eppendorf tubes 
and lyzed in 1 ml Trizol reagent (Invitrogen) for 5 mins at RT. 200 µl of 
chloroform is then added to the mixture at vortex for 15 secs. The suspension is 
left to stand at RT for 5 mins. The lyzed samples are then spin at 13000rpm for 15 
min at 4oC. The 500 µl of the clear top phase is then transferred to a new 
eppendorf tube and equivalent amount of isopropanol added. The tubes is mixed 
by vortex and left to stand for 10 mins at RT. The sample is then spin at 
13000rpm at 4oC for 15 mins and the supernatant removed. The pellet is then 
washed with 70% ethanol by spinning at 13000rpm for 5 mins at RT. The pellet is 
left to dry before re-suspension in 30 µl of DEPC-treated H2O. 
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2.2.2.8 Quantification of nucleic acid concentration 
The DNA or RNA concentration was determined by using an Ultospec 3000 
UV/visible spectrophotometer (Amersham Biosciences AB, Uppsala, Sweden). 
The samples were diluted 100-fold and the readings were taken at wavelenth 260 
nm and 280 nm.  
2.2.2.9 1st strand cDNA synthesis 
3 µg of RNA for each sample is converted into cDNA. The RNA are mixed with 
1 µl of 10mM dNTPs and 1 µl of oligo dT (invitrogen) and top up with DEPC-
treated H2O to a total volume of 12 µl. The suspension is then heated up to 65oC 
for 5 mins and transferred to ice to cool. 4 µl of Superscript Buffer, 2 µl of 0.1M 
dTT, 1 µl of RNaseOUT (Invitrogen), 1 µl of Superscript II (Invitrogen) is added 
to the RNA mixture. The 1st strand cDNA synthesis is then carried out at 42oC for 
50 mins. The reactions are terminated by heating the cDNA at 75oC for 15 mins.  
 
2.2.3 FACS protocols 
2.2.3.1 Cell death assays 
Cell viability was measured by several means.  Cell numbers were determined by 
seeding 1x105 cells/ml into 6 well plates followed by treatment with 100nM taxol. 
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Dead cells were removed by washing with PBS and adherent cells dislodged by 
trypsin and counted using Symex CDA cell counter every 24 hrs for 3 days. Cell 
death is measured by propidium iodide (PI) exclusion assay. Cells are seeded in 6 
well plates and treated with taxol for the indicated periods of time. Total cell 
population, including dead floating cells in the medium, is collected, washed 2X 
in PBS before re-suspension in 2 µg/ml PI and % of dead cells up-taking PI 
measured by BD Biosciences FACScalibur (Mountain View, CA). Apoptosis is 
determined by flow cytometry using fluorescence labeled antibody recognizing 
cleaved caspase-3 (BD Biosciences). Cells are harvested similar to PI assay. After 
harvest, the cells are fixed in 4% formaldehyde solution overnight at 4oC. The 
samples are then washed 2X with washing solution and incubated with 100 µl 
washing solution containing 2 µl of fluorescence labeled antibody recognizing 
cleaved caspase-3 for 30 mins at RT in the dark. After incubation the samples are 
washed once with washing solution and resuspended in 500 µL washing solution 
for FACS analysis. All experiments were performed at least thrice and the data 
are expressed as mean ± s.d. for triplicate. 
 
2.2.3.2 Cell cycle and phospho-histone-H3 analysis 
Samples were collected over indicated time points and fixed in 70% ethanol 
overnight. For cell cycle analysis, fixed cells were treated with RNase A for 20 
minutes before addition of 5 µg/ml PI and analyzed by FACS. For phospho-
histone-H3 analysis, fixed cells were washed 2X in PBS before incubating with 
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1:300 dilution of phospho-histone-H3 antibody (Upstate) for 1hr. After 2X wash 
with PBS, the samples are incubated with secondary FITC-conjugated rabbit 
antibody for another hour. The samples are then washed 3X in PBS before 
analysis with flow cytometry. 
 
2.2.4 Immunofluorescence staining and Confocal microscopy 
Mouse fibroblasts were seeded onto glass coverslips (Marienfeld laboratory 
glassware) at 5x104 cells/ml in 6 well plates overnight and were treated with 
200nM taxol for 18hrs. For mitochondria staining, 100nM mitotracker CMXRos 
(Molecular Probes Inc) were added into culture medium for 15 minutes before 
fixing with 4% paraformaldehyde in PBS for 30 minutes at room temperature 
(RT). Fixed cells were washed with PBS and permeabilized with 1% Triton X-
100 in PBS for 10 minutes. After washing with PBS, the coverslips were 
incubated with Bax antibody (N20, Santa Cruz Biotechnology Inc) diluted in 5% 
BSA/PBS for 1 hr at RT. They were then washed twice with 0.02% Tween 20 and 
1% BSA in PBS, followed by incubation with Alexa Flour 488 conjugated anti-
rabbit (Molecular Probes Inc) for 30 minutes at RT. After washing 3X with 0.02% 
Tween 20 and 1% BSA in PBS, the coverslips were mounted with Vectorshield 
containing DAPI (Vector Labs, CA). Cells were examined under a Ziess LSM 
510 Meta laser scanning fluorescence confocal microscope (Carl Zeiss 
Microscopy, GÖttingen, Germany). For staining of DNA to look at stage of 
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mitosis where Taxol and MG132 arrest the cells in, cells are fixed and mounted 
with Vectorshield for confocal microscopy. 
 
2.2.5 Protein isolation and analysis 
2.2.5.1 Total cell lysate 
Cells were harvested by first rinsing the monolayer with PBS, followed by 
trypsinzation with 0.25% trypsin for 3 to 5 mins. The cell suspension were then 
transferred to an eppendorf tube and pelleted by centrifugation at 2000 rpm for 10 
mins. The pellets were either frozen in -80oC or lyzed in protein lysis buffer. 
Pellets are re-suspended in 35 µl of protein lysis buffer containing protease 
cocktail inhibitors (Sigma) for 30 mins at 4oC. The suspension is then spin for 30 
mins at 13000rpm in 4oC. The supernatant is collected and used protein 
concentration measurement 
 
2.2.5.2 Cell fractionation 
After treatment and harvesting, the cells were washed 2X with cold PBS, 
followed by centrifugation at 1500rpm for 5 minutes. The cell pellet was 
resuspended in fractionation buffer (22 mmol/L mannitol, 70 mmol/L sucrose, 50 
mmol/L PIPES-KOH, pH 7.4, 50 mmol/L KCI, 5 mmol/L EGTA, 2 mmol/L 
MgCL2 and 1mmol/L dithiothreitol and protease inhibitors (Sigma).  After 30 
minutes incubation on ice, the cells were homogenized by pulling through a 25G 
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needle 20X. The homogenate was spun at 8000rpm for 15 minutes. Supernatants 
containing mitochondria fraction was removed and further spun at 13000rpm for 
15 minutes. The supernatant were removed and used as cytosol fraction. The 
pellet is washed once and lyzed with 2% CHAPS (Sigma) in PBS for 15 minutes, 
spun at 13000rpm for 15 minutes and lysate used as crude mitochondria extract. 
 
2.2.5.3 Determining of protein concentration 
Protein concentration was determined spectrophotometrically using Bradford 
method with protein binding dye (Pierce). For measurements, 1 µl of protein 
sample was added to 49 µl of PBS and 950 µl of the dye. Readings were recorded 
at wavelength of 595 nm. 
 
2.2.5.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
The 10% SDS-PAGE gel was cast using the Mini-PROTEAN III gel apparatus 
(Biorad Laboratories). The gels were prepared following the method outlined in 
Sambrook et al., (1989). The resolving gel was allowed to set at RT for 30 mins. 
A 5% stacking gel was prepared and loaded onto the resolving gel. The protein 
samples were boiled in 1X loading buffer before loading to the gel. The gel was 
run at 180V for 1.5 hrs in 1X SDS electrophoresis buffer. A pre-stained high 
molecular weight protein marker (14.2 kDa - 200 kDa; Invitrogen Life 
Technologies) was run as a reference. After electrophoresis, the proteins were 
 53
transferred from gel to polyvinylidene difluoride (PVDF) membrane at 20V 
constant voltages for 1 hr at 4oC in transfer buffer. 
 
2.2.5.5 Western hybridization 
The membrane was placed into blocking buffer for 1 hr at RT. The primary 
antibody was diluted in blocking buffer according to manufacturer’s 
recommendation. Following blocking, the membrane was incubated in the 
primary antibody for 1 hr at RT. Excess antibody was removed by washing the 
membrane in wash buffer for 30 mins with agitation, and changing the buffer 
every 10 mins. Secondary antibodies conjugated with horseradish peroxidase 
(HRP) were diluted in blocking buffer according to manufacturer’s 
recommendation. The membrane was then incubated in the secondary antibodies 
for 1 hr at RT with agitation. To remove the unbound secondary antibodies, the 
membrane was washed in washing buffer for 30 mins with agitation. Detection 
was performed using enhanced chemiluminescene’s detection system (Amersham 
Pharmacia), for endogenous p73 detection, SuperSignal West Dura Extended 
duration Substrate was used (Pierce Inc).  
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2.2.6 Semi-quantitative PCR 
PCR was performed using Taq polymerase (Qiagen) in a 30µl solution: 1 µl of 1st 
strand cDNA, 1 µl each of 10pmol/µl of primers, 1 µl of 10mM dNTPs, 3 µl of 
10X buffer and 0.4 µl of Taq polymerase, top up with H20 till 30 µl. 
Human p73 
Human p73-for: TCT GGA ACC AGA CAG CAC CT  
Human p73-rev: GTG CTG GAC TGC TGG AAA GT 
PCR reaction was amplified for 33 cycles at 94oC for 50s, 54oC for 30s and 72oC 
for 30s. 350 bp band is expected. All forms of TA-p73 can be detected using this 
primers. 
Human GAPDH 
human gapdh-for: ACC CCT TCA TTG ACC TCA AC 
human gapdh-rev: CAG CGC CAG TAG AGG CAG 
PCR reaction was amplified for 22 cycles at 94oC for 50s, 55oC for 30s and 72oC 
for 40s. 500 bp band is expected. 
Human mdm2 
human mdm2-for: ATG TGC AAT ACC AAC ATG TCT GTA CCT  
human mdm2-rev: AGG GGA AAT AAG TTA GCA CAA TCA TTT GA 
PCR reaction was amplified for 22 cycles at 94oC for 50s, 55oC for 30s and 72oC 
for 1 min 30s. 1500 bp band is expected. 
Human Bim 
Human bim-for: AGC CCA GCA CCC ATG AGT TGT GAC  
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Human Bim-rev: CTC TGG GCG CAT ATC TGC AGG 
PCR reaction was amplified for 35 cycles at 94oC for 30s, 55oC for 20s and 72oC 
for 20s. 100 bp band is expected. 
Human caspase-2L 
Human caspase-2L-for: GCG GCG CCG AGC GCG GGG TCT TGG 
Human cas2L-rev: GTG GGA GGG TGT CCT GGG AAC 
PCR reaction was amplified for 32 cycles at 94oC for 30s, 52oC for 30s and 72oC 
for 1 min 30s. 1300 bp band is expected. 
Human caspase-2S 
Human cas2S-for: GAT GTG GAC CAC AGT ACT CTA G 
Human cas2S-rev: TCA TAG AGC AAG AGA GGC GGT G 
PCR reaction was amplified for 36 cycles at 94oC for 30s, 52oC for 30s and 72oC 
for 30s. 350 bp band is expected. 
Human caspase-8 
Human caspase-8-for: CAA GAA CCC ATC AAG GAT GCC TTG 
Human caspase-8-rev: CCA AAG TCT GTG ATT CAC TAT CC 
PCR reaction was amplified for 30 cycles at 94oC for 30s, 52oC for 30s and 72oC 
for 30s. 600 bp band is expected. 
Human caspase-9 
Human caspase-9-for: TGA TCG AGG ACA TCC AGC GG  
Human caspase-9-rev: GAA GCG ACG CCG CAA CTT CTC AC 
PCR reaction was amplified for 30 cycles at 94oC for 30s, 52oC for 30s and 72oC 
for 30s. 450 bp band is expected. 
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Mouse gapdh 
Mouse gapdh-for: CAC CAT CTT CCA GGA GCG AGA C  
Mouse gapdh-rev: GCC AGT GAG CTT CCC GTT C 
PCR reaction was amplified for 25 cycles at 94oC for 30s, 55oC for 30s and 72oC 
for 30s. 450 bp band is expected. 
Mouse p53 
Mouse p53-for: GGA ATT CGC CAT GGA GGA GTC ACA GTCG  
Mouse p53-rev: CCC AAG CTT CAG TCT GAG TCA GGC CCC AC 
PCR reaction was amplified for 28 cycles at 94oC for 30s, 54oC for 30s and 72oC 
for 1 min. 1.1 kb band is expected. 
Mouse p73 
Mouse p73-for: CAC TTC GAG GTC ACC TTC CAG  
Mouse p73-rev: GCA CAA GCT CCA TCA GTT CTA G 
PCR reaction was amplified for 34 cycles at 94oC for 30s, 54oC for 30s and 72oC 
for 50s. 750 bp band is expected. 
Mouse mdm2 
Mouse mdm2-for: GGC TGT AAG TCA GCA AGA CTC  
Mouse mdm2-rev: CCA GGT AGC TCA TCT GTG TTC 
PCR reaction was amplified for 32 cycles at 94oC for 30s, 54oC for 30s and 72oC 
for 20s. 200 bp band is expected. 
Mouse bim 
Mouse Bim-for: AGG TGG ACA ATT GCA GCC TGC 
Mouse bim-rev: TGA ACT CGT CTC CGA TCC GCC 
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PCR reaction was amplified for 34 cycles at 94oC for 30s, 52oC for 30s and 72oC 
for 30s. 400 bp band is expected. 
2.2.7 Chromatin Immunoprecipitation 
Saos2 tet-on inducible 73β were cultured in 15 cm diameter culture dishes till 
80% confluence. Doxocycline were added at 2µM concentration for another 12 
hrs to induce p73 expression. The cells were then fixed with 1% formaldehyde for 
15 mins at room temperature (RT), stopped with glycin to final concentration of 
125mM for 15 mins at RT. Treated cells were then washed twice with PBS and 
once with KM buffer (pH 6.8, 10mM NaCl, 1.5mM MgCl2, 1mM EGTA, 5mM 
dithiothreitol, 10% glycerol, 10mM MOPS, 10 mins interval. Cells are then lysed 
for 30 mins using 4 ml KM buffer-1% NP40 + protease inhibitors in 4oC. After 
the buffer is adjusted with 2.7 ml 5M NaCl for 60 mins at 4oC. The dishes were 
washed with TE buffer and harvested to a 2 ml tube. The extracts were then 
sonicated (Branson, S-450D) 5 times for 10 secs pulse, 5 mins with break interval 
about 10 mins on ice. Sample is centrifuged at 13000 rpm at 4oC for 30 mins and 
supernatant collected. 400 µl of sample is used for immunoprecipitation with 10µl 
of p73 (Ab3, Oncogene Science, Cambridge, MA) or HA antibody (Santa Cruz 
Biotechnology Inc) for 2 hrs at 4oC on shaker. 10 µl of Dynabeads Protein A 
and G (Invitrogen) were added for a further 2 hrs. Immuno-complexes were 
washed with 2 times RIPA buffer, 1 times HS buffer (0.1% SDS, 1% Triton X, 
2mM EDTA, 20mM Tris-HCl, pH 8, 500mM NaCl), 1 times LS buffer (0.1% 
SDS, 1% Triton X, 2mM EDTA, 20mM Tris-HCl, pH 8, 150mM NaCl), 1 times 
0.25M LiCl buffer, 1 times 0.5M LiCl buffer at 37oC for 10 mins, follow by 2 
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times RIPA buffer, 2 times TE buffer. DNA protein complex was eluted with 100 
µl of TE buffer containing 1% SDS. Protein DNA complex was then reverse 
crosslinked by 200mM NaCl at 65oC for 4 hrs, followed by proteinase K 
treatment at final concentration of 500 µg/ml at 55oC for 2 hrs. DNA fragments 
are isolated using Qiagen PCR purification kit. Briefly, purified DNA solution is 
top up to 200 µl using water. 450 µl of QB buffer was then added to the solution 
and mixed. The mixture was transferred to a spin column and spin at 13 000 rpm 
for 1 min. The eluate is removed and the spin column washed with PE buffer. 
Excess PE buffer is removed by additional round of centrifugation. 50 µl of EB 
buffer was then added to the spin column and spin at 13 000 rpm for 1 min to 
collect the eluent containing the DNA fragments.  
PCR was performed using Taq polymerase (Qiagen) in a 50µl solution. 5 µl of 
DNA, 1 µl each of 10pmol/µl of primers, 1 µl of 10mM dNTPs, 5 µl of 10X 
buffer and 0.4 µl of Taq polymerase, top up with H20 till 50 µl. PCR conditions 
for RE1, RE2, RE3 and MDM2RE are the same. Heat start at 95oC for 3 mins, 
55oC annealing for 1 min, 72oC extension for 30 s, 39 times. 
RE1-for: GAC AGC TGA GGT CTA GCT CAG CAC, RE1-rev: ACG CTT TGT 
GTT TAA CTG CAA TAC. Product size of RE1 is around 300 bp. RE2-for: CAG 
GGC TTA TGA GCC ATA GGG A, RE2-rev: CTT GTA TGC TAA TCT GCT 
GTG. Product size of RE2 is around 300 bp.  RE3-for: CCC AAA GTA TCT 
TGA GGT TCC, RE3-rev: CTA TAT GCA ATT GGA GAC ATG GG. Product 
size of RE3 is around 300 bp. MDM2RE-for: GAT CGC AGG TGC CTG TCG 
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GGT CAC TA, MDM2RE-rev: GGT CTA CCC TCC AAT CGC CAC TGA 
ACA CA. Product size of MDM2RE is around 250 bp.    
PCR conditions for Caspase-2SRE is as follows: heat start at 95oC for 3 mins, 
50oC annealing for 1 min, 72oC extension for 30 s, 39 times. 
Caspase-2SRE-for: GGA CGC CCG CCC GAG CCG CTC, Caspase-2SRE-rev: 
AGT CTT TTC CCA CGA GAG AGA CAA GGC C. Product size of Cas2SRE is 
around 100 bp.   
PCR conditions for non specific genomic DNA is as follows: heat start at 95oC for 
3 mins, 54oC annealing for 1 min, 72oC extension for 30 s, 39 times. 
Non-specific-for: CTG TAG ACT GCA GTC CTG ATT C, non-specific-rev: 
GAA GCT GCA GAC CGT GGG CAC. Product size of non-specific DNA is 
around 300 bp. 
 
2.2.8 GST protein purification 
p73α, p73β and p53 were cloned into pGEX4T-1 (Pharmacia Biotech) for making 
of GST-73α, GST-73β and GST-p53 fusion proteins. The GST fusion protein 
plasmids were transformed into BL21 E.coli and cultured in 200 ml LB broth for 
4-5 hrs until 0.D600 = 0.5. 1mM of IPTG was then added to the cultures and 
further cultured at 37oC for 4 hrs. The cultures were harvested and washed in 
PBS. The bacteria were then resuspended in PBS containing 1% Triton-X, and 
broken by sonication (Branson, S-450D), rating 3, 30 secs pulse, 30 secs break, 
10X and the lysate collected by centrifugation. The lysates were incubated with 
gluthatione beads for 2 hrs at 4oC. The beads were then washed several times in 
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PBS and bound GST fusion proteins eluted with glutathione elution buffer 
(10mM Tris, pH 8, 5mM glutathione). 
 
 
2.2.9  In vitro DNA Protein Binding assay 
A 24 bp p73β recognition site on caspase-2S promoter, GAC GCC CGC CCG 
AGC CGC TCC GAG, were synthesized with 5’ biotin label on both strands. The 
biotein labeled recognition sequence was then attached to avidin conjugated 
sepharose beads (Invitrogen Life Technologies). Purified GST proteins diluted in 
RIPA buffer (0.1% SDS, 1% Triton X, 2mM EDTA, 20mM Tris-HCl, pH 8, 
150mM NaCl) were then incubated with the recognition sequence attached beads 
for 2 hrs at 4oC. After incubation the mix was washed six times with RIPA buffer. 
After the last wash, 30 µl of protein loading buffer were added to the beads and 
boiled for 5 mins before loading to the SDS-acrylamide gel.  
 
2.2.10 Luciferase assay 
All transfections for luciferase assay were done in 6-well plates. Transient 
transfections were performed with 100ng p73 plasmids as indicated and 0.5ug 
each of the indicated luciferase reporter constructs and 100ng of the plasmid 
encoding the beta-galactosidase gene for evaluating the transfection efficiency. 
Cells were generally collected 24 hrs post-transfection and in triplicates. Half the 
samples were used for immunoblotting to evaluate the expression status of the 
transfected plasmids. Upon harvest, the cells are washed twice with cold PBS 
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before addition of 1 ml of luciferase lysis buffer and shaken for 1 hr at 4oC. The 
lysate are then collected into 2 ml eppendorf tubes and spun for 30 mins at 4oC. 
The supernatant are then collected and used for measurement. To measure beta-
galactosidase activity, 100 µl of sample is added to 200 µl of β-gal assay buffer 
(Sodium phosphate buffer pH 8.0, 1mM MgCl2) containing 2 µl galacton and 
incubated in the dark for 1 hr. The samples are then measured for beta-
galactosidase activity using a luminometer (Biorads) with accelerator (0.2M 
NaOH, 33 µl of Emerald) as substrate. To measure luciferase activity, 100 µl of 
sample is added to 350 µl of luciferase assay buffer (25mM gylcerglycine, 5mM 
ATP, 15 mM MgSO4, 1mM dTT). Luciferase activity can then be measured from 
the samples using the luminometer with injection buffer (25mM glycerglycine 
and 10mM luciferin) as substrate. The values obtained from the luciferase activity 
readings are normalized against the readings obtained from beta-galactosidase 
activity. Average reading of three sets for each sample and the standard deviation 
is used to plot the graphs.  
 
2.2.11 Statistical analysis 
Statistical analysis was performed using student’s t test. Paired Student’s t test 
was used when comparing two related experimental groups. p value < 0.05 was 


























1.1 p53 tumor suppressor family 
The family of transcription factors consists of three members; p53, p63 and p73. 
The p53 family suppresses tumor formation through induction of genes necessary 
for apoptosis or cell cycle arrest. It does that by binding to p53-responsive 
elements located in the promoters of the target genes, and either transcriptionally 
activate or repress target genes. The p53 family members share significant 
sequence homology with each other (Irwin and Kaelin, Jr., 2001). Each of them 
consists of a N-terminus trans-activation domain, a central DNA binding domain 
and a C-terminus regulatory domain (Illustration 1). All three p53 family 
members can trans-activate overlapping subset of p53 target genes due to the 










Illustration 1: Primary protein structure of the p53 family of tumor suppressor. 
TA: transactivation domain, DBD: DNA binding domain, OD: oligomerization 
domain, SAM: sterile α motif domain. The numbers are the amino acid length of 
each protein. ∆N variants, which lack the TA domain is generated by alternate 
promoter usage.  
 
p53
1 45 113 290 319 363
TAp73α
1 54 131 310 345 484380 549
DNp73α
TAp63α
1 59 142 321 353 506397 571
DNp63α
TA DBD OD SAM
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1.1.1 p53 
Interestingly, p53, which is the first member of the p53 family to be discovered 
more than 26 years ago, was originally believed to be an oncogene (Lane and 
Crawford, 1979; Linzer et al., 1979). However subsequent experimental data 
proved otherwise and p53 was instead shown to be an essential component of the 
tumor suppression network (Vogelstein et al., 2000). More importantly, knockout 
of p53 in mice result in spontaneous tumor formations (Donehower et al., 1992). 
Conversely, over-expression of p53 kills the cells. Thus endogenous levels of p53 
must be kept extremely low. This tight regulation is mainly achieved at the level 
of the protein stability. p53 is rapidly degraded by Mdm2 and MdmX, both E3 
ubiquitin ligases that bind to and ubiquitinate p53, tagging it to proteasome for 
degradation. So tight is this regulation of p53 protein that embryonic lethality of 
Mdm2-/- and MdmX-/- mice can only be rescued by concomitant deletion of p53 
(Jones et al., 1995; Parant et al., 2001). p53 is activated by a variety of cellular 
stresses ranging from DNA damage to aberrant hyperproliferative signals. DNA 
damage and cytotoxic stress mainly work by stabilizing p53 via phosphorylation 
of p53 by upstream kinases such as ataxia telangiectasia mutated (ATM) and 
Chk2. Phosphorylation of p53 results in its dissociation from Mdm2/MdmX as 
well as recruitment of co-activators. Aberrant hyperproliferative signals from 
human cancer cells on the other hand usually result in activation of p14ARF which 
trigger the dissociation of p53 from Mdm2 thus stabilizing and activating p53 
(Stott et al., 1998). Once activated, p53 can promote either apoptotic cell death or 
growth arrest through trans-activation or repression of wide array of target genes.  
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However the decision of when to trigger apoptosis or cell cycle arrest by p53 
remains unclear. Besides transcriptional activation to regulate apoptosis, p53 has 
also been shown to regulate cell death via a transcriptional independent manner. 
p53 binds to anti-apoptotic Bcl family member Bcl-2 and Bcl-XL thereby freeing 
Bax, which in turn permeabilizes the mitochondrial membrane leading to 
activation of caspases and cell death (Chipuk and Green, 2004; Leu et al., 2004; 
Mihara et al., 2003). However these data are controversial to whether p53 exist in 
complex with Bcl-2 during normal or stress conditions and whether additional 
input is required before cell death is triggered. 
 
1.1.2 p63 
Two genes with significant homology to p53 were discovered eight years ago, 
named p63 and p73 (Jost et al., 1997; Kaghad et al., 1997; Yang et al., 2002). p63 
gene generates numerous different protein isoforms because of transcription from 
an alternate promoter located at the third exon as well as because of post-
transcriptional splicing events at the C-terminal of the transcripts. Alternate 
transcription generates either transcription capable p63 (TA-p63) or transcription 
deficient p63 (DN-p63). Unlike p53 null mice, which develop spontaneous 
tumors, p63 knockout mice die at birth (Mills et al., 1999). The pups develop 
numerous developmental defects, ranging from absence of apical ectodermal 
ridge, which is an embryological structure required for limb outgrowth, to 
absence of structures required for ectodermal-mesenchymal interactions during 
morphogenesis. These pups also have abnormal epidermal and p63 was shown to 
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be important for epithelial development (Koster and Roop, 2004; Koster et al., 
2004). Evidence suggests that the role of both TA-p63 and DN-p63 are important 
for epithelial development (Ihrie et al., 2005; Lee and Kimelman, 2002). In 
addition, p63 has also been implicated in neuronal and ovary oocytes apoptosis 
(Jacobs et al., 2004; Suh et al., 2006). 
 
1.1.3 p73 
Like p63, p73 has numerous N- and C-terminal isoforms, capable of trans-
activation (TA-forms) or dominant negative effect (DN-forms). However the 
phenotype of p73 knockout animals are vastly different from that of p63. p73-/- 
mice, though born alive, are runted and die within a few weeks of postnatal birth 
(Yang et al., 2000). The p73-/- mice develop immunological problems such as 
chronic inflammation, and nervous system defects such as hippocampal 
dysgenesis, olfactory neuron defects and sympathetic neuron loss (Pozniak et al., 
2000; Yang et al., 2000). However studies on mechanism underlying these 
phenotypes have been complicated due to the presence of multiple protein 
isoforms with opposing functions (TA- and DN- isoforms). For example, 
developmental sympathetic neuron cell death have been shown to be partially 
dependent on p53, thus it was expected that p73-/- mice will also show enhanced 
survival in its sympathetic neurons. However researchers found dramatic decrease 
in sympathetic neuron number in p73-/- mice sympathetic superior cervical 
ganglion (SCG) (Ponziak et al., 2000). This was because predominant form of 
p73 in SCG is the DN-isoforms. Nerve growth factor (NGF) deprived sympathetic 
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neurons result in decrease in DN-p73 expression and subsequent cell death, which 
can be rescued by DNp73 overexpression. This anti-apoptotic role of DNp73 is 
partially through antagonizing the apoptotic role of p53 (Zaika et al., 2002). 
 
1.1.3.1 p73 and cancers 
p73, unlike p53, is rarely lost or mutated in cancers. Extensive mutational analysis 
have failed to uncover significant p73 mutations in human cancers (Moll and 
Slade, 2004). Instead, overexpression of p73 mRNA and/or protein relative to the 
respective normal tissues has been demonstrated in a large variety of tumor types, 
including neuroblastoma, glioma, breast, lung, colon, stomach, ovarian, bladder, 
liver, cholangiocellular carcinoma, ependymoma, chronic myelogenous leukemia 
and acute myelogenous leukemia (Moll and Slade, 2004). Up-regulation of p73 in 
cancers is not restricted just to the DNp73 isoforms, but also to the TA-p73 
isoforms. While the over-expression of DNp73 in cancers can contribute to 
increase resistance to cell death through antagonizing p53 functions, the reason 
for over-expression of TA-p73 in cancers is not well understood. It could either be 
a response to control tumor development or a contributing factor to tumorigenesis 
in human cancers. Increasing evidence suggest the latter reason is more likely. 
Gastrin, a secreted peptide hormone that promotes cell growth and survival in 
gastrointestinal cells, has been shown to be regulated by p73 (Tomkova et al., 
2006). The authors further showed that over-expression of gastrin correlated with 
over-expression of TA-p73 isoforms in human gastric cancers. In addition, our lab 
have shown that over-expression of TA-p73, together with c-jun, can drive the 
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expression of cyclin D and collagenase, further suggesting a role of p73 in 
tumorigenesis (Vikhanskaya et al., 2007). 
Nonetheless, ectopic expression of p73 can induce apoptosis. Many 
chemotherapeutic drugs trigger apoptosis through activation of p73 (Irwin et al., 
2003). Current research suggests that p73 triggers apoptosis via two pathways 
(Ramadan et al., 2005). The first is via the trans-activation of scotin. Scotin 
induces endoplasmic reticulum stress, calcium release and caspases dependent 
apoptosis. The second pathway is through trans-activation of PUMA. Puma 
mediates Bax conformation change and translocation to the mitochondria where it 
triggers cytochrome c release.  
Therefore p73 appears to possess opposing functions in regulating cell death as 
well as tumorigenesis. Although the idea seems radical, it is not restricted just to 
p73 alone, as many other genes also have such dual ability e.g. E2F-1, c-myc and 
c-jun, suggesting deep complexity of p73 regulation and function (Secombe et al., 
2004; Eferl and Wagner, 2003; Bell and Ryan, 2004). 
 
1.1.3.2 p73 regulation 
Under normal circumstances, endogenous p73 protein levels are kept extremely 
low in the cells, implying its tight regulation. Given the similarity between p53 
and p73, it is not surprising that mdm2 will be able to degrade p73. Although 
mdm2 does bind to p73, this interaction stabilizes instead of degrading p73 
(Wang et al., 2001; Zeng et al., 1999).  The task of keeping p73 levels low in the 
cells is dependent on a HETC-E3-ubiquitin ligase, Itch, which targets p73 for 
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protein ubiquitination in a highly specific manner (Rossi et al., 2005). This 
regulation depends on the binding of p73 through its proline rich domain to the 
WW domain of Itch. Knockdown of Itch results an in increase in levels of 
endogenous TA- and DN-p73 isoforms. However, unlike mdm2, Itch null cells 
survive, indicating the presence of other mechanisms that regulate p73 levels. 
Indeed, p73 can be degraded via a Nedd8 conjugation pathway. Using a cell line 
containing temperature labile Nedd8 activation enzyme, the authors were able to 
show that upon inactivation of the enzyme, p73 protein level but not p53 
accumulate (Bernassola et al., 2004). Physiologically, Nedd8 conjugation to TA-
p73 was shown to be dependent on Mdm2 (Watson et al., 2006), though this 
finding contravene that of earlier studies showing Mdm2 stabilize p73. 
Transcriptionally, p73 is up-regulated by E2F-1, a G1/S regulating protein (Stiewe 
and Putzer, 2000). The ectopic expression of E2F-1 results in apoptosis, which is 
dependent on p73. Another group demonstrated that E2F-1 up-regulation of p73 
happens in the presence or absence of DNA damage (Urist et al., 2004). This 
raised the possibility that p73 may be cell cycle regulated and expressed at the 
G1/S stage of the cell cycle.  
 
1.1.3.3 p73 protein modifications 
Like p53, p73 transcriptional and apoptotic activities are also regulated post-
transcriptionally. Cisplatin treatment results in phosphorylation of tyr-99, ser-289 
at p73 by c-abl and protein kinase Cδ catalytic fragment respectively (Agami et 
al., 1999; Gong et al., 1999; Ren et al., 2002). In addition, cisplatin treatment also 
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results in phosphorylation of p73 at position ser-47 by Chk1 (Urist et al., 2004). 
The phosphorylation on p73 after DNA damage, allows the interaction of p73 
with Pin1, which is a peptidy-prolyl cis/trans isomerase (Urist and Prives, 2004; 
Mantovani et al., 2004). Pin1 dependent p73 prolyl isomerization, results in p73 
stabilization and ultimately the increase in its activity. Other forms of DNA 
damage agents such as doxorubicin have been shown to induce acetylation of p73 
by p300 (Zeng et al., 2000). All in all, modifications such as phosphorylation and 
acetylation of p73 upon DNA damage stabilize p73 and increase its pro-apoptotic 
ability (Illustration 2). 
In the non-stressed state, TA-p73 is phosphorylated in a cell cycle dependent 
manner. During mitosis, TA-p73 is phosphorylated by cdk1/cyclinB, which in 
turn decreases the ability of p73 to bind to DNA and activate transcription in 
mitotic cells (Fulco et al., 2003). Upon mitotic exit, p73 is hypo-phosphorylated 
and this modification seems to be important in regulating mitotic to G1 transition 



















Illustration 2: Post-translational modifications on p73 after DNA damage (Ozaki 
and Nakagawara, 2005). DNA damage induces phosphorylation of p73 by c-abl, 
chk1 and PKCδ. The phosphorylation in turn recruits other modifiers e.g. p300 to 
acetylate p73 and pin1 which induces p73 prolyl isomerization. These 





1.1.4 p53 family in apoptosis and as tumor suppressors 
Despite the numerous conflicting and confusing data on different isoforms of p63 
and p73 in regulating apoptosis or tumorigenesis, genetic data suggest that the key 
role of p53 family is in regulating cell death and tumor suppression. p53, together 
with p63 and p73 have been shown to play an important role in apoptosis in 
various biological systems (Flores et al., 2002; Irwin and Kaelin, Jr., 2001; 
Melino et al., 2003). Efficient apoptosis requires all the three p53 family 
members. This was demonstrated using genetic experiments where E1A-
transformed mouse embryonic fibroblasts (MEFs), lacking in p63 and p73, cannot 
undergo apoptosis after DNA damage, despite the presence of p53 (Flores et al., 
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2002). These experiments suggest that DNA damage activates either a single 
apoptotic pathway, which involves all three p53 family members, or activate 
several different apoptotic pathways, where individual p53 members acts 
separately to induce efficient cell death. However the data could not explain why 
p63 and p73 null mice do not develop spontaneous tumors like p53 null mice. The 
suspicion was because p63 and p73 null mice do not live long enough for tumor 
development. True enough, p73+/- and p63+/- mice, which survive, developed wide 
array of tumor phenotype (Flores et al., 2005). In fact, mice heterozygous for both 
p53 and p73 develop higher tumor burden as well as more metastatic tumors than 
p53+/- alone, suggesting p53 family members act through different mechanisms 
for tumor suppression. Together these data support the important role of p53 
family as tumor suppressors, at least in murine genetic systems. 
 
1.2 Control of genomic integrity 
The presence of abnormal chromosomal content is one of the most common 
hallmarks of cancer. The acquisition of abnormal chromosomal content is largely 
in part due to the lost of control checkpoints to remove abnormal cells from the 
system. The integrity of the genome is frequently challenged by DNA strand 
breaks caused by oxidative stresses induced by cellular metabolic activities, 
exposure to uv-irradiation and environmental agents capable of interacting with 
DNA. The p53 family plays an important role to maintain and prevent this lost of 
genomic integrity. Cellular surveillance mechanisms in normal cells help to detect 
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and repair the genome damage to ensure genomic integrity to the subsequent 
generations of cells.  
 
1.2.1 G1 checkpoint 
The most well studied checkpoint is that of the G1/S checkpoint or DNA damage 
checkpoint. This checkpoint prevents the replication of damaged DNA by 
arresting the cell at G1 phase of the cell cycle to allow the genome to be repaired 
or to initiate cell death. Central to this DNA damage response is p53, which 
activate a plethora of genes required for cell cycle arrest e.g. p21, p16, p57, for 
DNA repair e.g. GADD45, and for apoptosis e.g. Bax, Puma, 53AIP (Harris and 
Levine, 2005). Although how p53 decides to trigger either cell cycle arrest or 
apoptosis remains unclear. It is likely to depend on the extent of the DNA 
damage. If repair can be carried out cell cycle arrest may be triggered but if 
damage is too extensive, apoptosis ensures. In addition, the decision is also found 
to be cell type dependent; fibroblasts prefer arrest while lymphocytes and stem 
cells chose apoptosis upon DNA damage. Whatever the case, cells without p53 
have a defective DNA damage checkpoint and will continue progress into the S 
phase to duplicate its genome and enter G2 phase of the cell cycle with the 
mutated DNA.   
 
1.2.2 G2 checkpoint 
At the G2 phase of the cell cycle, cells with damaged DNA are arrested at the 
G2/M checkpoint. Unlike G1/S checkpoint, G2/M checkpoint can be maintained in 
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the absence of p53. Rather G2/M checkpoint is dependent on the cdc25 and cdk1 
interaction (Taylor and Stark, 2001). Under normal condition, cdc25 phosphatase 
removes inhibitory phosphorylation on cdc2 kinase, which allows it to complex 
with cyclin B1 and to drive cell into mitosis. DNA damage activates checkpoint 
kinases such as Chk1 and Chk2, which phosphorylate cdc25, keeping it inactive. 
Without dephosphorylation of Thr-14 and Tyr-15 on cdc2 by cdc25, cells arrest at 
G2 phase until the damage is repaired.  
 
1.2.3 Spindle checkpoint 
In the event where both G1 and G2 checkpoint are defective, cells with damage 
DNA can then enter mitosis where they encounter another checkpoint, the spindle 
checkpoint. The main responsibility of the spindle checkpoint is to ensure equal 
segregation of genetic material to each of the daughter cells during cell division 
(May and Hardwick, 2006). It occurs during metaphase of mitosis and it prevents 
anaphase transition until all chromosomes have obtained bipolar attachment. Cells 
with damaged DNA often fail to achieve stable bipolar chromosome alignment 
and arrest at this stage. Normal cells whose sister chromatids are aligned along a 
single plane and achieve bipolar attachment are allowed to enter anaphase. The 
entry into anaphase depends on the destruction of the cyclin B/cdk1 activity by 
anaphase promoting complex (APC), the critical component of the spindle 
checkpoint (Nigg, 2001). APC is a complex of 13 core subunits and either of the 2 
loosely associated regulatory subunits, cdc20 and cdh1 (Thornton et al., 2006). 
APC is an E3 ubiquitin ligase that ubiquitinate proteins whose degradation is 
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necessary for anaphase progression. APC is directed by regulatory subunit cdc20 
to its targets proteins during metaphase-anaphase transition. Besides cyclin B, 
another important target of APC is securin, whose degradation allows the release 
of separase which in turn cleaves cohesins, glue-like protein complexes holding 
sister chromatids together during mitosis, thus allowing chromatids to separate 
during anaphase towards opposing poles. In the cells, the spindle checkpoint is 
kept active through the binding of inhibitory proteins BubR1 and Mad2 to the 
APC. Only upon satisfaction of the chromatin alignment will this inhibitory 










Illustration 3: Molecular mechanism of chromosome segregation. At the 
metaphase-anaphase transition, APCcdc20 ubiquitinates securin and cyclin B. This 
results in the degradation of securin and cyclin B by the proteoasome. 
Degradation of securin activates separase, which then cleaves the Scc1 subunit of 
cohesion, allowing chromosome segregation. In response to sister chromatids not 
properly attached to the mitotic spindle, the spindle checkpoint promotes the 
assembly of checkpoint protein complexes that inhibit the activity of APC/C, 
leading to preservation of sister chromatid cohesion and delay in the onset of 




1.3 Mitotic catastrophe   
Failure of cells to overcome the spindle checkpoint can trigger mitotic 
catastrophe, which is a form of cell death resulting from abnormal mitosis 
(Roninson et al., 2001). It is the final mechanism in the cell cycle whereby cells 
with compromised genomic integrity are killed to prevent subsequent generation 
of cells from acquiring abnormal chromosomes number or mutated DNA. Many 
anti-cancer drugs work by acting on this stage of cell cycle checkpoint e.g. 
paclitaxel, docetaxcel, vincristine (Kisurina-Evgen'eva et al., 2006). These drugs 
act by interfering with microtubule dynamics, thus preventing proper alignment of 
sister chromatids. The cells treated with these drugs such as taxol arrest in mitosis 
due to abnormal spindle and subsequently undergo cell death (Illustration 4). 
Mitotic catastrophe can also be triggered by removal of certain genes regulating 
mitosis e.g. Plk1 (Liu and Erikson, 2003). Phenotypically, plk1 silenced cells 







Illustration 4: Spindle defects produced by anti-mitotic drug Taxol. A: A normal 
bipolar spindle of untreated cells at metaphase. B: Taxol-stabilized microtubules 





1.3.1 How mitotic arrest results in apoptosis? 
The morphological characteristics of cell death in mitotic catastrophe are similar 
to normal apoptosis such as membrane blebbing and DNA laddering. 
Mitochondria membrane permeabilization with release of cytochrome c and 
activation of caspase-9, caspase-2 and caspase-3 have also been described 
(Castedo and Kroemer, 2004). However despite the wealth of information, the 
sensory mechanism linking mitotic arrest to cell death remains unclear. For 
example what triggers the apoptotic processes during mitotic arrest? Is it the 
activation of the spindle checkpoint components? This hypothesis although 
reasonable, is unlikely to be the trigger because even during normal mitosis, 
spindle checkpoint is activated until the chromosomes are aligned, albeit for a 
shorter period of time compared with drugs induced spindle checkpoint arrest. 
This phenomenon suggests perhaps the length of time the cells spend in mitosis 
could be the determinant whether apoptosis will be triggered. Recently published 
work support the timing theory. They show that the inhibitory phosphorylation of 
caspase-9 by cdk1/cyclin B prevents the cells in mitosis to undergo apoptosis. 
Prolonged mitosis results in the gradual decay of cdk1 activity caused by cyclin B 
degradation which will trigger the activation of caspase-9 and thus apoptosis 
(Allan and Clarke, 2007). In addition, prolonged mitotic arrest bought about by 
inhibition of APC can also trigger mitotic catastrophe (Margottin-Goguet et al., 
2003; Teodoro et al., 2004). The prolonged inhibition of APC results in prolonged 
cdk1 activation, suggesting sustained cdk1 activity may initiate apoptosis. Though 
increase cdk1 activity can be detected in many other apoptotic conditions and 
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inhibition of cdk1 activity by chemical inhibitors such as roscovitine can block 
mitotic catastrophe induced by chk1 inhibition, it is unclear whether cdk1 activity 
directly initiates apoptosis or indirectly through initiating mitosis, which is 
required for mitotic catastrophe to occur (Castedo et al., 2002; Castedo et al., 
2004). Removal of BubR1 and Mad2 by knockdown approach have also been 
shown to protect cells from mitotic catastrophe induced by spindle poisons (Sudo 
et al., 2004). This raises an interesting possibility that BubR1, which has a kinase 
domain, could be the sensor that triggers apoptosis during prolonged mitotic 
arrest. Unfortunately this is complicated as inhibition of BubR1 also activates 
APC, thus allowing the cells undergoing mitotic arrest to exit mitosis 
prematurely, therefore escaping the possible catastrophe.  
The role of p53 family is regulating mitotic catastrophe has never been well 
studied. No studies were done to determine if p63 have any role in mitotic 
catastrophe. For p53, while it is required for DNA checkpoint to function 
properly, it has not been shown to play an important role in mitotic checkpoint. 
Apoptosis during mitotic catastrophe that happens during metaphase is p53 
independent. In fact, loss of p53 has been shown to sensitize cells to microtubule 
poisons, which kill cells by triggering mitotic catastrophe (Vikhanskaya et al., 
1998). Perhaps cells without p53 have a shorter cell cycle thus enter mitosis, the 
stage where spindle poison act on, faster than normal cells. However p53 plays an 
important role in regulating cell fate for cells that escape the mitotic checkpoint 
with aberrant chromosome segregation. These cells are arrested in post-mitotic G1 
state in a p53 dependent manner and eventually killed in a partially p53 dependent 
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manner (Andreassen et al., 2001). Cells without p53 and escaping mitotic arrest 
developed tetraploidy, leading eventually to polyploidy. Thus the major role of 
p53 in mitotic arrest seems to be at the polyploidy checkpoint, which is after 
mitotic checkpoint. The role of p73 in mitotic catastrophe is not known, although 
use of dominant negative p73 as well as knockdown techniques have been shown 
to reduce cell death attributed to spindle poisons (Irwin et al., 2003).  
 
1.4. Apoptosis   
Apoptosis or programmed cell death is a form of cell death where the cell plays 
an active role in its own demise. Classic features of apoptosis are chromatin 
condensation, mitochondrial release of proapoptotic proteins e.g. cytochrome c 
and AIF, caspases activation and DNA degradation (Castedo et al., 2004).  
The activation of apoptosis is effected through at least two pathways, the intrinsic 
and extrinsic pathway. The intrinsic pathway activates apoptosis via caspase-9 
activation while the extrinsic pathway activates apoptosis via the caspase-8 
pathway. Besides these two caspases, a third initiator caspase, caspase-2 has been 
shown to trigger apoptosis via intrinsic as well as extrinsic pathway (Shin et al., 
2005; Tinel and Tschopp, 2004).  
 
1.4.1. Caspase-9 activation pathway 
Upon mitochondria membrane permeabilization (MMP), pro-apoptotic factors 
such as cytochrome c, AIF, SMAC are released from the mitochondria inter-
membrane to the cytoplasm. Cytochrome c in particular induces a energy-
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dependent formation of an oligomeric complex known as apoptotic protease 
activating factor 1 (Apaf-1) apoptosome (Cain et al., 2002). This structure 
contains a caspase recruitment domain (CARD) that binds to procaspase-9 
zymogen, facilitating its autoactivation into a holoenzyme complex. In the 
apoptosome, close proximity of individual procaspase-9 initiates its autoactivation 
where procaspase-9 is cleaved into monomers, which then dimerized into 
catalytic active form. It is the active form that in turn cleaves and activates 
effector caspases such as caspase-3 and caspase-7. The effector caspases are 
responsible for the classic phenotype associated with apoptosis e.g. DNA 
laddering, membrane blebbing, nuclear envelope breakdown and proteolysis of 
cellular contents. Caspase-9 activation is regulated further at the post-proteolytic 
cleavage by inhibitors of apoptotic proteins (IAPs) (Miller, 1999). There are eight 
mammalian IAPs, which include XIAP, c-IAP1, c-IAP2, ML-IAP, ILP2, NAIP, 
Bruce and survivin. XIAP is the main IAP responsible for inhibiting caspase-9 in 
mammals. It does its function by binding to monomeric caspase-9, preventing 
caspase-9 dimerization and dimerization-dependent catalytic activity (Shiozaki et 
al., 2003). XIAP inhibition of caspase-9 is in turn negatively regulated by SMAC, 
which is released from mitochondria during MMP. SMAC has a similar IAP 
tetrapeptide binding motif that competes with caspase-9 for XIAP, thereby freeing 
caspase-9 to auto-activate (Srinivasula et al., 2001). Most intrinsic death signals 
e.g. from DNA damage or mitotic catastrophe result in the activation of this 
mitochondria-cytochrome c-caspase-9 pathway.  
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1.4.2 Caspase-8 activation pathway 
Caspase-8 activation, on the other hand, depends on the engagement of death 
receptors on the cell surface. Immune cells activate this extrinsic pathway during 
tumor surveillance to kill tumor cells. Binding of ligands such as FasL and tumor 
necrosis factor (TNF) to the FAS and TNF receptor respectively induced the 
formation of the death induced signaling complex (DISC). Procaspase-8 is 
recruited to the DISC through binding to fas-associated death domain (FADD) 
(Barnhart et al., 2003). As the activated death ligands are homo-trimeric, it 
induces the oligomerization of death receptor upon binding. This brings 
procaspase-8 together, facilitating in its autoactivation. Cleaved caspase-8 
dimerized together to form catalytic active units, which in turn activate other 
effector caspases to complete apoptosis.  
 
1.4.3 Caspase-2 pathway 
Caspase-2 has been implicated in both DNA damage as well as mitotic 
catastrophe induced apoptosis (Castedo et al., 2004; Lassus et al., 2002). Caspase-
2 deficient mice exhibit increase ovarian germ cells, indicating defect in female 
germ cell apoptois (Bergeron et al., 1998). Like initiator caspase-9, caspase-2 also 
contains a CARD domain for recruitment to adaptor protein complex such as 
apoptosome to aid its autoactivation. In this case, caspase-2 activation requires the 
assembly of a large protein complex containing adaptor protein, RIP-associated 
Ich1-homologous protein with a death domain (RAIDD) and the p53-induced 
protein with a death domain (PIDD), referred as the PIDDosome (Tinel and 
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Tschopp, 2004). However unlike well-studied caspase-9 or caspase-8 whose close 
proximity of seven caspase-9 or three caspase-8 trigger their respective 
autoactivation, the stoichiometry required for caspase-2 autoactivation in the 
PIDDosome remains unknown. 
 
1.5 Mitochondria membrane permeabilization (MMP) 
A key feature of apoptosis is the release of cytochrome c from the mitochondria to 
the cytoplasm. This event is generally termed as MMP with the outcome being 
cell death (Kroemer, 2002). The outer membrane permeabilization, which results 
in the release of cytochrome c, is regulated by the Bcl-2 family of proteins. This 
family consists of myriads of proteins, some forming pore complexes and 
promoting apoptosis e.g. Bax, Bak, others inhibiting this pore complex formation 
and blocking apoptosis e.g. Bcl-2, Bcl-XL, and yet others regulating these 
processes e.g. Bim, Bid and Bad (Green and Kroemer, 2004).  
Proapoptotic Bcl-2 family members Bax and Bak aid apoptosis by forming the 
pore complex in the outer membrane through which apoptotic factors are released 
from the mitochondrial intermembrane space (Korsmeyer et al., 2000). In the 
unstressed situation, Bax is either found loosely attached to the outer membrane 
of the mitochondria or sequestered in the cytosol (Guo et al., 2003; Nomura et al., 
2003). Similarly, Bak is attached to the outermembrane via interaction with 
voltage-dependent anion channel (VDAC) (Cheng et al., 2003). Upon apoptotic 
stimuli, Bax translocates to the mitochondria and together with Bak undergo 
conformation change, resulting in their oligomerization and pore complex 
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formation. These two proteins are absolutely important for MMP, as cells lacking 
Bax and Bak do not undergo outer membrane permeabilization and are 
completely resistant to wide array of apoptotic stimuli (Degli and Dive, 2003). 
Anti-apoptotic Bcl-2 family members have been proposed to work via inhibitory 
interaction with Bax and Bak, and thereby blocking their oligomerization and 
subsequent pore formation (Sedlak et al., 1995). Indeed transfection of MMP 
inhibitors such as Bcl-2 and Bcl-XL has been shown to block apoptosis (Zamzami 








Illustration 5: Schematic diagram of the role of different Bcl-2 family members 
on mitochondria outer-membrane permeabilization. In the unstressed state, Bax is 
either in the cytosol or attached to the mitochondria membrane, similar to Bak. 
Anti-apoptotic Bcl-2 members bind to and keep Bax/Bak inactive. BH3-only 
members are normally kept inactive e.g. Bim sequestered in the microtubules. 
Upon induction of apoptotic signal, Bax translocate to the mitochondria and 
oligomerized to form pore complex, releasing pro-apoptotic proteins cytochrome 
c and Smac into the cytosol. Bcl-2 are blocked by BH3-only proteins from 



















1.6 BH3-only Proteins 
While the interplay between Bcl-2 and Bax determine MMP, the BH3-only 
members of the Bcl-2 family determine when to induce apoptosis by sensing the 
various different stresses. Induction and activation of each of the BH3 members 
are subjected to the type of cell stimulus (Shibue and Taniguchi, 2006). Therefore 
unlike the Bax knockout model, which develops complete resistance to wide array 
of apoptotic stimuli, individual BH3 member knockout mice develop resistance 
only to specific stress signals. Nonetheless, all the BH3-only members act by 
interfering with anti-apoptotic Bcl-2 members, thus allowing Bax and Bak to 
promote apopotosis. Members of this BH3-only include Noxa, Puma, Bim, Bad, 
Bmf, Bid and Hrk. Of which, only Puma and Noxa are able to translocate directly 
to the mitochondria to activate apoptosis (Shibue and Taniguchi, 2006). Except 
for Noxa and Puma, the rest of the BH3-only members require post-translational 
modifications before being able to translocate to the mitochondria. 
 
1.6.1 Bim 
Bim is the BH3-only member that is of particular interest because Bim-/- cells are 
resistant to taxol, which is a spindle poison that causes mitotic catastrophe, hence 
suggesting an important role of Bim in regulating apoptosis during mitotic 
catastrophe (Tan et al., 2005). In addition, Bim-/- lymphocytes are resistant to 
other stresses such as, cytokine deprivation and calcium ion influx (Bouillet et al., 
1999). Bim knockout animals have abnormalities in the hematopoietic system and 
consistent with it, apoptosis of the hematopoietic cells involves bim (Boulliet et 
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al., 1999). Physiologically, Bim is attached to the microtubule in the cytoplasm of 
unstressed cells. Its pre-dominant forms (BimEL and BimL), in unstressed state, 
bind to the dynein light chain, a component of the microtubule dynein motor 
complex (Puthalakath et al., 1999). Upon specific stress such as anoikis, Bim 
dissociates from the microtubule and translocates to the mitochondria to promote 
apoptosis (Puthalakath et al., 1999; Puthalakath et al., 2001). Bim can bind to all 
members of the pro-survival Bcl-2 members to initiate MMP (Chen et al., 2005). 
Indeed no clones can be obtained from overexpression of Bim in fibroblasts 
(Chen et al., 2005). Unfortunately, the exact mechanism by which Bim 
dissociates from microtubules is not clear. Although studies have shown JNK 
phosphorylation of Bim upon UV stress allows Bim to dissociate from the 
microtubules, it is unclear if other stresses use the same mechanism (Lei and 
Davis, 2003). Transcriptionally, Bim is regulated by E2F-1, FOXO3A and Myc 
(Egle et al., 2004; Gilley et al., 2003; Hershko and Ginsberg, 2004). While Bim is 
not a known transcriptional target of p53 family, overexpression of DNp73β, a 
dominant negative form of p73, during NGF withdrawal in wildtype neurons 









Cells with damaged DNA or compromised genomic integrity have increased risk 
of becoming malignant. p53 family members prevent these cells from becoming 
cancerous by arresting the growth or initiating apoptosis. Although much work 
has been done to understand the role of p53 family during DNA damage response, 
not much is known about its role in maintaining genomic integrity through 
initiating mitotic catastrophe. The main aim of this research proposal therefore is 
to study if p73 regulates mitotic cell death. Specifically, the aims are: 
1) To study the role of p73 in mitotic cell death by 
(i) characterizing mitotic cell death induced by taxol; 
(ii) studying the function of p73 during mitotic cell death; 
(iii) determining the mechanism of action of p73 on inducing 
mitotic cell death. 
 
Caspases are key components that regulate apoptosis. Though the protein 
regulation of caspases is well studied, not much is known about its transcriptional 
regulation. Our initial data indicate that caspase-2S can be up-regulated by ectopic 
expression of p73β. For the secondary aim of the project, the potential role and 
mechanism of p73 in regulating caspase-2S will be discussed. Specifically, the 
aims are:  
2) To investigate the potential regulation of caspases by p73 
(i) establishing which caspases are regulated by p73 
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(ii) establishing the site of action by p73 on caspase-2S 
promoter 
(iii) investigating the mechanism of caspase-2S regulation; 



























Although mitosis is the shortest phase of the cell cycle, it is the most dynamic and 
visually stunning phase. Mitosis itself comprised of five main stages: prophase, 
prometaphase, metaphase, anaphase and telophase (Illustration 6). Cell entry into 
mitosis is marked by condensation of chromatin into well-defined chromosomes 
and migration of duplicated centrosomes into opposing ends. Centrosomes also 
begin to radiate highly dynamic microtubules in all directions and the nuclear 
envelope break down. This first stage is termed the prophase. The microtubules 
attached and detached randomly to kinetochores, which are proteinaceous 
structures located at the centromere of the chromosome. This process, which 
marked prometaphase, continues until stable bipolar attachment is achieved with 
microtubules emanating from opposing poles capturing each of the paired sister 
chromatids. At the metaphase stage, chromosomes are aligned along the 
metaphase plane, usually around the equatorial region of the cell, with each sister 
chromatids eventually attached to opposing centrosome via microtubules. Once 
this is achieved, sister chromatids will lose their cohesion and trigger the onset of 
anaphase. The separated chromatids are pulled towards the poles and once they 
arrived at the poles, nuclear envelope reform around the daughter chromosomes. 
Telophase is marked by chromatin decondensation and starting formation of 













Illustration 6: A series of photographs showing whitefish blastula cells 
undergoing various stages of mitosis. Adapted from Department of Zoology, 
University of Guelph, Guelph, Ontario, Canada. 
 
 
3.1.2 Chemotherapeutic drugs that target mitosis 
A successful mitosis is marked by inheritance of an equal set of chromosomes for 
each daughter cell. Cells that inherit abnormal set of genetic material may 
eventually become aneuploidy, a hallmark of cancer. Therefore cells erect control 
checkpoints during mitosis, which the most well studied being the spindle 
checkpoint, to ensure successful mitosis. Cells failure to overcome this checkpoint 
will trigger cell death during mitosis itself. Some cells, which may escape this 
checkpoint, in a term call mitotic slippage, can still die during later post-mitotic 
phases. This general cell death phenomenon caused by failed mitosis is coined 








Many chemotherapeutic drugs act by triggering mitotic catastrophe. Mechanistic 
insight into mitosis allows new drugs to be developed that specifically affect 
mitosis by targeting mitotic kinesins. Small molecular inhibitors of kinesin 
spindle protein have been shown during clinical trials to have good potential as 
chemotherapeutic drugs. Another class of drugs, which are the inhibitors of 
farnesyl transferase, histone deacetylase, and Hsp90, also act by directly interfere 
with the mitotic process. The most classic of mitotic drugs are the anti-
microtubule drugs such as taxanes and vinca alkaloids. They act by blocking 
microtubules dynamics, whose functions are important during mitosis for spindle 
pole formation and chromosomes alignment.   
 
 
3.1.2.1 Taxol  
One such anti-microtubule drug is Pacitaxel (Taxol), a compound found in the 
bark of the Pacific Yew, and is commonly used as a cancer chemotherapeutic 
drug. It stabilized microtubules by preventing its depolymerization. This 
stabilization effect is felt most strongly during mitosis where spindle assembly 
requires robust microtubules dynamics to attach and detach to kinetochores of 
sister chromatids such that each pair of sister chromatid will be ultimately 
attached to equal number of microtubules from opposing poles of the spindle. 
Taxol-treated cells, which are characterized by multi-polar spindles and non-align 
sister chromatids, fail to satisfy spindle checkpoint and arrest at the G2/M phase of 




Because mitotic catastrophe plays an important role in cancer therapy, it is 
important to understand the mechanism of mitotic cell death so as to enable better 
design of drugs to target this phase. Given the importance of p53 family in 
inducing cell death and that p53 has been shown not to play a role in mitotic cell 
death, we wanted to determine if its family member, p73, plays a role in mitotic 
cell death. Thus for this proposal, taxol-induced mitotic cell death will be used as 






























3.2 Taxol-induced mitotic cell death 
 
Mitotic catastrophe can be a type of cell death occurring during mitosis or 
resulting from mitotic failure, with each due to different mechanisms. To 
minimize complications, we first characterized the mitotic cell death induced by 
taxol. 
 
3.2.1 G2/M arrest induced by taxol treatment 
Cell cycle profile of p53 negative H1299 cells treated with 100 nM of taxol was 
measured to determine the time of entry and arrest of cells in the G2/M phase. Fig 
3.1 shows cell cycle profile, measured by flow cytometry, over time of human 
non-small cell lung carcinoma, H1299 cells, treated with 100nM of taxol. The M1 
peak represents population of cells having 4N DNA content or cells, which have 
already duplicated their genome, and are in the G2/M stage of the cell cycle. Taxol 
treatment of H1299 cells results in accumulation of cells, in the G2/M phase of the 
cell cycle, over time, indication of G2/M cell cycle arrest. The appearance of sub-
G1 population of cells, M2 peak, at later time points (30 hrs onwards), show that 

















Fig 3.1: Cell cycle profile of taxol treated H1299 cells over time. H1299 cells 
were synchronized at the G1/S phase with 24 hrs thymidine block. The cultures 
were then released in DMEM containing 100 nM Taxol and further cultured for 
36 hrs with samples taken every 6 hrs for cell cycle profile analysis. FACS figures 
shown are representative of triplicate. 
 
 
3.2.2 Mitotic arrest in taxol treated cells 
To further dissect the stage where the cells are arrested in, we probed the cells 
with anti-phospho histone H3 antibody and detect the positive cells using flow 
cytometry. H3 histones are phosphorylated only at the mitosis but not G2 stage of 
the cell cycle thus is used commonly as a marker for mitotic cells. As it can be 
seen in Fig 3.2, taxol treated cells enter mitosis around 12 hrs after treatment 
(19.1%) and maintain in mitosis till 24 hrs (31%) before gradually exiting mitosis. 
This data shows that taxol treated cells specifically enter mitosis and get arrested 
there, not at the G2 phase of the cell cycle. 
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Fig 3.2: Percentage population of taxol treated H1299 cells in mitosis over time. 
H1299 were treated and harvested as in Fig 3.1. The samples then probed with 
antibodies specific to phospho-histone H3 and analyzed by flow cytometry to 
determine population of cells in mitosis. FACS figures shown are representative 
of triplicate. The data for triplicate are representated in a graph shown in the 
lower panel ± SEM. 
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3.2.3 Initiation of apoptosis in mitotic arrested taxol treated cells 
Therefore we asked if the cells dying from taxol treatment seen in M2 of Fig 3.1 
come from mitotic cells or if, initiation of apoptosis correlates with cell entry into 
mitosis. To this end, we use an antibody that recognizes cleaved caspase-3, an 
early marker of apoptosis, to probe taxol treated cells. The labeled cells are again 
detected with flow cytometry. Fig 3.3 shows the percentage of taxol treated cells 
containing cleaved caspase-3 over time. Apoptosis initiate around 12 -18 hrs after 
taxol treatment, as shown by the increase in percentage population of cells with 
cleaved caspase-3. The results suggest initial detection of cleaved caspase-3 
correlates with entry and arrest of cells in mitosis. Fig 3.4 depicts the correlation 
between cleaved caspase-3 and phospho-H3 over time treated. As the percentage 
of cells stuck in mitosis increase, the percentage of cells with cleaved caspase-3 
also increase. This correlation is maintained for 30 hrs whereby after the 
percentage of cells in mitosis decrease while the percentage of cells with cleaved 
caspase-3 continues increasing. This discrepancy could be due to late stage 






































Fig 3.3: Percentage population of taxol treated H1299 cells undergoing apoptosis 
over time.  H1299 were treated and harvested as in Fig 3.1. The samples then 
probed with antibodies specific to cleave caspase-3 and analyzed by flow 
cytometry to determine population of cells in apoptosis. FACS figures shown are 
representative of triplicate. The data for triplicate are represented in a graph 
shown in the lower panel ± SEM. 
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Fig 3.4: Correlation of cells into mitosis with initiation of apoptosis. 
 
3.2.4 Taxol induced cell death during mitosis 
However correlation of taxol treated cells entry into mitosis with apoptosis does 
not prove initiation of apoptosis during taxol treatment requires cells to be in 
mitosis. In order to prove apoptosis happens within mitosis upon taxol treatment, 
we employed the aid of two chemicals, Purvalanol A (Purv A) and MG132. 
Purvalanol A is a potent cdk1 inhibitor. Cdk1 is the master regulator of mitosis 
(Nigg, 2001) and loss of cdk1 activity during mitosis override spindle checkpoint 
dependent arrest and the cell exit mitosis (D'Angiolella et al., 2003). MG132, on 
the other hand, is a proteasome inhibitor. Ubiquitinated targets of APC need to be 
degraded by the proteasome before the cell will be able to exit mitosis. MG132 
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arrest state”. Thus in essence, if taxol treated cells die by apoptosis during mitosis, 
application of Purv A will reduce apoptosis while application of MG132 will 
augment apoptosis. Indeed, this is observed when we add Purv A or MG132 to 
mitotic arrested (~ 15 hrs after taxol treatment) H1299 cells (Fig 3.5). Cleaved 
caspase-3 immunoblot shows taxol treated H1299 cells undergoing apoptosis 
around 20 hrs onwards. Addition of Purv A at 15 hrs abolishes appearance of 
caspase-3 cleavage bands. Addition of MG132, on the other hand, increases the 
intensity of cleaved caspase-3 bands. Cdc20 is used as an internal control to show 
that the cells are maintained in mitosis. Cdc20 is the co-activator of APC and its 
levels are the highest during mitosis. Cells that exit mitosis will show reduction of 








Fig 3.5: Treatment of taxol treated H1299 cells with Purv A abrogate apoptosis 
while MG132 augment apoptosis. H1299 cells were synchronized at the G1/S 
phase with 24 hrs thymidine block. The cultures were then released in DMEM 
containing 100 nM Taxol and incubated for a further 24 hrs. 10 µM of MG132 or 
Purv A were added at 15 hrs post taxol treatment. Cultures were collected at the 
indicated time points and western hybridization performed. Cdc20 is used as 
marker for cells entering and arresting in mitosis. Addition of Purv A results in 
lost of cdc20 as cells exit mitosis while increase intensity of cdc20 in MG132 
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3.2.5 Blockage of Taxol treated cells from entering mitosis prevent apoptosis  
To add further proof that taxol treated cells die only during mitosis, we arrest 
H1299 cells at G1/S phase of the cell cycle with 2mM thymidine block for 24 hrs 
before releasing the cultures in either taxol or taxol and thymidine containing 
medium for a further 24 hrs. Cultures released in taxol only containing medium 
will cycle into mitosis while cultures released in both taxol and thymidine 










Fig 3.6: Blockage of taxol treated cells with thymidine prevents cells from 
undergoing apoptosis. H1299 cells were blocked with thymidine for 24 hrs prior 
to release in either thymidine containing DMEM or thymidine and taxol 
containing DMEM and further cultured for the indicated time points. Western 










0 18Taxol (hrs): 24 0 18 24 
Thymidine free Maintained in thymidine
 75
As seen in Fig 3.6, cultures maintained in thymidine do not undergo apoptosis, as 
observed from lack of cleaved caspase-3 bands, from taxol treatment after 24 hrs. 
This double taxol and thymidine treatment cells also did not enter mitosis as seen 
by lack of phospho-H3 bands detected. To further confirm that the cultures 
maintained in both taxol and thymidine do not undergo cell death, we perform 
propidium iodide (PI) exclusion assay on the cultures exposed for 24 hrs to either 
taxol alone or taxol plus thymidine. Dead cells, unlike live cells, have porous 
plasma membrane that allows color dyes such as PI to enter, thus allowing live 
and dead cells to be separated and counted by flow cytometry. Fig 3.7 shows the 
assay results. The boxed region, R1, contained the PI positive cells and the 
number in percentage depicted the population of cells dead. Indeed, the PI 
exclusion results are similar to the immunoblot results in Fig 3.6, where only 
taxol alone treated cells die, while cells maintained in thymidine block did not, 
despite the presence of taxol. All in all, the above experiments show that taxol 
treated H1299 cells arrest in mitosis and the subsequent apoptosis that occur 







































Fig 3.7: PI exclusion assay showing lesser cell death in double taxol and 
thymidine treated cells. H1299 cultures were treated as in Fig 6 and harvested for 
cell death assay. Top panel shows FACS profile representative of a single 
experiment. Bottom panel represent the data for triplicate in a graph ± SEM. 
Taxol and thymidine treated 































p = 0.023 
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3.3 p73 is required for mitotic cell death 
3.3.1 Silencing of p73 block taxol induced cell death 
Thus having defined a system where we can use to study mitotic cell death, we 
went on to study whether p73 have any role in mitotic cell death. Small 
interfering RNA (siRNA) was first employed to study the role of p73 in mitotic 
cell death in human H1299 cells. Short 19-23 nucleotides long RNA duplex 
complementary to gene of interest can be used to silence specific gene of interest 
expression in mammalian system (Fire et al., 1998). Therefore if p73 has a 
positive role in promoting mitotic cell death, silencing of p73 will protect cells 
from taxol induced cell death. p73 siRNA was transfected into H1299 cells 24 hrs 
prior to taxol treatment. The taxol treated cells were further cultured for 24 hrs 
before being used for PI exclusion and cleaved caspase-3 assay (Fig 3.8). Both 
percentage of total cell death measured by PI exclusion assay and percentage 
apoptotic cells measured by cleaved caspase-3 assay show that silencing p73 in 
H1299 cells reduces mitotic cell death bought about by taxol treatment. This 


































Fig 3.8: p73 is required for mitotic cell death. Control or p73 siRNA were 
transfected into H1299 cells for 24 hrs prior to taxol treatment. Top left panel 
showing knockdown of p73 in taxol treated H1299 cells reduce cell death 
measured by cleaved caspase-3 while top right panel showing similarly treated 
cells measured by PI exclusion assay. Bottom panel is the graphical representation 
of the average of triplicate experiments performed for both cleaved caspase-3 and 
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3.3.2 Up-regulation of p73 early during taxol treatment  
To confirm the siRNA of p73 is functional, we performed immunoblot analysis 
on p73 in Control or p73 siRNA transfected cells. H1299 cells were transfected 
with either control or p73 siRNA and maintained in 2mM thymidine, to 
synchronized the cells at G1/S phase, for 24 hrs prior to release in 100nM Taxol 
containing medium. Samples were taken every 4-6 hrs for immunoblot analysis 
until 28 hrs. The results of the experiment are shown in Fig 3.9. p73 levels 
increase between 6-12 hrs after taxol treatment which after its level gradually 
tapered off. Transfection of p73 siRNA almost completely abolishes this up-
regulation. Further probing with antibodies against cleaved caspase-9 and 
caspase-3 show that silencing of p73 reduces amount of both cleaved caspases. 
Further confirming the PI exclusion and cleaved caspase-3 assay that p73 is 
required to induce apoptosis in taxol treated cells. Interestingly, we observed 
cleaved caspase-9 forms appear very early after taxol treatment (~12 hrs) though 
the cleavage of down stream effector caspases e.g. caspase-3 cannot be detected 
until much later time (~20 hrs). This is unusual as we expect activation of initiator 
caspases to result in processing of effector caspases. This suggests that after the 
initiation of apoptosis during mitotic block, there is a significant delay before 


















Fig 3.9: Absence of cleaved caspase-3 bands in si73 taxol treated cells. H1299 
cells were synchronized at the G1/S phase with 24 hrs thymidine block. The 
cultures were then released in DMEM containing 100 nM Taxol and incubated for 
28 hrs with samples harvested at indicated time points for protein immunoblot. 
p73 is up-regulated around 6 hrs after taxol treatment, no p73 bands can be 
detected in samples transfected with p73 siRNA. Early caspase-9 cleavage can be 
detected 12 hrs after taxol treatment while cleaved caspase-3 can only be detected 
20-28 hrs after taxol treatment. In lanes which p73 is knockdown, there are reduce 














Taxol (hrs):  0     6   12   16   20   24    28    0    6    12   16   20   24   28    
Control siRNA p73 siRNA 
 81
3.3.3 Silencing of p53 does not block taxol induced cell death 
p53 has been shown not to play any role in taxol induced cell death (Debernardis 
et al., 1997). To confirm p73, and not p53, plays the pro-apoptotic role in mitotic 
catastrophe, we decide to silence the expression of either p53 or p73 and test their 
response to taxol. As H1299 is p53 negative, we used a wildtype p53 containing 
osteosarcoma cell line, U2OS, for this purpose.  Fig 3.10 shows the immunoblot 
of p53 and p73 after silencing with either p53 and p73 siRNA in U2OS cells. 
After confirming the siRNA works in U2OS cells, p53 or p73 siRNA were 
transfected into U2OS cells for 48 hrs prior to treatment with taxol for a further 











Fig 3.10: Immunoblot showing knockdown of p53 and p73 proteins in U20S 
cells. Control or p53 or p73 siRNA were transfected into U20S cells and 
incubated for 48 hrs before harvest and used for western hybridization.  
 
 
















Fig 3.11: PI exclusion analysis of p53 or p73 knockdown taxol treated U20S 
cells. Top panel; Representative FACS profile showing lesser cell death after 
silencing of p73 but not p53 in taxol treated U20S cells. Bottom panel is the 
graphical representation of the average of triplicate experiments performed for PI 







































p = 0.029 
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Indeed silencing of p53 has no effect on cell death caused by taxol treatment; in 
fact cell death is accentuated in the absence of p53 as shown in Fig 3.11, control: 
12%, p53 siRNA: 18% and p73 siRNA 7% The results is comparable with those 
obtained from another group which show inactivation of wildtype p53 using 
papilloma virus E6 protein in human ovarian cell line increases sensitivity of the 
cells to pacitaxel (Vikhanskaya et al., 1998). In accordance with our earlier results 
in H1299 cells, silencing of p73 prevent cell death from taxol treatment. 
However, it can be noted that percentage of cell death are much lesser compared 
with those obtained from H1299 cells. This may be attributed to cell type 
differences e.g. U20S grow slower thus take longer time to enter mitosis 
compared with H1299 cells. 
 
3.3.4 p73 null mouse fibroblasts are resistant to taxol induced cell death 
To further show p73 and not p53 plays an important role in mitotic cell death, we 
used mouse fibroblasts which have either p53 or p73 knockout for our 
experiments. Reverse transcription polymerase chain reaction (RT-PCR) was used 
to show the fibroblasts are indeed p53 and p73 negative (Fig 3.12). This is 



















Having confirmed the identity of the fibroblasts, we treated them with 100nM 
taxol for 36 hrs and analyze the cell death with PI exclusion assay. The data is 
shown in Fig 3.13. As it can be seen, high level of cell death can be observed in 
both wildtype and p53-/- fibroblasts but not in p73-/- fibroblasts (34%: 27%: 8% 
respectively). Thus p73, in both in human and murine system, is required for 



























Fig 3.13: p73-/- fibroblasts are resistant to taxol induced cell death but not 
wildtype or p53-/- fibroblasts. Wildtype, p53-/- and p73-/- fibroblasts were seeded 
in triplicates into 6-well plates and treated with 100 nM of Taxol. After 36 hrs, the 
cultures were harvested and used for PI exclusion assay. Top panel is the 
representation of PI exclusion profile of each genotype treated with taxol. Bottom 
panel is the graphical representation of the average of triplicate experiments 
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Fig 3.14: p73-/- fibroblasts maintain in a G2/M block even after 60 hrs of taxol 
treatment but not wildtype or p53-/- fibroblasts. Wildtype, p53-/- and p73-/- 
fibroblasts were treated with 100 nM of Taxol and cultures harvested at indicated 
time points for cell cycle profile analysis. M1 represents G2/M population of the 




3.3.5 p73-/- fibroblasts maintain in G2/M block 60 hrs after taxol treatment 
Next, we investigate what happen to the p73-/- fibroblasts if they are not killed by 
taxol. Do they continue with cell cycle or do they enter a state of permanent 
arrest? We therefore monitored cell cycle profile of the fibroblasts treated with 
taxol over 60 hrs and the results seen in Fig 3.14. M1 represents G2/M population 
of the cells, or the stage where cells arrest after taxol treatment. M2 represents the 
sub-G1 population of the cells, or the dead cells. M3 represents the polyploid 
population of the cells, or cells, which did not undergo a successful mitosis but 
has exited mitosis and continue duplicating their genome to 8N. A normal cell 
will only have 2N amount of DNA and before mitosis 4N. From the cell cycle 
profile in Fig 3.14, it can be seen that majority of wildtype cells die after 60 hrs of 
taxol treatment. p53-/- cells arrest at G2/M for around 24 hrs after taxol treatment, 
whereby after majority of the culture continue to progress through cell cycle and 
develop 8N population by 48 hrs. p73-/- cells, on the other hand, maintained at the 
G2/M arrest stage after taxol treatment throughout the entire time course. These 
experiments suggest that p73-/- cells are arrested at the G2/M phase without 
undergoing cell death.  
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3.3.6 No decrease in number of adherent p73-/- cells after taxol treatment 
Finally to confirm p73-/- cells do not undergo cell death and cell cycle progression 
after taxol treatment, we seeded 1X105 cells of each genotype, wildtype, p53-/- and 
p73-/-, and count the number of adherent cells every 24 hrs for 72 hrs of culture in 
the presence of taxol. A cell number to time course curve is plotted and the results 
illustrated in Fig 3.15. As it can be seen in Fig 3.15, while both wildtype and p53-/- 
cells display decrease in total adherent cell numbers over time, p73-/- cell number 
remain relatively constant throughout 72 hrs. All and all, we show that mitotic 
cell death induced by taxol require presence of p73 but not p53, and although p73-
/-
 cells do not die from taxol treatment, they also do not continue to progress 
through cell cycle but maintain in a G2/M phase stasis.   
 
 
Fig 3.15: Number of adherent p73-/- cells remain stable 72 hrs after taxol 
treatment. Wildtype and p53-/- cells show steady decrease in number of cells over 
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3.4 p73 play a role in mitotic cell death induced by other means 
3.4.1 MG132 induced mitotic cell death 
To show that p73 plays a role in mitotic cell death induced by means, we used 
several other systems to induce mitotic cell death and demonstrate that the 
absence of p73 negate the apoptotic effect. The first method we used to induce 
mitotic catastrophe is MG132. Exit from mitotic arrest depends on the 
degradation of APC substrates by the proteasome. MG132 blocks this activity and 
thus the cells maintain in mitotic arrest. To minimize side effects of MG132, the 
cultures were synchronized in thymidine for 24 hrs before released in growth 
medium for 10 hrs to allow cells to reach mitosis stage, 10µM of MG132 is then 
added for a further 14 hrs to induce mitotic catastrophe. As seen in Fig 3.16, the 
above treatment results in the arrest of H1299 cells at the G2/M phase (M1) after 








Fig 3.16: MG132 treatment results in G2/M block. H1299 cells were treated with 
10 µM of MG132 10 hrs after release from thymidine block. The cultures were 
further incubated for 14 hrs at harvest for cell cycle analysis. 
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In addition, we performed confocal microscopy to analyze the stage of mitotic 
















Fig 3.17: Immunofluoresence showing condensed chromosomes of mitotic block 
MG132 and taxol treated cells. The chromosomes are stained blue by DAPI. 
Untreated interphase cells generally show diffused nuclei while taxol and MG132 
treated cells show condensed chromosomes. MG132 treated cells show 
chromosomes aligned along a single plane (arrows) while taxol treated cells show 
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The DNA is labeled blue by DAPI. DNA of interphase cells is confined within the 
nucleus, while chromosomes of mitotic cells appear condensed. As seen in Fig 
3.17, MG132 treated H1299 cells have condensed chromosomes and appear 
aligned along the spindle (white arrows). This confirms our earlier results, 
proving MG132 arrests cells at mitosis, or more precisely, at the metaphase-
anaphase stage of mitosis as evidence by the aligned chromosomes. Taxol treated 
cells, used as a positive control, also arrest at mitosis as evidence by the 
condensed chromosomes seen, however, the chromosomes are not aligned along 
the spindle but appear disorganized. Next, we asked if this mitotic arrest leads to 
cell death. Caspase-3 activity was measured from MG132 treated H1299 cells and 
the results are shown in Fig 3.18. Indeed treatment of cells with MG132 results in 
induction of apoptosis as evidenced by the increase in population of cleaved 
caspase-3 cells compared with untreated H1299 (4% vs 27%). Similar to taxol 
treatment, addition of cdk1 inhibitor Purv A to force mitotic exit can also reduce 
cell death from MG132 treatment (MG132: 27%; MG132 +Purv A: 15.5%). 
Suggesting like taxol treatment, MG132 induced cell death requires entry and 

























Fig 3.18: MG132 treatment results in apoptosis after 24 hrs release from 
thymidine block. H1299 cells were treated with MG132 as Fig 16 except for an 
additional set where Purv A was added 5 hrs after MG132. The cultures were 
collected 24 hrs after thymidine released and used for cleaved caspase-3 assay. 
Top panel show the representation cleaved caspase-3 assay of the triplicate 
experiment performed. Bottom panel shows the graphical representation of the 
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3.4.1.1 p73 is required for MG132 mitotic cell death 
Therefore if p73 is involved in mitotic catastrophe and not just taxol induced cell 
death, silencing of p73 in MG132 treated cells will also results in reduced 
population of cells with cleaved caspase-3. The experiment was done and the 
results shown in Fig 3.19.  Absence of p73 indeed reduces the amount of cell 
death induced by mitotic arrest from MG132 treatment as measured by % of 
cleaved caspase-3 (control MG132: 22.3%; si73 MG132: 13.4%). The lesser cell 
death difference between control and p73 knockdown MG132 treated samples 
could be due to the increase stability of p73 after MG132 treatment. It can also be 
attributed to other unknown side effects of MG132. Nonetheless, it confirms our 















































Fig 3.19: Silencing of p73 reduces % of apoptotic cells treated with MG132. 
H1299 cells were transfected with control or p73 siRNA for 24 hrs prior to 
thymidine block. MG132 were added 10 hrs after cells were release from G1/S 
block and cultures harvested 14 hrs later for cleaved caspase-3 assay. Top panel 
shows a representation of the cleaved caspase-3 assay for the triplicate set 
performed. Bottom panel shows the graphical representation of the average of the 
triplicate experiments performed ± SEM.  
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3.4.2 Mitotic cell induced by Plk1 silencing require p73 
Polo-like kinase 1 (Plk1) is an essential kinase for many different stages of 
mitosis (Golsteyn et al., 1995). Loss of function, overexpression of dominant 
negative mutants and siRNA mediated silencing of Plk1 lead to mitotic arrest, 
cytokinesis failure and cell death ((Seong et al., 2002;Spankuch-Schmitt et al., 
2002;Liu et al., 2006). Therefore we ask if the mitotic catastrophe induced by 
Plk1 silencing is also dependent on the presence of p73. To answer this, p73 
siRNA were transfected into H1299 24 hrs before a second round of Plk1 siRNA 
was transfected. In order to prevent premature entry into mitosis, cells were 
maintained in thymidine after Plk1 siRNA transfection for a further 24 hrs before 
release into normal growth media for another 24 hrs. The results of the 
experiments were measured by percentage of cleaved capase-3 (Fig 3.20a) as well 































Fig 3.20a: p73 is required for Plk1 silencing induced mitotic cell death. p73 
siRNA were transfected into H1299 24 hrs before a second round of Plk1 siRNA 
was transfected. Immediately after Plk1 siRNA, cells were maintained in 
thymidine block. After 24 hrs, cells were released from thymidine block into 
normal DMEM. Cultures were harvest 24 hrs after release for cleaved caspase-3 
assay. Top panel shows a representation of the cleaved caspase-3 assay for the 
triplicate set performed. Bottom panel shows the graphical representation of the 
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Fig 3.20b: p73 is required for Plk1 silencing induced mitotic cell death.  Cells 
were treated as in Fig 20a but the cultures harvested for PI exclusion assay. Top 
panel shows a representation of the PI exclusion assay for the triplicate set 
performed. Bottom panel shows the graphical representation of the average of the 
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From both PI exclusion and cleaved caspase-3 assay, it can be seen that while 
thymidine dependent G1/S blocked Plk1 silenced cells did not die, cells released 
from the block enter mitosis and undergo mitotic catastrophe and cell death (33% 
by cleaved caspase-3; 24.5% by PI exclusion). However lesser cell death was 
observed in cultures where p73 was silenced (20% by cleaved caspase-3; 9.8% by 
PI exclusion). Immunoblot analysis (Fig 3.21) were also performed to 
demonstrate the Plk1 siRNA indeed cause mitotic cell arrest, as measured by 
increase brightness of phospho histone H3 bands. Plk1 levels are also low in G1/S 











Fig 3.21: Immunoblot showing knockdown of Plk1 resulting in mitotic block as 
measured by phospho-H3 intensity. Cells were treated as Fig 3.20 but the cultures 
























3.4.3 p73 is required for γ-irradiation induced cell death 
Double strand DNA breakage caused by γ-irradiation results in G2/M cell cycle 
arrest. Mitotic catastrophe can happen under this situation in cancer cells lacking 
sensors in DNA damage or cell cycle arrest (Castedo et al., 2002). Therefore, we 
asked if cancer cell line, H1299, exposed to γ-irradiation undergo mitotic 
catastrophe and if this is also dependent on p73. H1299 were exposed to 20G γ-
irradiation and samples harvested every 12 hrs for cell cycle analysis by flow 
cytometry. As it can be seen from the cell cycle profile (Fig 3.22), γ-irradiated 
H1299 accumulated in G2/M phase of the cell cycle for until 60 hrs after 
irradiation (M2). This is accompanied by increase in population of sub-G1 cells 
(M1), indicating cell death from irradiation. Thus the cell cycle profile analysis 
suggests that cell death in γ-irradiated H1299 occurs during the G2/M phase of the 
cell cycle. Therefore to check if p73 again play a role in γ-irradiation cell death, 
p73 were silenced in γ-irradiated H1299 and cell death analyzed by immunoblot. 



















Fig 3.22: Arrest of γ-irradiated H1299 cells at the G2/M phase. H1299 cells were 
exposed to 20G γ-irradiation and cultured for 60 hrs with harvest at indicated time 










Fig 3.23: Silencing of p73 reduce PARP cleavage (arrow) after γ-irradiation in 
H1299 cells. Control or p73 siRNA were transfected into H1299 cells and then 
treated as Fig 3.22 and harvested for protein analysis. PARP cleavage (arrow) also 
correlates with intense phospho-histone H3 staining in control siRNA treated 
cells. No PARP cleavage can be detected in p73 silenced samples though cells 
arrest in mitosis as indicated by increase phospho-histone H3 staining. 
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Fig 3.24: Decrease in cell death after γ-irradiation in p73 knockdown H1299 
cells. Control or p73 siRNA were transfected into H1299 cells and then treated as 
Fig 3.22 and harvested 60hrs for PI exclusion assay. Graph shown above is the 
representation of  triplicate experiments performed ± SEM.  
 
 
From Fig 3.23, it can be seen that cells enter mitosis around 24 hrs after γ-
irradiation and peak around 36 hrs before exit by 60 hrs, as evidence by level of 
phospho-histone H3 staining, in both control and p73 silenced samples. Poly 
(ADP-ribose) polymerase (PARP) cleavage is a hallmark of apoptosis and is often 
used as a marker for cell death (Herceg and Wang, 1999). PARP cleavage caused 
by γ-irradiation coincides with cells in mitosis (mitosis 24-48 hrs; PARP cleavage 
36-48 hrs), suggesting the irradiated cells undergo mitotic cell death. Indeed 
silencing of p73 in irradiated samples reduces the level of cleaved PARP, 
suggesting p73 also play a role in mitotic cell death induced by γ-irradiation. 
Similar results is reflected using PI exclusion assay, where 25% of control γ-
irradiated cells died as compared with only 14% of p73 knockdown γ-irradiated 
























p = 0.023 
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Overall, we shown that mitotic cell death induced by means other than taxol, such 
as application of proteoasome inhibitor MG132, silencing of mitotic kinase, plk1 
and γ-irradiation requires the presence of p73. Absence of p73 reduces the cell 
death and apoptosis induced during mitotic catastrophe.    
 
3.5 p73 does not regulate Bubr1 and Mad2 
Having proved that p73 is a positive regulator of apoptosis during mitotic 
catastrophe, we next tried to uncover how p73 regulate mitotic cell death. Our 
first link is from Bubr1 and Mad2. These two proteins are integral part of the 
spindle checkpoint machinery. They bind to the Cdc20 of the APC, inhibiting its 
activity, thus keeping the spindle checkpoint active. Only upon complete and 
proper alignment of the spindle do Bubr1 and Mad2 detach from cdc20 and allow 
APC to function. Silencing of Bubr1 and Mad2 has been shown to block taxol 
induced apoptosis (Sudo et al., 2004), similar to the effect of silencing of p73. We 
postulate that perhaps the pro-apoptotic function of p73 in mitotic catastrophe 
work through Bubr1 and Mad2. We hence test the results obtained by Sudo et al., 
2004 that silencing of Bubr1 and Mad2 protect cells from taxol induced cell 
death. Fig 3.25 shows the efficiency of bubr1 and mad2 siRNA in H1299 cells. 
Then p73, Bubr1 and Mad2 siRNA were transfected into H1299 cells for 48 hrs 
before exposure to 100 nM of Taxol for another 24 hrs. As expected, silencing of 
Bubr1 and Mad2 reduced the population of cells with cleaved caspase-3 after 24 









Fig 3.25: Immunoblot showing the knockdown of Bubr1 and Mad2 in H1299 
cells. H1299 cells were transfected with Bubr1 or Mad2 siRNA for 48 hrs prior 

















p73 siRNA UT Control siRNA UT Bubr1 siRNA UT Mad2 siRNA UT 
































Control Bubr1 Mad2 siRNA:
 
 104
Fig 3.26: Reduction in percentage of population of taxol treated cells undergoing 
apoptosis in p73, Bubr1 and Mad2 knockdown cells. H1299 cells were transfected 
with either p73, Bubr1 or Mad2 siRNA for 48 hrs. The cells were then exposed to 
100 nM Taxol for 24 hrs and harvested for PI exclusion assay. Top panel shows a 
representation of the PI exclusion assay for the triplicate set performed. Bottom 
panel shows the graphical representation of the average of the triplicate 
experiments performed ± SEM.  
 
 
As p73 is a transcription factor, we envisage that Bubr1 and Mad2 are 
transcriptionally positively regulated by p73 upon taxol treatment. Loss of p73 
equates to lost of Bubr1 and Mad2, thus less cell death after taxol treatment. 
However analysis of immunoblot of p73 silenced taxol treated H1299 show that 
Bubr1 and Mad2 levels remain relatively unchanged despite the absence of p73 
(Fig 3.27). Bubr1 is phosphorylated during spindle disruption although the effect 
of this modification is unknown (Li et al., 1999). Silencing of p73 also does not 
affect this modification as seen in Fig 3.27 (Bubr1 phosphorylated bands appear 
as doublets between 12-24 hrs after taxol treatment). In summary, this experiment 























Fig 3.27: Immunoblot showing no change in level of Bubr1 and Mad2 after 
knockdown of p73. H1299 cells were transfected with p73 siRNA for 24 hrs prior 
to exposure to 100 nM Taxol. Cultures were collected at indicated time points and 
used for Bubr1 and Mad2 detection. The graph is a representation of one of the 
triplicate experiments performed. 
 
3.5.1 Mechanism of p73 on mitotic cell death differs from that of Bubr1 and 
Mad2 
If p73 does not regulate Bubr1 and Mad2 to induce cell death during taxol 
treatment, then what is the difference in cause between the decrease in cell death 
seen upon taxol treatment caused by silencing of p73 or Bubr1 and Mad2? 
Analysis of the phospho histone H3 levels upon silencing of p73 or Bubr1 or 
Mad2 during taxol treatment suggest the reason. As it can be seen in Fig 3.28, 
where the y-axis represent phospho histone H3 level of taxol treated H1299 cells 
Actin
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measured by flow cytometry, while knockdown of p73 does not affect phospho 
histone levels, knockdown of Bubr1 and Mad2 greatly reduced the level of 
phospho histone levels. The reduced phospho histone H3 in Bubr1 and Mad2 
silenced cells indicate these cells have already exited mitosis, in contrast with p73 
siRNA cells, which remain under mitotic arrest. This suggests mode of protection 
from silencing of p73, Bubr1 and Mad2 during taxol treatment is different. BubR1 
and mad2 are essential for maintaining mitotic arrest during taxol treatment, 
silencing of these two genes results in exit in mitosis and thus lesser cell death.  In 
effect, similar to addition of Purv A to force the cells to exit mitosis, thus 
preventing activation of apoptosis. For final proof that the mechanism of action of 
p73 and Bubr1or Mad2 is different, the respective genes were silenced in H1299 
cells, following treatment with 10µM of MG132. The cultures were then 
measured 14hrs later for cleaved caspase-3 and phospho histone H3 by flow 
cytometry. Fig 3.28 shows the phospho histone level of p73, Bubr1 and Mad2 
silenced H1299 cells treated with MG132. Unlike taxol treatment, MG132 
treatment maintains the high level of phospho histone in both Bubr1 and Mad2 
silenced cells. This is because MG132 override the activation of APC bought 
about by Bubr1 and Mad2 silencing, preventing APC substrates from degrading 
and thus maintain mitotic arrest. Interestingly, this inability of Bubr1 and Mad2 
silenced cells to exit mitosis coincides with the increase in cell death observed 
when these cells are treated with MG132 (Fig 3.29). In contrast, silencing of p73 
prior to MG132 treatment maintains the ability of these cells to survive the 
subsequent mitotic catastrophe, similar to taxol treatment. In summary, we can 
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conclude that mechanism of p73 action to regulate mitotic cell death is not 
















Fig 3.28: Different mechanism of action between p73 and Bubr1 and Mad2 in 
regulation of mitotic cell death. Top panel: Bubr1 and mad2 silenced cells exit 
mitosis during taxol treatment but p73 silenced cells maintained in mitosis. H1299 
cells were transfected with either p73, bubr1 or mad2 siRNA for 24 hrs after 
which they were blocked in thymidine for another 24 hrs. After release, the cells 
were exposed to 100 nM Taxol for 24 hrs and harvested at 12 and 24 hrs for 
histone H3 analysis. Bottom panel: Bubr1, mad2 and p73 silenced cells 
maintained in mitosis during MG132 treatment. H1299 cells were transfected 
with either p73, Bubr1 or Mad2 siRNA for 24 hrs after which they were blocked 
in thymidine for another 24 hrs. The cells were then release into normal DMEM 
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24 hrs for phospho-histone H3 analysis. The graph is a representation of one of 



































Fig 3.29: Knockdown of Bubr1 and Mad2 did not protect the cells from MG132 
dependent apoptosis. H1299 cells were transfected with either p73, bubr1 or mad2 
siRNA for 24 hrs after which they were blocked in thymidine for another 24 hrs. 
The cells were then release into normal DMEM for 24 hrs and MG132 added at 
the 10th hr. Cultures were then harvested at 24 hrs post-release from thymidine 
block for cleaved caspase-3 assay. Top panel shows a representation of the 
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3.6 Caspase-9 is the apical caspase activated during mitotic cell death 
From the above results, p73 is unlikely to regulate mitotic machinery to contribute 
to mitotic cell death. Therefore, we ask how then p73 contribute to mitotic cell 
death? Our approach to solve this problem is first to find out, which apoptotic 
pathway does metaphase arrested cells utilize to initiate apoptosis. We postulate 
that p73 will most likely regulate certain component or process in that pathway. In 
mammalian cells, apoptotic response is mediated either through the intrinsic 
pathway or the extrinsic pathway. The intrinsic pathway is mediated by the 
mitochondria through release of cytochrome c, which activate the caspase-9 
pathway for cell death. The extrinsic pathway is initiated by binding of 
extracellular death ligand to its receptor. The oligomerization of the receptor in 
turn trigger caspase-8 cleavage pathway for cell death. In addition to these two 
well-studied initiator caspase activation pathway is the caspase-2 activation 
pathway, which can be triggered by both death receptor mediated pathway as well 
as through PIDDosome pathway (Tinel and Tschopp, 2004;Shin et al., 2005). 
Thus to determine which pathway is responsible for mitotic cell death, we 
employed siRNA to silence the expression of each of the initiator caspase before 
taxol treatment. RT-PCR was performed to ascertain that each of the caspases is 














Fig 3.30: RT-PCR showing efficiency of siRNAs. siRNA corresponding to the 
indicated lanes were transfected into H1299 cells for 24 hrs before harvest for 
RNA extraction. 3 µg of RNA were used for 1st strand cDNA synthesis and 
subsequent RT-PCR. 
 
Having confirmed the effectiveness of the caspases siRNA, they were used for 
further cell death experiments. Cell death is measured by % of cleaved caspase-3 
using flow cytometry. Surprisingly, knockdown of all three initiator caspases 
results in less cell death as compared with control siRNA transfected cells (Fig 
3.31). This result confirm earlier findings by other groups that caspase-8, -9 and -
2 play a role in taxol induced cell death (von et al., 2003;Castedo et al., 2004;Park 





  caspase-8 
  caspase-9 
  caspase-2 
           p73 
































Fig 3.31: Knockdown of all three initiator caspases reduces the percentage of 
population of taxol treated cells undergoing apoptosis. H1299 cells were 
transfected with indicated siRNAs for 24 hrs prior to another 24 hrs thymidine 
block. The cultures were then released in 100 nM Taxol containing medium for 
24 hrs. The cultures were then harvested for cleaved caspase-3 assay. Top panel 
shows a representation of the cleaved caspase-3 assay for the triplicate set 
performed. Bottom panel shows the graphical representation of the average of the 
triplicate experiments performed ± SEM. control vs caspase-2 p = 0.021, control 





















































Unfortunately, this makes it difficult to link an apoptotic pathway to p73 role in 
mitotic cell death. However closer analysis of the results by immunoblot suggests 
that caspase-9 is the most important initiator caspase to be activated upon taxol 
treatment. Silencing of caspase-9 abrogate cleavage of caspase-8 and -2 after 
taxol treatment (cleavage bands highlighted by arrow heads in Fig 3.32). On the 
other hand, silencing of caspase-8 and -2 did not block caspase-9 cleavage (Fig 
3.33). This suggests that caspase-8 and caspase-2 role are secondary to caspase-9, 











Fig 3.32: Caspase-9 is the apical caspase during Taxol induced cell death. H1299 
cells were transfected with control or caspase-9 siRNA and treated with Taxol as 
in Fig 3.31. Cultures were harvested as at the above indicated times and used for 
immunoblot analysis. Immunoblot show absence of caspase-8 and caspase-2 
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Fig 3.33: Caspase-9 can be cleaved in absence of caspase-2 or caspase-8. H1299 
cells were transfected with control or either caspase-2 or caspase-8 siRNA and 
treated with Taxol as in Fig 3.31. Cultures were harvested as at the above 
indicated times and used for immunoblot analysis. Immunoblot show visible 
cleavage bands (arrows) of caspase-9 despite the absence of caspase-8  (top half 
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3.7 p73 regulate cytochrome c release during mitotic cell death 
Caspase-9 is activated by cytochrome c release from the mitochondria. Therefore 
if p73 acts along this pathway, we speculate that absence of p73 may affect this 
process. To this end, we treated p53-/- and p73-/- fibroblasts with taxol and 
harvested them at different time points for cytoplasmic extraction. The 
cytoplasmic extract is then used for immunoblot to detect released of cytochrome 
c. The results of the experiment are shown in Fig 3.34. As expected, while 
cytochrome c is released from p53-/- fibroblasts after taxol treatment, no 
cytochrome c released is detected in p73-/- fibroblasts. Increased levels of cleaved 









Fig 3.34: p73 regulate cytochrome c release during taxol induced cell death. p53-/- 
and p73-/- fibroblasts were treated with 100 nM of taxol and incubated for 25 hrs. 
Samples of each genotype were harvested every 5 hrs for cytoplasmic 
fractionation. Immunoblot show cytochrome c release in the cytoplasmic extract 












3.8 p73 does not regulate Bax translocation during mitotic cell death 
No cytochrome c release from taxol treated p73-/- fibroblasts suggests that p73 
regulates the upstream process before cytochrome c is released from the 
mitochondria. Cytochrome c release from the mitochondria depends on the 
regulation and interplay of the pro-apoptotic and anti-apoptotic Bcl-2 family 
members. Cells lacking Bax and Bak do not undergo outer membrane 
permeabilization (Degli and Dive, 2003). Bax, in particular, exist as inactive 
monomer in the cytoplasm, but migrates to the mitochondria membrane upon 
death signal where it oligomerizes to form pore complex for the release of 
cytochrome c. Over-expression of p73 has been shown to regulate bax 
translocation (Melino et al., 2004). Therefore we tested if p73 regulates Bax 
translocation in mitotic cell death. To this end, we used confocal microscopy to 
observe Bax localization before and after taxol treatment in p53-/- and p73-/- 
fibroblasts. As seen in Fig 3.35, Bax (stained green) does not co-localize with the 
mitochondria staining (in red) in untreated p53-/- and p73-/- cells. Blue staining 
represents the DNA. However after 16 hrs taxol treatment, Bax translocation to 
the mitochondria can be observed in both p53-/- and p73-/- fibroblasts, as indicated 


























Fig 3.35: No co-localization of Bax with mitochondria in untreated p53-/- and p73-
/-
 fibroblasts. p53-/-and p73-/- fibroblasts treated for immunofluoresence as 
described in material and methods. Confocal imaging (20X) showing Bax (green) 
do not co-localized with mitochondria (red) in untreated p53-/- and p73-/- 
fibroblasts. Nuclei are stained in blue by DAPI. Mitotic cells are those cells that 
have condensed chromosomes. 
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Fig 3.36: Bax co-localization with mitochondria can be detected in both taxol 
treated 53-/- and p73-/- fibroblasts. Cells were treated with 100 nM of Taxol and 
incubated for 16 hrs before treated for immunofluoresence. Confocal imaging 
showing Bax (green) co-localized with mitochondria (red) in mitotic arrested 








The co-localization of bax and mitochondria is only obvious in cells with 
abnormal condensed chromosomes. From the immunofluoresence images, it can 
be seen that absence of p73 does not affect Bax translocation. This suggests that 
p73 does not act through Bax translocation to induce cytochrome c release from 
the mitochondria. To further confirm the imaging results, we collected crude 
mitochondria extract from taxol treated p53-/- and p73-/- cells over time and 
analyze the Bax levels using immunoblots. The results of the experiment are 











Fig 3.37: Cytoplasmic and mitochondria fractionation. Left panel: mitochondria 
extract showing inverse relationship between Bax and cytochrome c in p53-/- cells. 
Bax levels also gradually increase in p73-/- cells. Right panel: cytoplasmic extract 
showing translocation of bax to the mitochondria and release of cytochrome c into 
the cytoplasm in p53-/- cells. Bax translocation is visible in both 53-/- and p73-/- 
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Bax begin translocating into the mitochondria 10 hrs after taxol treatment 
(decrease in p53-/- cells cytoplasmic Bax levels matched by increase in 
mitochondria Bax levels). This is followed by concomitant decrease in 
mitochondria cytochrome c and increase in cytoplasmic cytochrome c in the p53-/- 
cells. Although p73-/- cells seems to have more Bax in the cytoplasm, Bax 
translocation to the mitochondria can still be detected at later time points. 
However no cytochrome c is release into the cytoplasm in taxol treated p73-/- 
cells. ANT is used as a marker for the mitochondria. Taken together, these results 
show that p73 regulate mitotic cell death through the release of cytochrome c. 
Though the mechanism is not through regulation of Bax translocation from the 
cytoplasm to the mitochondria.  
 
3.9 Bim is not up-regulated in p73-/- fibroblasts upon taxol treatment  
Therefore how then can p73 regulate cytochrome c release independent of Bax? 
Cytochrome c release can also occur through the activation of BH3-only proteins. 
BH3-only proteins are Bcl-2 family proteins that can induce MMP under specific 
apoptotic signals. They act by disrupting heterotypic interactions between 
prosurvival Bcl-2 and proapoptotic Bcl-2 family members. Thereby allowing 
activation of proapoptotic Bax and Bak, and the subsequent release of cytochrome 
c from the mitochondria. Thus to determine if p73 regulates members of this 
BH3-only family, we analyze immunoblots of p53-/- and p73-/- fibroblasts treated 
with taxol to see if there are any differences in the expression profile of a few 
members of the BH3-only proteins (Fig 3.38). Very interestingly, while 
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expression of Bik and Puma do not seem to induce and show no obvious 
difference between the two genotypes tested, expression of Bim is induced upon 












Fig 3.38: Up-regulation of Bim after taxol treatment in p53-/- cells but not p73-/- 
cells. p53-/- and p73-/- fibroblasts were treated with 100 nM Taxol for the indicated 
time points and harvested for immunoblot analysis. The immunoblot were 
detected with selective antibodies against BH3-only family members. Only Bim 
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Further analysis of the bim mRNA using semi-quantitative RT-PCR in p53-/- and 
p73-/- fibroblasts treated with taxol over time also showed that the up-regulation 
of Bim initiate from the transcription levels (Fig 3.39). Bim mRNA levels are 









Fig 3.39: RT-PCR showing up-regulation of bim in p53-/- cells occurs at the 
transcriptional level. p53-/- and p73-/- fibroblasts were treated with 100 nM Taxol 
for the indicated time points and harvested for RNA extraction and 1st strand 
cDNA synthesis. bim mRNA levels are up-regulated in taxol treated p53-/- 
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3.10 p73 transcriptionally activated Bim 
Overall the above results suggest p73 can up-regulate Bim transcriptionally. To 
test if this is true, we ectopically expressed p73α and p73β in p73-/- cells and 
check for Bim levels in the transfected cells. Expectedly, bim mRNA levels are 
up-regulated by p73 over-expression (Fig 3.40). Mdm2, a known target of p73 is 












Fig 3.40: p73 up-regulate bim mRNA levels. pcDNA, p73α and p73β were 
transfected into p73-/- fibroblasts and RNA extracted after 24 hrs for 1st strand 
cDNA synthesis. RT-PCR then performed on Bim, mdm2, p73 and gapdh. RT-




















We repeated the experiment using human osteosarcoma Saos2 doxocycline p73β 
inducible cell line. Upon addition of 1µM of doxycycline, p73β will be expressed. 
Total RNA from induced cells was collected over time and bim mRNA levels 
determined by semi-quantitative RT-PCR (Fig 3.41). The results mirrored that 
using ectopic p73 expression in p73-/- cells. Upon induction of p73β, bim mRNA 












Fig 3.41: RT-PCR showing induction of p73β in Soas2 cells resulting in up-
regulation of bim mRNA levels. p73β was induced in Saos2 cells with 1 µM 
Doxycycline for 5 to 10 hrs and cultures harvested for RNA extraction and 1st 
strand cDNA. RT-PCR performed for Bim, mdm2 and p73. Similar as ectopic 
p73 expression in p73 null fibroblasts, induction of p73 in Saos2 can up-regulate 





g a p d h
m d m 2
p 7 3
S ao s2 -7 3 b  
+ D o x (h rs ): 0 1 05
 
 124
3.10.1 p73 binds to response elements in Bim intron 1 region 
Therefore we search the human Bim gene 5’ region upstream of exon 1 for p53-
like recognition binding site (RE), which p73 is known to bind. No binding sites 
were found, however three p53-like binding sites are located within intron 1 of the 
Bim gene, using online p53 family gene recognition database (Sbisa et al., 2007). 
These three binding sites are located at 111601570, 111605691 and 111606633 
position with reference to ENSG00000153094_1 (Table 1). Primers flanking 
these three sites, represented by black arrowheads, were ordered and chromatin 
immunoprecipitation (ChIP) performed to determine in vivo binding of p73 to 












Illustration 7: ChIP primers used for PCR of RE1, RE2 and RE3 on Bim intron 
1. 
 
>ENSG00000153094_1|BCL2L11 CHR:2 STRAND:1 CHR_START:111601570 
acacatgcat taa gcacttgaca ta ggactagtct (RE1) 
>ENSG00000153094_2|BCL2L11 CHR:2 STRAND:1 CHR_START:111605691 
aagataatat caaactaa ggacaggatt gatggtaa gtacatgctc (RE2) 
>ENSG00000153094_3|BCL2L11 CHR:2 STRAND:1 CHR_START:111606633 
agggaactgt gt agacaaggta cc aggcctgtct (RE3) 
Exon1 Exon2RE1 RE2 RE3
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Saos2 p73β inducible cells were induced with doxocycline for 10 hrs before 
harvested for ChIP. Induced samples were immunoprecipitated with either p73 
specific antibodies or non-specific HA antibodies. DNA bound to p73 will be 
immunoprecipitated together with p73. Specific DNA sequences, which p73 bind, 
can then be detected by PCR. Therefore if the p53 REs in Bim intron 1 bind to 
p73, PCR of p73 immunoprecipitated samples will give stronger PCR band 
compared with HA immunoprecipitated samples. The results of the ChIP are 
shown in Fig 3.42. Without a doubt, induced p73β can bind to RE1 and RE2, but 
not RE3 of the Bim intron 1. p73β binding to known mdm2 RE was used as a 











Fig 3.42: p73 bind to p73RE in Bim intron 1. p73 was induced by doxycycline for 
10 hrs in Saos2 cells and harvested for ChIP. PCR performed on the DNA 
fragments co-precipitated with p73 show that p73 can bind to RE1 and RE2 on 

















In addition to using inducible p73 system, we perform ChIP on endogenous p73 
to show the binding to Bim RE1 and RE2 are real. p73 protein levels are 
relatively high during G1/S phase of the cell cycle (Stiewe and Putzer, 2000). 
Therefore we harvested H1299 cells from three stages of the cell cycle, G0/G1 
(serum starved), G1/S (thymidine blocked) and G2 (thymidine blocked and release 
for 8 hrs), and used it for ChIP. Indeed we were able to observe p73 binding to 
Bim RE1 and RE2 during the G1/S transition phase of the cell cycle where p73 
levels are high (Fig 3.43). The immunoblot and RT-PCR gel is use to show high 









Fig 3.43: Cell cycle dependent binding of p73 to Bim promoter. p73 levels which 
is the highest during G1/S phase of the cell cycle, bind to RE1 and RE2 on the 


















































Fig 3.44: High p73 level during G1/S phase of the cell cycle correlate with 
increase bim mRNA levels. H1299 cells were treated by serum starvation for 72 
hrs to induce G0/G1 or blocked at G1/S with thymidine for 24 hrs, or thymidine 
block and release for 8 hrs to allow cells entry into G2. Cultures from these 
indicated treatments were harvested for protein and mRNA expression studies. 
Left panels show highest level of p73α protein is during G1/S stage of the cell 
cycle. Right panels show corresponding increase in bim transcripts during the 
G1/S phase of the cell cycle. All full length p73 species are detected by RT-PCR.  
 
 
3.10.2 Silencing of Bim protect cells from mitotic cell death induced by Plk1 
depletion and taxol treatment 
Finally to show that p73 up regulation of Bim is responsible for its role in mitotic 
cell death, we subject Bim or p73 siRNA silenced H1299 cells with taxol or Plk1 
siRNA treatment. The subsequent cell death were analyze with PI exclusion assay 
(Fig 3.45a for Plk1 siRNA treatment; Fig 3.45b for taxol treatment). Knockdown 
of Bim, similar to p73 knockdown, protect H1299 cells from taxol as well as Plk1 



























































































Fig 3.45a: Bim knockdown protect cells from Plk1 induced mitotic cell death. 
H1299 cells were co-transfected with control/control, control/p73, control/Bim, 
Plk1/control, Plk1/p73, Plk1/Bim siRNA combinations and maintained in 
thymidine block for 24 hrs before release in DMEM for another 24 hrs. Cultures 
were harvest for PI exclusion assay. Reduction in percentage of population of 
Plk1 knockdown H1299 cells undergoing apoptosis can be detected in p73 or Bim 
concurrent knockdown cells. Top panel shows a representation of the PI exclusion 
assay for the triplicate set performed. Bottom panel shows the graphical 
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Fig 3.45b: Bim silencing reduce % of cells from undergoing taxol-induced 
mitotic cell death. H1299 cells were transfected with control, p73 or Bim siRNA 
for 24 hrs and further blocked with thymidine for another 24 hrs. The cultures 
were then released in taxol containing DMEM for 24 hrs before harvest for PI 
exclusion assay. Top panel shows a representation of the PI exclusion assay for 
the triplicate set performed. Bottom panel shows the graphical representation of 
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The core component of the apoptotic machinery is a proteolytic system involving 
a family of proteases known as caspases (Shi, 2002). There are 14 members in 
this family, which can be generally grouped into two main groups according to 
their functions. Those involved in cytokine processing (caspase-1, -4, -5, -11, -12, 




 Caspase-2 is one of the most unique enzymes among the caspases. It has both 
caspase-recruitment domain (CARD) as well as effector caspase substrate 
specificity. Meaning it can behave like both initiator and effector caspase to 
control apoptosis. Caspase-2 has been implicated in the onset of apoptosis 
triggered by insults such as UV irradiation and growth factor withdrawals. 
Caspase-2 can be activated via both intrinsic and extrinsic pathways. The extrinsic 
pathway is thought be to due to its association with RAIDD, a death effector 
domain involved in death receptor mediated apoptosis through association with 
adaptor protein RIP and TRADD (Shearwin-Whyatt et al., 2000). The intrinsic 
pathway is mediated through its activation by PIDDosome (Tinel and Tschopp, 
2004).  
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Caspase-2-/- mice are viable and show normal susceptibility to apoptosis in 
response to multiple stimuli. The only observed apoptotic defects in these mice 
are excessive germ cells in the ovaries of female mutant mice, resistance of 
oocytes to chemotherapeutic drug-induced apoptosis, and a reduced death of 
lymphocytes after treatment with granzyme B. Interestingly, cell death of both 
motor neurons during development as well as NGF-deprived sympathetic neurons 
of caspase-2 deficient mice are more efficient, suggesting both positive and 
negative role of caspase-2 as a cell death effector. The opposing role of caspase-2 
in apoptosis in the caspase-2 deficient mice has been hypothesized to be due to 
existing of at least two forms of caspase-2 mRNA species (Bergeron et al., 1998). 
The long isoform, caspase-2L was shown to induce cell death upon over-
expression while the short isoform, caspase-2S was shown to inhibit cell death 
upon over-expression (Kumar et al., 1994;Wang et al., 1994). While the dominant 
form caspase-2L is expressed in most tissues, caspase-2S is preferentially 
expressed in brain and skeletal muscles (Wang et al., 1994).  
 
4.1.3 Transcriptional regulation of Caspase-2S  
Caspase-2S isoform is produced from the insertion of a 61-base pair (bp) exon at 
the 3’ end of the caspase-2 pre-mRNA, which introduces a premature stop codon 
(Wang et al., 1994). In addition, the two mRNA differs at their 5’ end, suggesting 
the existence of distinct transcriptional start sites for both caspase-2L and -2S 
(Logette et al., 2003). Indeed using 5’ RT-RACE and RNase protection assay, the 
same group shows that the main transcription start site of caspase-2S differs from 
 133
the transcription start site of caspase-2L. Consistent with the expression profile, 
caspase-2L promoter activity is also stronger than caspase-2S. Interestingly, the 
presence of a TATA box in caspase-2S promoter suggests a regulated expression 
from a single major transcription start site, indicating that under specific 
conditions, caspase-2S expression can be up-regulated (Logette et al., 2003) 
(Illustration 8). (Droin et al., 1998)), confirmed this, by showing treatment of 
cells with etopside results in up-regulation of caspase-2S mRNA in human 
leukemic cell line, U937, without effecting caspase-2L mRNA levels. Though, 
this up-regulation of caspase-2S during etopside treatment did not alter the cell 
fate, which was death, suggesting caspase-2S may not be a major player in DNA 
damage induced cell death. Thus the transcription factors regulating the 









Illustration 8: A schematic representation of CASP-2 promoter. Arrows denote 
the transcription start sites. Transcription of Caspase-2L initiate from the -3110 bp 
promoter while transcription of Caspase-2S initiate from an alternate promoter in 










p73 regulates cell death through its transcriptional regulatory activities. Caspases 
play critical role in regulation of apoptosis. However the transcriptional regulation 
of caspases are not well studied, therefore we are interested to investigate if p73 
has any role in regulating caspases to control cell death. We found out that 
caspase-2S variant is up-regulated transcriptionally by ectopic expression of p73.  
Therefore for the second part of my thesis, I will like to contribute our findings on 

















4.2 Caspase-2S but not caspase-2L, caspase-8 and caspase-9 is up-regulated by 
p73β 
During the course of our investigation on the mechanism of p73 action on mitotic 
cell death, we evaluate if p73 can regulate any of the initiator caspases 
transcriptionally. p73β is ectopically expressed in H1299 cells and caspase-8, -2 
and -9 mRNA levels measured by semi-quantitative RT-PCR. The results of the 











Fig 4.1: Semi-quantitative RT-PCR showing up-regulation of caspase-2S, not 
other caspases transcripts, by p73β. pcDNA and p73β expression constructs were 
transfected into H1299 cells for 36 hrs before harvest for RNA extraction and 1st 
strand cDNA synthesis. RT-PCR performed for caspase-2, caspase-8, caspase-9 

















Interestingly, although none of the full-length initiator caspases were up-regulated 
by p73β over-expression, a short isoform of the caspase-2, caspase-2S, is up- 
regulated. Unfortunately, we were unable to detect endogenous caspase-2S protein 
levels even after p73β over-expression. Nonetheless, we check if this increase in 
caspase-2S mRNA can also be caused by over-expression of p53, p63 or p73α 
isoform. Surprisingly, we found that only p73β can activated caspase-2S mRNA 
expression but not p53, p73α or p63α (Fig 4.2). More so was that p73α, which is 
the longest p73 isoform and have the same DNA binding domain as p73β, was 













Fig 4.2: RT-PCR showing up-regulation of caspase-2S is specific to p73β, not to 
p73α, p53 or p63. pcDNA, p73α, p53, p63α and p73β expression constructs were 






















strand cDNA synthesis. RT-PCR performed for caspase-2 and caspase-2S 
transcripts according to conditions stated in methods. 
 
4.3 p73β can induce caspase-2S promoter reporter construct 
To further confirm this up-regulation is true as well as to find out the mechanism 
of how p73β up-regulate caspase-2S expression, we obtained several caspase-2 
promoter luciferase gene reporter constructs from Corcos group in France 
(Logette et al., 2003). They have previously reported that caspase-2S can be 
transcribed from an alternate promoter within intron 1 of the caspase-2 gene.  
Using these caspase-2 promoter deletion reporter constructs, we tried to find out 
where p73β acts on to activate caspase-2S transcription (Fig 4.3). Expectedly, 
p73β is able to dramatically increase the reporter activity of the construct 
containing only caspase-2S promoter located within intron 1 (Del 4). However 
p73β is not able to up-regulate reporter activities of construct containing full-
length caspase-2L promoter (PCM2). Its activity on constructs containing caspase-
2L exon 1 and intron 1 (Del 1, Del 2 and Del 3) is also weaker than when 
compared with construct containing only caspase-2S promoter (Del 4). This is 
despite all these constructs contain the caspase-2S promoter located in intron 1. 
All the same, the results from the luciferase assay and our RT-PCR results 



















Fig 4.3: Induction of caspase-2S promoter by p73β. The indicated caspase-2 
promoter reporter constructs were transfected together with p73β and β-gal into 
H1299 cells for 24 hrs. The cultures were then lyzed and used for luciferase assay.   
Upper panel show the reporter constructs used for the luciferase assay.         
represents the TATA box. Lower panel show the luciferase assay demonstrating 
induction of activity in Del 4 reporter construct containing caspase-2S promoter 
by p73β. The luciferase assay was repeated thrice. The graph above is 
representation of average of triplicate for each set ±SED.     
 
Luciferase assay were also performed on p53, p63α and co-transfected with Del 4 
reporter construct to confirm the earlier findings that only p73β but not p53 or 
p63α can up-regulate caspase-2S expression (Fig 4.4). Again the results reflect 
our RT-PCR results, only p73β is able to increase Del 4 reporter activities but not 
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Fig 4.4: Induction of activity in Del 4 reporter construct containing caspase-2S 
promoter specific only to p73β, not p53 or p63. The indicated caspase promoter 
reporter constructs were transfected together with either p53 or p73β or p63α and 
β-gal into H1299 cells for 24 hrs. The cultures were then lyzed and used for 
luciferase assay. The luciferase assay was repeated thrice. The graph above is 
representation of average of triplicate for each set ±SED. Lower panel shows the 


































4.4. p73β act through a 22 bp sequence in caspase-2S promoter 
We then tried to find the site on the caspase-2S promoter which p73β acts on. Our 
approach is to make sequential deletions in the Del 4 promoter luciferase reporter 
construct. We assumed that the transcription factor binding site should lie 
upstream of the TATA box (in grey) (Table 2), thus we make sequential deletions, 
highlighted with /, starting from the 5’ towards the 3’ end before the TATA box 
(Table 2 and Illustration 9). These constructs, Del 4.1, 4.2 and 4.3, were 
transfected together with p73β and luciferase assay performed. The results are 
shown on Fig 4.5. From the plot in Fig 4.5, it can be seen that p73β cannot 
activate any of the subsequent Del 4 deletion constructs. This suggests that the 
site which p73β activate caspase-2S promoter lies upstream of Del 4.1. The 








Table 2: DNA sequence of the caspase-2 gene contain in Del 4 reporter construct. 
Bold and underline in grey is the TATA box while / highlight the sequential 

































Fig 4.5: Luciferase assay using sequential truncations of Del 4. The sequential 
truncated Del4 reporter constructs were transfected together with p73β and β-gal 
into H1299 cells for 24 hrs. The cultures were then lyzed and used for luciferase 
assay. The luciferase assay was repeated thrice. The graph above is representation 





























4.5 p73β bind directly to caspase-2S promoter 
4.5.1 p73β does not act through Sp1 to induce caspase-2S promoter 
Further analysis show that this region contains a GC box (highlighted in bold in 
Illustration 10). GC box is the recognition site of Sp1 transcription factor 
(Kadonaga et al., 1987). To determine if p73β activates caspase-2S promoter 
through Sp1 interactions, we silenced Sp1 gene expression in H1299 cells using 
Sp1 specific siRNA 24 hrs prior to co-transfection of p73β and Del 4 reporter 
construct. The cultures were harvested 24 hrs later for luciferase assay and the 










Fig 4.6: Knockdown of Sp1 does not prevent activation of Del4 promoter by p73. 
Control or Sp1 siRNA were transfected into H1299 for 24 hrs. Del4 reporter 
constructs were transfected together with p73β and β-gal into H1299 cells for 
another 24 hrs. The cultures were then lyzed and used for luciferase assay. The 
luciferase assay was repeated thrice. The readings from Control and Sp1 siRNA 
samples were divided against vector to normalize the data for comparison. The 
graph above is representation of average of triplicate for each set ±SED. Right 
panel is the immunoblot showing the effectiveness of the Sp1 siRNA transfection.  
Sp1
Actin 









































Silencing of Sp1 results only in marginal reduction of Del 4 activity by p73β 
compared with control siRNA transfected cells, suggesting p73β does not act 
through Sp1 to induce caspase-2S transcription. Next, site directed mutagenesis 
was performed to destroy the GC box in Del 4 reporter construct (mutated 





Illustration 10: Site directed mutagenesis of GC box in Del 4 reporter construct. 
 
The Del 4 SP1mutated construct was used for luciferase assay and the results 
shown in Fig 4.7. The profile is similar to that of Sp1 siRNA, although there is 
decrease in activity in p73β transfected with Del 4 SP1mutated promoter, 
compared with p73β transfected with Del 4 promoter, the former readings are still 
much higher compared with pcDNA vector transfected with Del 4 SP1mutated 
control. Overall, the results imply p73β does not act through Sp1 to induce 





















Fig 4.7: Mutation of GC box did not affect p73β ability to induce Del4 promoter. 
Del4 and Del4 SP1mut reporter constructs were transfected together with p73β 
and β-gal into H1299 cells for another 24 hrs. The cultures were then lyzed and 
used for luciferase assay. The luciferase assay was repeated thrice. The readings 
from Del4 and Del4 SP1 mutant samples were divided against vector to normalize 
the data for comparison.  The graph above is representation of average of 
triplicate for each set ±SED. p73β Del4 vs p73β Del4 SP1mut p = 0.0014. 
 
4.5.2 DNA binding domain of p73β is required for inducing caspase-2S activity 
p73 consensus binding sequences are generally p53-like consensus sequences. 
The 22 bp sequences in Del 4 construct do not match the p53 consensus sequence 
at all. Therefore to determine if p73 directly bind to the DNA sequence in Del 4, 
we used two strategies. The first is to test if p73β with non-functional DNA 
binding domain, p73β-292, or a p73β with no transactivation domain (TA), 




































From the results (Fig 4.8), it can be seen that p73β with a non-functional DNA 
binding domain cannot induce Del 4 activity. More interestingly, p73β without 
the TA domain (DNp73β) but have normal DNA binding ability can induce Del 4 
activity. The bottom panels of Fig 4.8 show the protein expression of the p73 












Fig 4.8: DNA binding ability of p73β is essential for induction of Del4 promoter 
activities. Del4 reporter constructs were transfected together with either p73β or 
p73β-292, or DNp73β or DNp73β-292 together with β-gal into H1299 cells for 
another 24 hrs. The cultures were then lyzed and used for luciferase assay. The 
luciferase assay was repeated thrice. The graph above is representation of average 
of triplicate for each set ±SED. Lower panels are the immunoblots showing 




















4.5.3 p73β and DNp73β bind to endogenous caspase-2S promoter 
The second strategy is to check if p73β can bind endogenously to caspase-2S 
promoter using ChIP. We used two cell lines for this purpose: Saos2 doxocycline 
p73β inducible cell line, and human neuroblastoma Sh5y cell line stably 
expressing DNp73β. Fig 4.9 shows the up-regulation of caspase-2S mRNA levels 
upon p73β induction in Saos2 cells, and increase caspase2S mRNA levels in 










Fig 4.9: Up-regulation of caspase-2S in Saos2 p73β inducible cell line and Sh5y 
stably expressing DNp73β. Left panel: p73β is induced in Saos2 for 10 to 24 hrs 
and RNA extracted from the cells. RT-PCR was performed to analyze caspase-2S, 
p73 and control mdm2 levels. Right panel: RNA was extracted from Sh5y stably 































Having confirmed that caspase-2S is up-regulated in the cell lines going to be used 
for ChIP, p73β is induced in Saos2 inducible for 15 hrs before cell lysis and 
immunoprecipitation with either p73 or HA specific antibodies. Saos2 non-
induced is treated in a similar manner to serve as control. PCR flanking the region 
surrounding p73 binding site in caspase-2S promoter is then performed to on the 














Fig 4.10: ChIP of p73 on 18 bp p73 binding site identified on the caspase-2S 
using Soas2 p73β inducible cell line. p73β is induced in Saos2 inducible for 15 
hrs before harvested for ChIP procedures. Top panel: location of primers (arrows) 
used for ChIP of Cas2RE and non-specific control. Bottom panel: ChIP showing 
p73β binding to Cas2RE and not to non-specific control.  Cas2RE cannot be PCR 
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More intense PCR band can be seen in doxocycline induced Saos2 
immunoprecipitated with p73 antibodies compared with induced Saos2 
immunoprecipitated with HA antibodies (Fig 4.10, Cas2RE panel, compare lane 1 
and 2). PCR was also performed on crude lysates before used for 
immunoprecipitation as a control (seen as Input). This experiment suggests p73β 
can bind to endogenously to the site identified by luciferase assay on the caspase-
2S promoter. 
Similar ChIP is performed on Sh5y cells stably expressing either pcDNA vector 
or DNp73β. The results show stronger PCR band on lysates of Sh5y expressing 
DNp73β immunoprecipitated with p73 specific antibodies than with HA specific 
antibodies (Fig 4.11, compare lane 1 and 2). No band can be detected on vector 
containing Sh5y (Fig 4.11, compare lane 4 and 5). The results support that of the 
luciferase assay that DNp73β, without the TA domain, can still bind to the site 
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Fig 4.11: DNp73β can bind to caspase-2S promoter. ChIP of DNp73β on the 
identified p73 binding site was performed on the caspase-2S using Sh5y stably 
expressing DNp73β, Sh5y carrying pcDNA vector was used as a control. 
 
 
4.5.4 p73β bind directly to the identified 22 bp RE site on caspase-2S promoter 
Although we have shown p73β binds endogenously to caspase-2 promoter by 
ChIP, the 22 bp site on caspase-2S promoter which p73β sits on is different from 
the generally recognized consensus p73β-binding site. Thus p73 could bind 
through a third party to this site on capsase-2S promoter. Though Sp1 have been 
ruled out, we cannot rule out possibility of p73β binding to other proteins sitting 
on capase-2S promoter. Therefore to rule out this possibility, we performed in 
vitro binding assay using bacteria purified GST-73β and the 22 bp caspase-2S 
oligonucleotide attached to agarose beads. GST-73α and GST-p53, which cannot 
up-regulate caspase-2S is used as a negative control. The results are shown in Fig 
4.12. From Fig 4.12, it can be seen that only GST-73β can bind in vitro to the 22 











































































































































































Fig 4.12: In vitro DNA GST-p73 binding assay. Briefly purified GST-p73 
proteins were incubated with biotinylated 22 bp caspase-2S promoter sequence for 
2 hrs. The mix was then transferred to avidin-conjugated beads and incubated for 
another 2 hrs. GST-p73 proteins without prior incubation to the biotinylated DNA 
were mixed with the beads as negative control. The beads were washed several 
times in RIPA buffer and loaded into SDS-acrylamide gel for western 
hybridization. Left panel: lane 1 show GST-p73β bound to beads containing 22 
bp RE, but not beads that do not have the 22 bp RE (lane 2). Lane 3 shows eluate 
used for assay contains GST-p73 protein. Right panel: GST-p53 and GST-p73α 
cannot bind to 22 bp RE bound to the beads.  
 
4.6 Potential biological role of p73 in regulation of caspase-2S 
4.6.1 Increase survival of Sh5y expressing DNp73β during serum deprivation 
Over-expression of caspase-2S has been shown to protect cells from cell death 
induced by serum deprivation (Wang et al., 1994) Therefore, we asked if the Sh5y 
DNp73β stable cells, which express higher level of caspase-2S mRNA, are also 
more resistant to serum deprivation induced cell death. Sh5y pcDNA and Sh5y 
DNp73β cells were seeded in 6 well plates in triplicates and serum starved in 
serum free DMEM for up to 72 hrs. Cultures were harvested at Day 0, Day 1, Day 
2 and Day 3 during serum starvation for cell cycle analysis. % of sub-G1 
population, indication of dead cells, from both cell lines were measured, plotted 
and the results shown in Fig 4.13.  
From the results in Fig 4.13, it can be seen that there are less cell death upon 
serum deprivation in Sh5y cells stably expressing DNp73β. This correlation 
provides evidence that DNp73β up-regulate caspase-2S to protect cells against 













Fig 4.13: Sh5y cells stably expressing DNp73β are resistant to serum starvation. 
Sh5y pcDNA and Sh5y DNp73β cells were seeded in 6 well plates in triplicates 
and serum starved in serum free DMEM for up to 72 hrs. Cultures were harvested 
at Day 0, Day 1, Day 2 and Day 3 during serum starvation for cell cycle analysis. 




4.6.2 Caspase-2 silencing has no effect on p73β mediated cell death 
Over-expression of p73β results in cell death while over-expression of caspase-2S 
has been shown to protect cells from apoptosis (Wang et al., 1994;Melino et al., 
2004). Thus we asked if there is any paradox in up-regulation of Cas2S by p73β. 
Perhaps up-regulation of caspase-2S during p73β over-expression may modulate 
cell death by p73β. Thus we silenced caspase-2 expression in H1299 cells before 










Day 0 Day 1 Day 2 Day 3















exclusion assay and the results shown in Fig 4.14. From the figures it can be seen 
that knockdown of Caspase-2 has no effect on the cell death caused by over-
expression of p73β (Control siRNA: 28%; Caspase-2 siRNA: 24.7%). Extent of 











Fig 4.14: Knockdown of caspase-2 has no effect on p73β-induced cell death. 
Caspase-2 siRNA were transfected into H1299 cells for 24 hrs. pcDNA or p73β 
expression plasmids were then transfected into the cells and incubated for 48 hrs 
before harvest for PI exclusion assay. Left panel show the PI exclusion assay 


















































For my PhD work, I have shown that p73 gene can play a dual role in regulation 
of cell death: p73 has an important pro-apoptotic role in regulation mitotic cell 
death, it can also play an anti-apoptotic role by up-regulation of caspase-2S. 
The mitotic death, which is dependent on p73, requires the activation of spindle 
checkpoint and is triggered by the increasing length of time the cell spend in the 
mitotic phase of the cell cycle. This metaphase-associated mitotic cell death is 
only mediated by p73, not p53, highlighting the specific role of p73 in this 
process. In addition, we establish that p73 regulates mitotic cell death through the 
induction of Bim expression. Bim in turn promotes mitochondria membrane 
permeabilization, release of cytochrome c and the subsequent activation of 
caspases. 
In addition, we show that caspase-2S is a target gene of p73β and DNp73β. 
Ectopic expression of p73β up-regulates caspase-2S mRNA levels as well as 
caspase-2S promoter reporter constructs. This p73 activation of caspase-2S is 
through direct binding to a 22 bp element on the caspase-2S promoter. Resistant of 
cell death to serum deprivation in Sh5y cells stably expressing DNp73β may be 







5.2 Regulation of mitotic cell death by p73 
5.2.1 p73-dependent mitotic cell death require spindle checkpoint activation and 
mitotic arrest 
During mitotic catastrophe, cell death can happen in two distinct phases: during 
the mitotic metaphase-anaphase transition phase itself or at post-mitotic G1 phase, 
upon the activation of the polyploidy checkpoint (Castedo et al., 2004). The taxol-
induced mitotic cell death, which is regulated by p73, occurs during the mitosis 
only. Several lines of evidence support this. Firstly, at the time of measurement of 
cell death, usually 24 hrs, by PI exclusion or caspase-3 cleavage, the cells have 
not completed its first cell cycle, as measured by phospho-histone H3 levels (Fig 
3.1, 3.2, 3.3 and 3.4). Secondly, G1/S blocked H1299 cells treated with taxol do 
not undergo cell death. This indicate that taxol treated cells require cell cycle 
progression for initiation of cell death. Thirdly, cells blocked in mitosis can 
escape cell death if they are forced to exit mitosis by addition of cdk1 inhibitor 
Purvalanol A. Lastly, taxol-treated cells forced to maintain in mitosis by addition 
of proteasome inhibitor, MG132, exhibit larger population of taxol-treated cells 
undergoing cell death (Fig 3.5). The last two points provide evidence that cells 
need to enter mitosis and stay in mitosis for initiation of cell death. 
The augmentation of taxol-induced cell death by MG132 is because of mitotic 
slippage, a term which describes cells arrested in metaphase anaphase transition 
and then escaping from the block. These cells exit mitosis without proper 
segregation of sister chromatids. Mitotic slippage occurs from degradation of 
cyclin B via a proteasome dependent mechanism (Brito and Rieder, 2006). 
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MG132 blocks the degradation of cyclin B, thus ensuring these population of cells 
that may escape mitotic block stays in mitosis and eventually undergo mitotic 
catastrophe.  
Besides, it was also found that the spindle checkpoint needed to be evoked for 
p73-dependent mitotic cell death. Silencing of Mad2 and Bubr1, which are 
inhibitors of APC, inactivates the spindle checkpoint, allows taxol treated cells to 
exit mitosis and abrogates mitotic cell death. However knockdown of Mad2 and 
Bubr1 in MG132 treated cells fails to protect the cells from mitotic cell death, 
because spindle checkpoint is maintained upon MG132 treatment (Fig 3.29). 
Moreover, treatment of cells with cytochalasin D, which blocks cells at late 
cytokinesis and does not induce the spindle checkpoint, did not lead to cell death 
(data not shown).  Thus, it is likely that the signal to initiate apoptosis comes from 
the mitotic machinery at the pro-metaphase stage where spindle checkpoint is 
active.  
 
5.2.2 p73, not p53 has a role in mitotic cell death 
One of the most important aspect of this work is that we have shown that mitotic 
cell death is specifically regulated by p73, not p53. This is despite their similarity 
is DNA binding domain and target genes. Significantly, it highlights differences 
in physiological function between p53 and p73. Many groups have shown that 
p73 is required for cell death induced by various means (Flores et al., 2002;Irwin 
et al., 2003;Lin et al., 2004). Studies comparing p53-/-p73-/- MEFs to p53-/-or p73-
/- MEFs also revealed that the double knockout MEFs were more resistant to death 
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than single knockouts (Flores et al., 2002), suggesting that both p53 and p73 can 
have roles independent of each other in regulating apoptosis. Further evidence of 
independent roles of p73 in tumor suppression is the development of different 
spectrum of tumors in p73+/- compared with p53+/- mouse (Flores et al., 2005). 
Indeed from our results, we have shown that p73, not p53 is required for mitotic 
cell death induced by spindle poison, Taxol, in both human cancer cells as well as 
murine fibroblasts. In fact, loss of p53 in human U20S cells augment cell death 
caused by taxol treatment (Fig 3.11). This finding is also confirmed by many 
other groups (Hawkins et al., 1996;Wahl et al., 1996;Vikhanskaya et al., 1998). 
This is believed to be due to the p53 role in post-mitotic checkpoint following 
spindle disruption (Lanni and Jacks, 1998). Spindle damaged cells, which escape 
mitotic block, arrest at a tetraploid G1 state by p53. Thus preventing the damaged 
cells from entering the cell cycle and the subsequent generation of aneuploidy 
cells. Our results confirm to the role of p53 in post-mitotic checkpoint, p53-/- 
fibroblasts that escape the mitotic arrest induced by taxol continue to progress 
onto the next cell cycle as evidence by the polyploidy population seen in the 
FACS profile of 72 hrs taxol treated p53-/- fibroblasts. Eventually, cells deficient 
for p53, after failing to arrest at the post mitotic G1 state, continue to 
endoreduplicate their genome, leading to apoptosis, mainly in the S phase (Minn 
et al., 1996).  
While we do agree that this mechanism is likely to have function to kill the 
aneuploid cells, we suspect a more simple answer to why removal of p53 sensitize 
cancer cells to mitotic cell death. At the time of measurement of cell death, 
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usually 24 hrs for cleaved caspase-3, the cells are unlikely to have progress to the 
second cell cycle stage yet. The increase cell death seen is likely to be due to the 
loss of cell cycle control bought about by the absence of p53, leading to shorter 
and faster cell cycle progression into mitosis.  
Besides the two above possible reasons, regulation of Plk2 by p53 could be 
another possible reason why loss of p53 sensitized cells to mitotic catastrophe 
(Burns et al., 2003). As silencing of plk2 sensitizes cells to apoptosis upon taxol 
treatment, it has been suggested that loss of p53 may reduce the levels of plk2 and 
thus increase cell death.  
Another angle to look at why only p73 regulates mitotic cell death and not p53 
could be the temporal manner, which they are activated. p73 is up-regulated early 
upon taxol treatment (around 6 hrs) which after it disappears. This implies that 
p73 up-regulation of Bim probably happen early before mitosis, to prime the cells 
for death. The idea is well supported by our data, which shows p73 binding to 
Bim promoter during G1/S phase of the cell cycle. While p53 is only up-regulated 
at later time points where it play an important role to maintain a post-mitotic G1 
checkpoint via up-regulation of p21. 
 
5.2.3 p73 regulate mitotic cell death induced by other factors 
Mitotic catastrophe can be induced not just be spindle poisons alone, but also by 
other means such as DNA damaging agents. Thus proving p73 plays a role in 
these forms of mitotic cell death, not just taxol induced cell death, is imperative. 
Indeed we are able to show that absence of p73 reduces mitotic cell death induced 
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by proteaosome inhibition, Plk1 siRNA and γ-irradiation (Fig 3.19, 3.20 and 
3.23). What is important is that the three means to induce mitotic catastrophe act 
on difference aspect of mitosis: MG132 works by preventing degradation of APC 
substrates, Plk1 siRNA works by preventing mitotic progression, γ-irradiation 
works by inducing DNA damage thus mitotic arrest, yet all depends on p73 to 
induce cell death. This suggests a common pathway utilized during mitotic cell 
death. The requirement of Bim in Plk1 siRNA induced and taxol induced mitotic 
cell death advocates the p73-Bim-caspase-9 activation cascade as the probable 
chief pathway used during metaphase associated mitotic cell death.   
 
5.2.4 Prolonged mitosis results in apoptosis 
A more interesting aspect of this work has been the discovery that prolonging the 
period of mitosis in cell can trigger apoptosis. The increased in length of time 
each cell spend in mitotic arrest is a common feature among all the stresses used 
to induce mitotic catastrophe. A normal cell only spend about an hour in mitosis 
every cell cycle while stressed cell can spend between six to twelve hours in 
mitosis. While it can be argued that mitotic cell death in Plk1 siRNA and taxol 
treated or γ-irradiated cells can be due to abnormal spindle formation or due to 
lost of additional functions due to absence of Plk1 or DNA damage, mitotic cell 
death still happen in MG132 treated cells which have normal bipolar spindle and 
aligned sister chromatids. The triggering of apoptotic cascade in these cells seems 
to be due to the prolong metaphase arrest cause by MG132 as addition of Purv A 
to induce mitotic exit in MG132 treated cells reduces the population of cells 
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undergoing apoptosis. Although, we cannot rule out other unknown side effects of 
MG132 could be triggering the apoptosis. Nonetheless, there are increasing 
supporting evidence such as knockdown of APC1, a major APC subunit, can 
cause mitotic arrest and trigger apoptosis, suggesting that prolong mitosis indeed 
can trigger cell death (Teodoro et al., 2004). The mechanism seems to be an 
internal timer clocking the length of time a cell spend in mitosis, whereby 
exceeding the limit of time will automatically trigger apoptosis. Some evidence of 
this hypothesis can be seen in Fig 3.9, entry of cells into mitosis at 12 hrs 
correlates with the cleavage of caspase-9 but not caspase-3, which is cleaved 
much later, around 20 hrs. This opposes the general belief that activation of 
upstream initiator caspases will result in immediate activation of downstream 
effector caspases. Our initial deduction was that cleaved caspase-9 could be kept 
inactive by some mechanism e.g. binding to IAPs linked to the timer of mitosis. 
Indeed a recent work showed that caspase-9 is kept inactive during mitosis by 
phosphorylation by cdk1. This phosphorylation gradually diminish over time due 
to APC independent cyclin B degradation, triggering apoptosis (Allan and Clarke, 
2007).   
 
5.2.5 Same phenotype but different mechanism 
Even as outcome of p73 and Bubr1/Mad2 knockdown in taxol induced cell death 
is the same, the mechanism of p73 and Bubr1/Mad2 in inducing cell death after 
taxol treatment is different. Bubr1 and Mad2 do not induce apoptosis per se rather 
their absence allows the mitotic arrest cells to prematurely exit mitosis, thus 
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saving the cells from apoptosis. Knockdown of Bubr1 or Mad2 allow the APC to 
function despite non-aligned chromosomes. However if the downstream of APC 
function is blocked e.g. by MG132, the knockdown of Bubr1 and Mad2 will have 
no effect as the net effect is still mitotic arrest. Thus mitotic cell death induced by 
MG132 cannot be prevented by Bubr1/Mad2 siRNA. p73, on the other hand, 
control a more downstream mechanism to induce  mitotic cell death thus siRNA 
of p73 protect cells from both MG132 and taxol induced cell death. 
 
5.2.6 p73 act upstream of apical caspase-9 
Although we have shown that in the absence of p73, caspase-9 cleavage is 
reduced, there are conflicting reports suggesting other initiator caspases may play 
a role in mitotic catastrophe (von et al., 2003;Castedo et al., 2004;Park et al., 
2004). Indeed siRNA of all three initiator caspases, -9, -8 and -2 reduce cell death 
caused by taxol treatment. However only caspase-9 cleavage is still apparent in 
caspase-8 and caspase-2 siRNA (Fig 3.33). Conversely, silencing of caspase-9 
results in absence of caspase-8 and caspase-2 cleavage bands, suggesting caspase-
9 act upstream of the other two initiator caspases (Fig 3.32). While this explain 
why caspase-9 is the apical caspase, the data does not explain why silencing of all 
three initiator caspases are able to reduce taxol induced cell death. It is likely that 





5.2.7 p73 regulate cytochrome c release independent of Bax 
As caspase-9 promotes mitochondrial-mediated apoptosis, we hypothesized that 
p73 would act upstream of the caspase-9 pathway. Indeed, it was not surprising 
when we found that cytochrome c release from the mitochondria, which is 
required for caspase-9 cleavage, was affected in p73-/- fibroblasts.  p53-/- cells 
treated with taxol released cytochrome c into the cytosol, which does not happen 
in p73-/- cells (Fig 3.34). The data demonstrates that p73 play an important role in 
cytochrome c release upon taxol treatment, thereby modulating mitotic death.  
Although cytochrome c release is proposed to be dependent on the translocation 
of the pro-apoptotic Bax to the mitochondria and on the Bax/Bcl-2 ratio, which is 
maintained by the anti-apoptotic and pro-apoptotic Bcl-2 family members (Willis 
and Adams, 2005) and over-expression of p73 have also been shown to regulate 
Bax translocation (Melino et al., 2004), our results, using confocal imaging and 
mitochondria fractionation procedures, suggest Bax translocation was not affected 
by p73 absence. The difference between our results and the over-expression 
studies on Bax translocation could be due to several reasons. Ectopic expression 
of p73 may up-regulate more target genes that perhaps aid in the Bax movement. 
The difference on Bax translocation can also be attributed to cell type differences. 
Lastly, our findings are based on endogenous p73 up-regulation by spindle 





5.2.8 p73 regulates Bim to prime cell for mitotic catastrophe 
Instead, p73 was found to regulate Bim to induce cytochrome c release from the 
mitochondria. Bim is a BH3-only member. It works by binding to anti-apoptotic 
members of the Bcl-2 family, thus allowing pro-apoptotic members Bax and Bak 
to promote MMP. This added regulation helps fine-tune the MMP process, 
preventing accidental release of cytochrome c. Bim was reduced in the absence of 
p73 upon taxol treatment, in contrast to p53-/- cells, suggesting that p73 was 
required for efficient Bim expression to induce mitotic death (Fig 3.38). Previous 
work has also shown that Bim is required for cell death induced by taxol (Bouillet 
et al., 1999), indicating that Bim could be a target for p73 in mitotic death. In 
addition, it is noted that exogenous expression of DNp73, a dominant negative 
version of p73, in cultured sympathetic neurons is able to suppress Bim 
expression (Lee et al., 2004). Together these data suggest p73 up-regulates Bim to 
induce mitotic cell death. Expectedly, over-expression of p73α or p73β led to the 
increase in bim mRNA, suggesting that p73 regulates Bim transactivation. Indeed, 
we are able to locate three p73 like binding sites along intron 1 of human Bim 
promoter. Subsequent ChIP experiments proof that p73 does bind to two of the 
p73 recognition sites. Interestingly, endogenous Bim are inactivated through 
binding to microtubules, only upon appropriate death signals such as spindle 
perturbations do Bim translocate to the mitochondria to perform its death function 
(Puthalakath et al., 1999). Together with the evidence that p73 get up-regulate 
early after mitotic stress, prompt us to hypothesis that perhaps p73 prime the cells 
before mitosis by up-regulating Bim. This p73 dependent Bim up-regulation do 
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not induce cell death, rather a second trigger is required for initiation of apoptosis. 
The second signal required to trigger apoptosis is suspected to be linked to the 
increased in the length of the mitotic phase bought about by mitotic arrest. Yet 
unknown regulation during prolong mitotic arrest could allow the continuous 
release of Bim to the mitochondria, thereby providing the opportunity for 
apoptosis to occur. However we do not rule out multi-level of regulation to 
control mitotic cell death. Work by another group has shown other mechanism, 
which is the mitotic dependent inhibitory phosphorylation of caspase-9, may be 
possible as well (Allan and Clarke, 2007).  
Physiologically, p73 protein level is highest during the G1/S phase of the cell 
cycle, which is also observed is Taxol treated cells. And indeed only during this 
phase of the cell cycle are we able to observe p73 binding to Bim promoter. While 
we did not observe concurrent increase in Bim protein levels, mRNA levels of 
Bim are up-regulated during this phase. This discrepancy could be due to post-
transcriptional regulation of bim mRNA that prevent premature translation of Bim 
protein. Nonetheless, it can be postulated that this up-regulation of Bim by p73 
during G1/S phase of the cell cycle is likely to help prepare the cells for a possible 
unsuccessful mitosis. The absence of Bim during later phases could be due to 
other regulatory elements, which may suppress/degrade Bim in the absence of 
Taxol. 
In addition to p73, Fox03a and E2F-1 has been shown to regulate Bim 
transcriptionally (Sunters et al., 2003;Hershko and Ginsberg, 2004). Fox03a 
especially have been shown to regulate Bim in response to taxol-induced cell 
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death. Although we have shown absence of p73 leading to decrease Bim levels, it 
is not clear whether Fox03a can replace p73 to regulate Bim during taxol-induced 
cell death. It is likely both transcription factors may be required to regulate Bim 
transcription. 
Unfortunately, we were unable re-sensitize p73-/- to taxol through introduction of 
Bim back to these cells as over-expression of Bim in known to kill the cells (Chen 
et al., 2005). Nonetheless, we shown that knockdown of Bim in H1299 cells 
behave similar to p73 silenced cells in their response to taxol as well as Plk1 
siRNA. Although the absolute values for cell death upon Bim knockdown are 
lower than that of control sample, the ratio between apoptotic cells in taxol treated 
and untreated cells is only slightly lower in p73 and Bim siRNA compared with 
control. Suggesting further complexity in role of p73 regulating Bim during 
mitotic cell death induced by taxol. Recent work have also shown a role of p73 
and Bim axis in regulating apoptosis in the absence of p53 (Amin et al., 2007). 
Overall our data strongly suggest p73 up-regulate Bim to promote mitotic cell 
death. 
In summary, we have shown that p73 plays an important role in regulating 
apoptosis during mitosis. This occurs via the activation of Bim, leading to MMP, 
release of cytochrome c and caspase-9 cleavage. Prolong mitotic arrest provides 
the necessary second signal that allows the manifestation of the priming effects of 
p73-mediated Bim activation. As many cancers have no or mutant p53, drugs 
targeting mitotic catastrophe and activating p73 can be used as an effective 
therapy. 
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5.3 Caspase-2S is a target of p73β 
The finding that ectopic expression of p73β can induce caspase-2S mRNA 
expression is rather surprising. Because caspase-2S is known to have anti-
apoptotic role (Wang et al., 1994;Ito et al., 2000) while p73β expression is known 
to induce apoptosis. This induction can be traced to a 22 bp site within intron 1 of 
the caspase-2 gene. This site lays 273 bp upstream of the caspase-2S transcription 
start site. Only β-variants of p73, not α-variants, p53 or p63 can activate the 
caspase-2S promoter activities. The regulation of caspase-2S by p73 require DNA 
binding activity of p73β and p73β binding to this site can be detected by ChIP as 
well as by in vitro DNA protein binding assay. Unfortunately, we were unable to 
find any physiological significance about this induction of caspase-2S by p73β. 
 
5.3.1 Induction of caspase-2S is specific to p73β isoforms only 
Caspase-2S expression can only be induced by p73β but not p53 and p63. All 
three p53 family members share similar DNA binding domain. Thus all three p53, 
p73 and p63 can activate a large subset of p53 target genes (Wang et al., 
1994;Jacobs et al., 2006). While we can argue that this could be because they 
only share similar DNA binding domain and the subtle differences may result in 
different affinity, it cannot explain why p73α, which also share the same DNA 
binding domain as p73β, cannot induce caspase-2S expression. The sterile alpha 
domain (SAM) domain present in p73α but not p73β has been shown to play 
inhibitory role in transactivation (Wang et al., 2001;Liu and Chen, 2005). As such 
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p73α generally show weaker transactivation ability compared with p73β. Perhaps 
this could be one reason why p73α do not activate caspase-2S.  
The ability of both full-length p73β and DNp73β to induce caspase-2S promoter 
activities is also rather surprising (Fig 4.8). This is because DNp73β lacks the N-
terminal transactivation domain (TA). TA domain is essential for transcription 
factors to recruit co-factors for transactivation of target genes. This suggest 
DNp73β have unique transactivation ability, not just functioning as a dominant 
negative protein to p73 and p53. This phenomenon has been also demonstrated by 
other groups which show DNp73 ability to regulate genes independent of p53 
(Kartasheva et al., 2003). Alternatively, DNp73β may recruit other transcription 
factors to help induce capase-2S promoter activity. Our ChIP and in vitro DNA 
protein binding assay is not sensitive enough to answer the possibility.  
Intriguingly, although ectopic expression of p73β is often used to show cell death, 
physiologically, p73β transcripts are not readily detectable (Yang et al., 2000). 
This suggests the function of p73β to induce caspase-2S may be physiologically 
relevant only under certain specific conditions. Or this induction, which can 
promote survival, may only be seen in specific situations such as certain cancers, 
which has been shown to over-express different p73 isoforms (Kovalev et al., 






5.3.2 p73β bind directly to the 22 bp site on Caspase-2S promoter 
The 22 bp site on caspase-2S promoter do not resemble the p73 consensus binding 
site. Instead, it contains a GC box, a putative binding site for Sp1 transcription 
factor. We speculate that p73β could either activate other factors, which bind to 
this site to activate the promoter, or act through Sp1 via direct or indirect 
interactions. Mutation of GC box and used of Sp1 siRNA maintain p73β ability to 
activate caspase-2S promoter, suggesting that p73β do not depend on Sp1 to 
activate the promoter (Fig 4.6 and 4.7). More interestingly, DNA binding 
defective p73β, both TA and DN-β isoforms were not able to activate the 
promoter. This suggests either p73β activate other factors to induce caspase-2S 
promoter or can bind to caspase-2S promoter directly. ChIP experiments, which 
show endogenous p73β and DNp73β binding to caspase-2S promoter (Fig 4.11), 
give evidence for the latter. In addition, in vitro 22 bp oligonucleotides and 
bacterial purified GST-p73β binding assay proof that p73β can bind directly to 
the caspase-2S promoter. Overall, revealing that p73β can directly sit on caspase-
2S promoter to induce caspase-2S up-regulation. 
 
5.3.3 Role of caspase-2S up-regulation by p73  
DNp73β is the variant of p73 dominantly expressed in the brain and sympathetic 
neurons (Pozniak et al., 2000). p73 knockout mice display severe defects in their 
nervous system including massive cell death, suggesting DNp73β plays an anti-
apoptotic role in the brain (Yang et al., 2000). Over-expression of DNp73β in 
sympathetic neurons was also able to rescue cell death resulting from nerve 
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growth factor withdrawal (Lee et al., 2004). Similarly, caspase-2S is highly 
expressed in the brain and over-expression of caspase-2S has been shown to 
protect cells from cell death induced by growth factor deprivation (Wang et al., 
1994). Using neuroblastoma Sh5y cell line stably expressing DNp73β, which 
express higher level of caspase-2S compared with pcDNA control Sh5y, we are 
able to show increase survival of these cells upon serum starvation compared with 
vector controls (Fig 4.9 and 4.13). Overall our data suggest that physiologically, 
DNp73β may act together with caspase-2S to protect neuronal cells from cell 
death induced by growth factor withdrawal. 
However we could not uncover any physiological role of the induction of caspase-
2S by p73β. If over-expression of p73β kills the cells, knockdown of caspase-2S 
should further increase cell death. However knockdown of caspase-2 did not 
modulate cell death induced by p73β over-expression. However we cannot rule 
out this could be because of concurrent caspase-2L silencing. Unfortunately, we 
are not able to generate functional siRNA targeting only caspase-2S. Because the 
only region, which the two caspases variant do not share, is the 5’ UTR of the 
caspase-2S, which is derived from caspase-2S exon 1. siRNA targeting 5’ UTR 
have a poor record of generating knockdown.  
Lastly, we cannot detect any increase in reporter activity upon p73 expression 
from full-length caspase-2 promoter. Only after truncating the promoter to retain 
the caspase-2S promoter region could increase in promoter activity by p73β 
expression be detected. This suggests repressor elements present upstream may 
interfere with the induction of caspase-2S by p73β. Perhaps only under specific 
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conditions or cell types will this induction of caspase-2S by p73β show any 
phenotype. 
 
5.3.4 Over-expression of p73 in cancers 
Although it is hard to conceive why a pro-apoptotic full length p73β would 
regulate an anti-apoptotic protein, caspase-2S, many clinical reports have shown 
that p73 full length is over-expressed in many cancer types (Kovalev et al., 
1998b;Zaika et al., 1999a;Hong et al., 2007). While it is unknown whether the up-
regulation of p73 in cancers are a cause or effect, our lab have shown that co-
expression of p73 with another proto-oncogene, c-jun, can promote cell growth 
and survival (Vikhanskaya et al., 2007; Toh et al., 2004). As with the case of 
caspase-2S up-regulation, ectopic p73β expression, in cooperation with c-jun, can 
up-regulate cyclin D1 expression. p73β was found to cooperate with c-jun to 
trans-activate cyclin D1 through an AP1 site, thus driving cell growth and 
survival. In addition, ectopic expression of p73β have been shown in our lab to 
block p53 suppression of telomerase activity in cancer cells (Toh et al., 2005), as 
the result, promoting cell growth and survival. Therefore under certain 
circumstances, it is possible for p73 to promote cell survival and growth. Overall, 
indicative that caspase-2S up-regulation by p73β could be yet another mechanism 











 Illustration 11: Overview of p73 functions. Summary of current research 
demonstrate both tumor suppressive functions as well as survival promoting 
functions of p73. 
 
5.4 Conclusion and future directions 
On the whole, my thesis has demonstrated two seemingly opposing functions of 
p73, in the regulating mitotic cell death and in the up-regulation of anti-apoptotic 
gene caspase-2S. While p73 pro-apoptotic role can be demonstrated in 
physiological settings i.e. unsuccessful mitosis triggering apoptosis, p73 anti-
apoptotic role of caspase-2S up-regulation can only be demonstrated under over-
expression conditions. This critical role of p73 is regulating mitotic cell death is 
important for maintaining genomic integrity, and its tumor suppressor role. 
However it will be premature to rule out up-regulation of caspase-2S by p73β as a 
biochemical phenomenon as many clinical studies have shown cancers expressing 
high levels of p73. Perhaps p73 may be a “janus” protein, taking on pro-apoptotic 
roles during normal development but assuming some anti-apoptotic potential 
during tumorigenesis. The role of p53 in regulation of G1/S DNA checkpoint and 
p73 in mitotic checkpoint suggests each p53 family member may be regulating 















for efficient killing of compromised cells. One suggested future direction can be 
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